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ABSTRACT 
Biosensor design utilizing particle-bound enzymes 
Cassi J. Henderson 
There is a clear need for affordable point-of-care diagnostics, especially in vulnerable 
low- and middle-income countries where access to laboratory-based testing is limited. 
This thesis explores whether recombinant protein technology in combination with a low-
cost support matrix could provide a basis for an inexpensive, simple, and robust 
production process for the bio-sensing element of a diagnostic that would be amenable to 
manufacture in resource constrained settings. Silica was selected as the solid support for 
this work, given its biocompatibility and wide-availability (including extraction from 
natural sources, like sand, as demonstrated here). 
By employing an affinity binding sequence for silica in fusion with the central assay 
reagent protein targeting the analyte, simultaneous isolation and immobilisation onto 
silica carrier particles was achieved directly from lysate. In addition, the incorporation of 
a coloured fluorescent protein in the fusion enabled the protein production and 
immobilisation to be followed visually without significant laboratory equipment.  
Diagnostic sensing activity was retained in the immobilised fusion proteins, even over 
two months at 20-22 ⁰C in a dried state. A comparable limit of detection was achieved 
with immobilised reagents as with the soluble form. Taken together with the reduced 
downstream processing attained by a one-step purification and immobilisation approach, 
this supports the use of particle-bound reagents in the development of point-of-care tests. 
To make use of the particle-bound reagents, a novel falling particle biosensor design was 
explored in this thesis, where the sedimentation of the silica particles was used to drive 
mixing in an otherwise stationary fluid compartment. The performance of this design was 
compared against two other formats commonly employed with bio-functionalised 
particles – (A) a simple suspension in a microcentrifuge tube and (B) a packed bed in a 
microfluidic channel. The falling particle device outperformed both formats. 
Overall, this work has demonstrated that the integrated functionality of the fusion proteins 
could facilitate a production pathway from raw material to end diagnostic, highlighting 
the use of silica as a protein carrier and presenting a novel biosensor format for utilizing 
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6H polyhistidine tag (6 histidines) 
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ABTS 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
ANOVA analysis of variance 
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FTIR Fourier-transform infrared  
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HIV human immunodeficiency virus 
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IPTG isopropyl β-D-1-thiogalactopyranoside 
IVD in vitro diagnostic 
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LMICs low- and middle-income countries 
LOD limit of detection  
mCh mCherry 
micro-CT micro computed tomography 
MS mass spectroscopy 
MBP magnetic binding protein  
NAA nucleic acid amplification 
NCD non-communicable diseases 
Ni-NTA nickel-charged affinity resin (nitrilotriacetic acid) 
PBR packed bed reactor 
PBS phosphate buffered saline 
PCR polymerase chain reaction  
PDMS polydimethylsiloxane 
pI isoelectric point 
PIV particle image velocimetry 
PMMA poly(methyl methacrylate) 
PMT photomultiplier tube 
POCT point-of-care test 
PPP purchasing power parity 
PSA prostate specific antigen 
QCM(-D) quartz crystal microbalance (with dissipation monitoring) 
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R5 silaffin tag 
RGB Red-Green-Blue channels  
RNA ribonucleic acid 
SA surface area 
SBP silica binding peptide/protein 
SC South Carolina, USA (sand source) 
SD standard deviation of the response 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis  
SOx  sarcosine oxidase 
ST Santorini, Greece (sand source) 
TEOS tetraethyl orthosilicate 
TGA thermogravimetric analysis  
TGP thermal green protein 
TMB 3,3’,5,5’-tetramethylbenzidine 
TPI total protein immobilised  
UK Southwold, UK (sand source) 
WHO World Health Organisation 
WT wild-type 
XRF x-ray fluorescence 
YFP yellow fluorescent protein 
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α statistical significance level 
A absorbance  
a active area between QCM electrodes 
b slope of the linear regression 
C concentration of the protein added to QCM 
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di particle diameter 
Ds substrate diffusivity 
ε millimolar extinction coefficient 
F0 frequency at the start of association/dissociation 
Fmax frequency shift observed from F0 to signal plateau 
Ft frequency at time t 
f0 resonant frequency 
Δf frequency change 
g gravitational acceleration 
h device height 
hA void volume of a packed bed reactor 
I fluorescence intensity of the sample 
I0 fluorescence intensity of the blank 
Istandard fluorescence intensity of the standard 
k parameter for Bonferonni correction  
ka association constant 
kcat enzyme turnover rate 
kd dissociation constant 
KD equilibrium dissociation constant 
Km Michaelis constant 
l pathlength  
m mass 
ηf dynamic viscosity 
ρf density, fluid 
ρq density, quartz (for QCM) 
ρs density, silica particle 
Pi quantity of product produced by settled particle of diameter di  
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Q volumetric flow rate through a packed bed 
S0 initial substrate concentration 
θp particle volume fraction 
θv void volume fraction 
ti time of settling for particle of diameter di 
tinver. time between inversions 
up relative velocity of the fluid to the falling particle 
us superficial velocity 
μq shear modulus, quartz (for QCM) 
v final volume of the assay 
V rate of product formation under kinetic control 
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1 INTRODUCTION 
 The need for affordable in vitro diagnostics  
Disease diagnosis is paramount for both individual case management of ill patients and 
for public health monitoring. For individual patients, diagnosis allows for the correct 
treatment to be given, hopefully improving prognosis. With respect to public health 
initiatives, widespread testing is necessary to accurately profile disease prevalence in 
order to measure the performance of prevention and treatment programs and inform future 
funding.  
Accurate diagnosis of disease makes use of clinical observation of symptoms and signs 
as well as diagnostic tests and procedures. However, in its study on increasing access to 
diagnostics in low- and middle-income countries (LMICs), the World Health 
Organization (WHO) reports that diagnostic tests are not affordable in these vulnerable 
countries where the burden of disease is highest [1]. The absence of affordable medical 
diagnostics undermines the cornerstones of effective clinical decision-making [2]. 
Clinicians often don’t have enough information, so syndromic or presumptive treatment 
is particularly common.   
The absence of diagnostic tests becomes particularly evident in the case of differentiation 
between viral and bacterial infections, a major cause of mortality in LMICs [3]. These 
infections present with similar febrile symptoms but require distinctly different 
treatments. Incorrect treatment not only hinders recovery of the individual but also is 
implicated in wider public health issues such as the rise of antibiotic resistance. The lack 
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of diagnostics is leading to unnecessary or inappropriate use of antibiotics and has been 
cited as the “Achilles Heel” in combating antimicrobial resistance [4,5].  
In LMICs, the conventional focus has been upon the control of communicable diseases, 
but chronic, non-communicable diseases (NCDs) account for more than half the burden 
of disease and the greatest global share of death and disability [6]. NCDs include 
cardiovascular disease, diabetes, cancers, degenerative and inflammatory conditions, 
affecting people of all ages, nationalities and classes. For many of these diseases, frequent 
monitoring and/or screening is key for improving survival, often assisted by diagnostic 
technologies. However, this beneficial monitoring is often lacking in LMICs. One 
illustrative example of the contrast with high income countries is the case of diabetes care 
in Mozambique; only 6 % of healthcare facilities could carry out a blood glucose analysis 
and personal monitoring with handheld blood glucometers is not available in general [7]. 
The contribution of NCDs to global deaths is predicted to rise over the next few decades 
[8,9], especially in LMICs. It is estimated that two thirds of new cancer diagnosis will 
occur in LMICs by the end of the next decade [10,11]. In cancer treatment, the need for 
early detection and triage is well established. For example, five year survival rates for 
localised prostate cancer (one of the leading causes of cancer death among men 
worldwide [12,13]) are nearly 100 %; however, this drops to ~ 30 % when the disease has 
become metastatic [14]. Unfortunately, early diagnosis programs are not affordable in 
LMICs, which acts as an impediment for surveillance and clinical management. 
The rewards for versatile low-cost diagnostics could be considerable with respect to both 
communicable and non-communicable diseases. It has been proposed that low-cost in 
vitro diagnostics (IVDs) in clinical practice can, in general, facilitate decision-making to 
guide management of the patient pathway with improved cost effectiveness [15,16].   
 Design requirements for diagnostics for resource-limited 
settings 
Traditional medical diagnostic testing is primarily done in centralised laboratory facilities 
with large and expensive analytical machines. However, access to laboratory testing 
facilities in LMICs is extremely limited [17]. Even where facilities exist, they are often 
under-resourced and under-staffed which lengthens sample processing times [18]. These 
turnaround times are too slow to influence the first response in patient treatment. 
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Point-of-care tests (POCT) offer an attractive alternative to laboratory based IVDs. 
POCTs are medical diagnostic tests that are performed outside the laboratory in close 
proximity to the patient and the delivery of care [19]. POCT tests have been developed 
that cover the range of IVDs – from immunoassay to small molecule to nucleic acid 
testing. Many of these detect the presence or quantity of the target substance using a 
biological component (e.g. proteins) in combination with physio-chemical transduction 
methods (electrochemical, optical, acoustic, thermometric, etc.) – i.e.  biosensor. Often 
POCTs are performed by nurses or other personnel without training in laboratory 
techniques. These tests should not require sample preparation and should have the 
reagents stored in the device. POCTs can be used stand-alone or with a user-friendly, 
dedicated analytical instrument, providing an integrated sample-to-answer solution. Most 
importantly, they have a short turnaround time to enable result-informed therapeutic 
action in that visit [20]. 
These characteristics make POCTs especially amenable to healthcare in LMICs. Enabling 
care in the same visit as the diagnostic test is critical, as patients may have walked several 
hours to reach the clinic. If asked to return for their test results, many will fail to do so 
[18]. Sample-to-answer solutions are even more important because of low levels of 
training and high demand on healthcare workers’ time [21].  
The environment of healthcare provision in LMICs imposes further constraints on any 
POCT (Figure 1.1). Especially in rural areas, healthcare is often provided in facilities with 
limited access to clean water and reliable electricity, if any at all [22]. Harsh 
environmental conditions such as extreme temperatures and dust make many technologies 
designed for controlled laboratory environments unreliable [23]. When they break down, 
technical support and repair options are extremely limited [24]. Often the supply chain is 
unreliable [25], and  can lack cold-chain storage, which cuts into the shelf-life of sensitive 
reagents [26]. Finally, with significantly smaller governmental healthcare budgets in 
LMICs [27], cost remains a significant factor in accessibility. 
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Figure 1.1 A diagnostic testing lab in a rural health centre. Image taken in Nyaishozi, Tanzania.  
In light of these challenges, the WHO has developed a framework for the design of 
POCTs, describing the ideal characteristics for use in resource-limited settings. POCTs 
should be A.S.S.U.R.E.D.: affordable, sensitive, specific, user-friendly, rapid & robust, 
equipment-free and deliverable to those in need [28]. These guidelines were developed in 
relation to tests for sexually transmitted infections, such as human immunodeficiency 
virus (HIV), but can be applied more broadly to POCTs intended for use in LMICs. 
 Potential for a local production approach 
There have been numerous attempts to propose low-cost diagnostics for LMICs that meet 
the A.S.S.U.R.E.D criteria using a variety of platform technologies (e.g. microfluidics 
[26,29], paper diagnostics [30,31], nanotechnology enhanced lateral flow assays [32]), 
however they remain at a high cost when examined in the context of the local economy. 
As a result, many of the IVDs that are available in LMICs are the result of international 
donors supporting disease-specific initiatives. The enormous value of these initiatives is 
seen, for example, in HIV and malaria testing [23], but tests need to become self-
sustaining [5], without charitable donor commitment. Furthermore, even in relatively well 
supported urban laboratories that have been equipped by investment from donors and 
non-governmental organisations, instrumentation sits idle since reagent and kit costs have 
rendered it beyond operating budgets [33].  
A workshop held during the Geneva Health Forum 2016 considered how to increase 
access to quality diagnostics in LMICs using social innovation [34], centring production 
around local communities [35]. However, even basic raw materials to achieve this vision 
have to be imported at too high a cost due to a lack of agreement between currency 
exchange rates and Purchasing Power Parity (PPP). PPP is an approach that compares the 
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currencies of two countries through the relative price of the same bundle of goods [36], 
allowing a comparison of costs adjusted for the in-country purchasing power of a unit of 
currency. For example, the polymerase for a nucleic acid diagnostic is at nearly the same 
cost price in the Philippines as in US and Europe (> 80 %), despite the average household 
income being 80-90 % lower [37]. As a result, the development of local enterprises and 
infrastructure for diagnostic technologies in LMICs is not competitive [23]. Often the 
locally produced product, even when marketed at an unsustainable small margin, would 
still be more expensive than the imported finished (unaffordable) product [38]. There is 
a need to consider a different approach that doesn’t presume the use of expensive off-the-
shelf reagents. Innovation is therefore required to empower LMICs, through local 
production, without subsidies or major infrastructure investment [39–41]. 
Specifically, enabling the local production of the required biological reagents (e.g. 
enzymes, antibodies) for POCTs could be significant step as this can be the largest 
proportion of the total cost of a device [42]. Production methods vary dependent on the 
biological reagents required, which vary with the type of diagnostic test. For example, 
immunoassays require antibodies specific to the pathogen antigen, small molecule assays 
require enzymes that act upon the target substrate, and nucleic acid assays require 
polymerases to amplify the DNA/RNA of interest in the sample. Antibodies are often 
harvested from the serum of host animals exposed to the antigen, a resource intensive 
process. Certain enzymes can also be derived from animal sources, while others can be 
extracted from plants; however, the seasonal and/or geographical nature of plant growth 
limits the utility of plants as a source. Production in microorganism hosts like E. coli is 
an increasingly popular approach especially with the advent of recombinant technology 
for the production of enzymes or other proteins not naturally produced by these organisms 
[43]. All of these production processes have typically required extensive know-how and 
large capital investment in equipment.  
Recent reports have recognized the need for decentralised bio-manufacturing, especially 
in remote locations with limited infrastructure. Some have proposed microfluidic systems 
to automate the various steps of the process over a smaller footprint (e.g. [44,45]), while 
others have demonstrated magnetic nanoparticle-based systems for simplifying the 
purification step from crude cell lysate (e.g. [46–48]); however, these lab-on-chip and 
nanoparticle-based approaches have complex fabrication requirements. Alternatively, 
Pardee et al. have proposed portable, on-demand bio-manufacturing using cell-free 
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production technology and demonstrated the approach for a range of proteins, including 
antimicrobial peptides, enzymes and antibody conjugates for vaccines, in a proof-of-
concept study [40]. From a production perspective, cell-free expression has the advantage 
that encoding DNA sequences and corresponding expression parameters can be rapidly 
screened for utility in the absence of the cell wall. Freeze-dried cell extracts have also 
been incorporated into diagnostic platforms such that the bio-sensing protein is produced 
in situ [49,50]. While freeze-dried cell-free extracts potentially support distributed 
manufacturing with their lack of requirement for cold-chain distribution, the production 
of the extracts still requires much of the same specialised and costly equipment as 
classical protein production [51].  The challenges in extract production and the ensuing 
high cost of cell-free reagents remain as major barriers to the widespread implementation 
of this approach [52,53].  
Despite classical production with microorganisms requiring significant capital and 
knowledge resources, molecular biology can be harnessed to bypass many of the normal 
steps in producing, isolating and integrating the biological element of the diagnostic 
device. The rise of “Garage Biotech” where do-it-yourself scientists, with limited 
experience, have successfully produced proteins without conventional laboratory 
resources [54] supports the applicability of a molecular biology approach for production 
in resource-limited settings without highly trained personnel.  
With a molecular biology approach, protein engineering techniques can be used to 
integrate multiple functionalities into a single fusion protein produced by bacterial hosts. 
The protein providing the desired assay functionality can be genetically fused with 
peptide tags having specific affinity for low-cost materials that can act as the stationary 
phase in purification from the remainder of the material produced by the host organism. 
While the classical method of protein purification uses a peptide tag (poly-histidine, often 
referred to as His-tag), the necessary ligand modification of the resin surface to enable 
affinity with the His-tag makes this method expensive, estimated at $ 2 per mg of purified 
protein [55]. Alternative peptide tags have been developed that have affinity for cheaper 
purification matrix materials and don’t require additional modification steps. Peptide tags 
have been identified with affinity for organic materials (e.g. graphene oxide [56], carbon 
nanotubes [57], cellulose [58]), metals (e.g. Au [59–61], Ag [62,63], and oxides (e.g. 
TiO2 [64,65], ZnO [66,67], Cu2O [68], SiO2 [69,70]). Given that purification costs are 
primarily associated with the price of the stationary phase [71], the support material 
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should be low-cost and widely available in order to be amenable to local production of 
low-cost diagnostics. Silica (SiO2) fits this description and has a history of use as a low-
cost substrate for biosensor design given its biocompatibility [72–74]. In addition, it is 
easily extractable from local materials (e.g. sand [75,76], rice husk, bamboo leaves, 
sugarcane bagasse [77], iron slag [78]), making it a good choice as an initial platform for 
a local approach. 
Not only is the inclusion of a peptide tag key for purification of the target protein, but it 
can also have a secondary function – immobilisation of the assay reagent without 
additional steps. Immobilisation has been shown to add retention of enzyme activity and 
increase enzyme thermal stability [79–81], critical features in the shelf-life of a diagnostic 
test. In addition, using the immobilised version of the enzyme in the diagnostic device 
eliminates several steps in the production process, e.g. the need to purify the target protein 
from the agent used to displace it from the affinity matrix and the need to remove the 
affinity tag. Simultaneous purification and immobilisation is proposed to reduce the total 
work effort and cost of the process [79,82]. 
Traditional methods of immobilisation to a support surface include entrapment within a 
gel/polymer matrix, adsorption-based methods via a range of intermolecular forces or 
covalent attachment using chemical reagents [83,84] (Figure 1.2). Entrapment is a 
classical strategy for enzyme immobilisation in catalysis and has been explored 
extensively, however, the limited rate of diffusion of the substrate to the entrapped 
enzyme can reduce the apparent activity of the enzyme. Alternatively, chemical surface 
modification can be used to unite the bio-sensing element with the solid support. Common 
covalent surface modification strategies include carbodiimide or glutaradehyde coupling, 
however, these require the target proteins and support materials to undergo multiple 
modification steps and require additional chemical reagents which would be unlikely to 
be locally sourced. In addition, chemical modification to achieve immobilisation can 
cause protein degradation or in the case of enzymes, block the active centre or result in 
the enzyme orientation being incorrect for reaction with its substrate [85]. Multi-point 
attachment and resulting rigidity can be another challenge [86]. Another common strategy 
to achieve surface immobilisation is coupling via high-affinity pairs, such as 
streptavidin/biotin or antibody/antigen couplings, where one component is fused with the 
bio-sensing element and the other onto the support material surface [56,87]. Although 
one-half of the pair could be expressed as a genetic fusion with the target protein, this 
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strategy still requires attachment of the other half of the pair to the solid matrix, often 
using similar chemistry mentioned above. In general, these approaches require already 
purified proteins. Opting instead to use peptide tags that are incorporated with the 
functional assay protein during the production process but that bind directly with the 
target support material via intermolecular forces can reduce complexity and cost. In 
addition, using peptide tags can achieve oriented immobilisation that can result in less 
conformational changes than direct association of the protein and the substrate [88], and 
generally results in higher activities relative to random immobilisation [80].  
 
Figure 1.2 Common immobilisation strategies to join proteins with solid-support materials.  
By designing the biological reagent through recombinant protein technology, additional 
functionality can be incorporated into the protein. Not only can the fusion protein contain 
the functional assay protein and a built-in purification and immobilisation tag, but also a 
‘visualisation’ protein (e.g. fluorescent protein) can be incorporated (Figure 1.3). This 
element of the fusion could facilitate visual monitoring of the production and isolation 
without a laboratory infrastructure and provide a reference measurement in the final 
diagnostic. The integrated functionality in the fusion protein, which would normally be 
fulfilled through separate materials and/or procedures, could reduce production steps and 
facilitate an integrated pathway from raw material to end diagnostic.  
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Figure 1.3 Schematic of the silica-immobilised fusion protein showing the three functional elements. 
 Research Aims 
There is a clear need for versatile affordable POCTs with respect to both communicable 
and non-communicable diseases, especially in vulnerable LMICs where access to 
laboratory-based testing is limited. There have been numerous attempts to propose low- 
cost diagnostics for LMICs that meet the A.S.S.U.R.E.D criteria, however, there is a need 
to consider a different approach that doesn’t presume the use of expensive off-the-shelf 
reagents and looks to empower low-income countries, through local production, without 
subsidies or major infrastructure investment. Specifically, enabling the in-country 
production of the required biological reagents (e.g. enzymes, antibodies) for POCTs could 
be significant step.  
The overall goal of the research was to explore whether recombinant protein technology 
in combination with a low-cost support matrix could provide a basis for an inexpensive, 
simple, and robust production process for the bio-sensing element of a diagnostic. The 
approach was to merge protein purification and immobilisation into a single step and 
integrate the resulting bio-functionalised particles directly into an assay format. This 
thesis is focused on the use of silica as the low-cost support matrix due to its abundance 
and biocompatibility.  
In line with the above goal, the objectives of this work were as follows: 
 To evaluate the potential of silica, including silica extracted from a natural 
resource, as the stationary phase for the purification and immobilisation of 
designer fusion proteins containing peptide affinity tags 
 To investigate the retention of activity by the silica-immobilised proteins and to 
test their potential sensing capability 
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 To explore a novel design for a biosensor using bio-functionalised silica as the 
mobile phase in conjunction with theoretical modelling of the kinetic and mass 
transport rates for the bio-functionalised particles 
 To compare the sensing performance of a range of simple, low-cost biosensor 
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As described in Chapter 1, enabling the local production of the required biological 
reagents (e.g. enzymes, antibodies) could be a significant step towards affordable 
diagnostic testing. By designing fusion proteins through recombinant protein technology, 
additional functionality can be incorporated into the biological reagent, including a built-
in purification and immobilisation peptide tag. Simultaneous purification and 
immobilisation bypasses many of the normal steps in isolating and integrating the 
biological element of the diagnostic device, but to be amenable to local production, the 
stationary phase must be a low-cost and widely available material. A material that fits this 
description is silica, or silicon dioxide (SiO2).   
Silica has a history as the stationary phase in purification techniques as silica gel is a 
commonly used resin in column chromatography because of its mechanical strength, 
easily controlled particle size and porosity, and low cost [89]. However, it has been 
primarily used as the backbone for functionalised analytical and preparative 
chromatography resins rather than used directly. The use of unmodified silica gel has 
previously been explored for both lab and for process-scale purification (e.g. for insulin-
like growth factor-I and related proteins [90]) but examples are limited.  
This chapter will look to evaluate the potential of unmodified silica as the stationary phase 
for the purification and immobilisation of designer proteins. Silica particles can be 
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obtained via a range of synthesis processes (Section 2.1.1), including extraction from 
natural resources which could be available locally in LMICs. One such source, sand, will 
be investigated and the resulting product characterised and compared to industrially 
produced silica. The interaction between silica and proteins is mediated via a range of 
intermolecular forces and is influenced by both the surface composition of the silica and 
the amino acid residues of the protein (Section 2.1.2 and Section 2.1.3). Peptide tags with 
specific affinity for silica harness these interactions and can provide specific and oriented 
immobilisation when genetically appended to proteins of interest. There are a range of 
options for silica binding peptides/proteins (SBPs) (Section 2.1.4), one of which will be 
evaluated in this work. The peptide tags are appended to fusion proteins incorporating the 
bio-sensing element for the diagnostic. A model assay system (Section 2.1.5) will be used 
to investigate the retention of diagnostic activity by the silica-immobilised fusion 
proteins.  
2.1.1 Sources of silica 
Silica is the most abundant material in the earth’s crust [91] where it exists in several 
crystalline phases (quartz is the most common). It can also exist in an amorphous form, 
as is the case for most synthetic production processes. At an industrial scale, silica is 
produced by either a gas phase process of pyrogenic flame hydrolysis resulting in fumed 
silica or by a wet process resulting in silica gel or precipitated silica. Silica gel is an 
amorphous form of SiO2 with variable porosity and is made via a sol-gel reaction with 
sodium silicate and mineral acid, such as sulphuric or hydrochloric acids. The monomers 
polymerize first into particles and then into 3-dimensional networks, the properties of 
which can be adjusted based on reaction conditions (e.g. pH). Silica gel particles of 
various diameters and pore sizes are widely available. Precipitated silica is formed using 
similar reactants but under higher temperatures. As a result, precipitated silica has 
minimal porosity. Both types of silica are washed, dried and milled to the appropriate size 
range [92].  
Another sol-gel technique, known as the Stöber process, is commonly used to fabricate 
silica nanoparticles where controllable and uniform size is desired [93]. Here, the 
precursor tetraethyl orthosilicate (Si(OEt)4, TEOS) is hydrolysed in alcohol (typically 
methanol or ethanol) and ammonia is used as a catalyst. Biomimetic silica formation from 
monosilic acid (generally hydrolysed TEOS or tetramethoxysilane) follows a similar 
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process but occurs under aqueous conditions where peptides with high affinity for silica 
act as the catalyst [94,95].  
Silica can also be easily extracted from a variety of natural sources. Sand is often used as 
source as silica makes up a large fraction of the material (> 90 % in some sands) 
[75,76,96] but clay can also be used as a source  [97]. Agricultural waste products, after 
an initial high-temperature sintering step to form ash, can be used to produce silica with 
varying degrees of success (rice husk > sugarcane bagasse > bamboo) [77]. Other waste 
products such as glass bottles [98] and iron slag [78] can also be used for silica extraction. 
Typically, silica extraction from sand and other sources follows a process of alkali 
treatment and subsequent acidification (Figure 2.1). The silica source can be combined 
with sodium hydroxide (NaOH) in either a dry or hydrothermal process, and NaOH reacts 
with SiO2 in the source to form sodium silicate. The sodium silicate that forms is soluble 
in water and dissolves when the mixture is washed. Any remaining solid material is 
removed by filtration. Acidification of sodium silicate (Na2SiO3) in the filtrate with 
sulphuric acid (H2SO4) produces silicic acid which readily decomposes to silicon dioxide. 
Other strong acids such as hydrochloric acid (HCl) can also be used in this step (as done 
by Munasir et al. [75] and Arunmetha et al. [76]). Final wash steps and drying produces 
a precipitate. This process produces largely amorphous phase SiO2, although Munasir et 
al. observed a small amount of crystalline phase in their production of silica nanoparticles 
from sands [75]. Provided the common acids and bases required for extraction of silica 
are accessible, the production of the support phase from locally-available natural 
resources could be advantageous for the in-country production of diagnostics, as it could 
remove dependence on an additional foreign-supplied reagent.  
SiO2 + 2NaOH → Na2SiO3 + H2O 
Na2SiO3 + H2SO4 → SiO2 + Na2SO4 + H2O 
Figure 2.1 Reaction steps for the extraction of silica from sands 
Whether extracted from natural sources or produced industrially, the utility of unmodified 
silica as the stationary phase for purification and immobilisation will depend on the 
binding affinity of proteins for the silica surface. This is influenced by the composition 
of the silica surface [99,100].  
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2.1.2 Composition of the silica surface 
In amorphous SiO2, silicon atoms are coordinated to oxygen atoms in a tetrahedral 
arrangement through siloxane bonds. The surface of the material contains these siloxane 
groups, usually considered to be hydrophobic [101], and unreacted hydroxyl groups 
called silanols (Si-OH). These have been shown to exist in various forms - isolate (single), 
geminal (silanediol), or vicinal (H-bonded), each with a distinct pKa value (Figure 2.2). 
These groups determine the ionisation state of the silica surface in aqueous solution as a 
function of ionic strength and pH. Above pH ~3, these silanol groups start to become 
deprotonated, resulting in siloxide groups (SiO-) and an increased negative charge on the 
surface [91]. For example, Puddu et al. have shown that the degree of ionization of 80 nm 
SiO2 nanoparticles fabricated in a Stöber process increases from 9 % to 18 % to 50 % at 
pH 5, 7.4 and 8.5, respectively [102]. The degree of surface ionisation along with the area 
density of the silanol groups and the prevalence of different types (single, vicinal, 
germinal) all influence the surface properties of silica in aqueous environments. 
 
Figure 2.2 Types of silanol groups and siloxane bridges on the surface of amorphous silica. 
The density and degree of ionization of the silanol groups depends on the synthetic origin 
and thermal history of the silica [102,103]. While the chemical composition is essentially 
the same (SiO2), silica produced under hydrated processes like sol-gel have an 
approximately 4–fold higher density of silanol groups compared with fumed silica [104]. 
Similarly, the surfaces of biomimetic silica structures are highly hydroxylated while 
thermally grown films made under dry oxidation have low hydroxyl content [74]. Even 
among silica types produced with a wet process, differences in ionization state are 
observed [100]. For example, at pH 7.5 and 0.1 M ionic strength, silica sol is reported to 
have 0.21-0.56 siloxide groups/nm2 [105–107] compared to 0.56-1.0 siloxide groups/nm2 
for precipitated silica [108,109]. The effect of silica type on binding affinity, and thus the 
effect of surface composition, is evident in the lack of convergence between peptide 
sequences selected from combinatorial libraries for their affinity for different silica types 
(e.g. biogenic silica [110], thermally grown silica [74], and quartz powder [111]). 
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However, binding interactions are complex and depend not only on surface properties but 
also on the binding environment and nature of the binder, in this case proteins.   
2.1.3 Nature of the silica-protein interaction 
Experimental and computational studies about the interaction at the interface between 
peptides and silica reported that several forces were implicated in the process 
(electrostatic and van der Waals forces, hydrogen bonds and hydrophobic interactions) 
[16,18,21,27,28]. While silica surface charge is dependent on the synthetic origin and 
thermal history of the silica, the surface charge of proteins is determined by their exposed 
amino acid residues. Although proteins often display multiple positive and negatively 
charged surface patches [112], their overall electrostatic nature is described by their 
isoelectric point (pI) or the pH at which the protein’s net charge is zero [113].  
The interaction between electrically charged bodies can generally be described by the 
Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory [114–116]. The DLVO theory 
considers two types of forces: the electrical double-layer repulsion and the van der Waals 
attraction. (In the case of silica-silica interactions, this theory has been extended to include 
hydration forces to help explain the short range repulsions observed between silica 
surfaces [117,118].) The electrostatic interactions are on dependent the pH and ionic 
strength in the medium, and the degree to which they affect protein adsorption is 
dependent of the role electrostatics plays in adsorption [119]. For instance, increasing 
ionic strength (and thus increasing shielding of the surface charge [119]) increased the 
adsorption of bovine serum albumin (BSA) onto fused silica at high pH (pH > pI) where 
surface and protein had like charges, but had little effect at low pH (pH < pI) where they 
exhibited opposite charges [112]. In contrast, short-range interactions (e.g. hydrophobic) 
are largely independent of the ionic strength [112,117], provided changes in pH and ionic 
strength don’t significantly affect protein conformational stability [119]. 
A neutral or basic pH the negative charge of the ionized silanols attracts positively 
charged species by electrostatic forces [74,91,100]. This includes basic side chains (e.g. 
lysine (Lys, K), arginine (Arg, R)) as well as the N-termini of peptide chains, all of which 
are protonated at neutral and basic pH (pKa > 7). Under such conditions, protein 
adsorption on a silica surface is expected to be entropically driven by the release of water 
molecules and sodium ions on the surface [74,120]. 
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While electrostatic forces are expected to dominate for cationic peptides containing these 
residues, adsorption was also observed at low pH (i.e. 3.0) [102], suggesting simultaneous 
H-bonding and van der Waals interactions are also important, especially when the surface 
is less charged. The importance of these interactions is supported by the adsorption of 
non-cationic peptides (containing serine (Ser, S) and aspartic acid (Asp, D) residues) onto 
silica surfaces [100]; however, these peptides show a preference for heat-treated silica 
(where there is a loss of hydroxyl groups) and have a higher minimum threshold 
concentration for adsorption [102]. The higher the theoretical pI of the peptide, the lower 
the threshold concentration, suggesting more positive peptides have a higher affinity to 
silica under physiological conditions.  
Similar trends are also observed for the interaction of larger protein structures with silica 
[121]. For instance, Ghose et al. investigated the suitability of unmodified silica as a 
stationary phase for protein purification (without an affinity tag) and found a correlation 
between the mechanism of retention on silica (electrostatic vs. hydrophobic, or some 
combination) and the molecular properties of the proteins (pI and surface hydrophobicity) 
[89]. Both electrostatic and hydrophobic interactions were shown to be significant for 
those proteins that were cationic and hydrophobic in nature, while hydrophobic 
interactions were shown to be dominant for anionic but hydrophobic proteins. While this 
knowledge can be exploited for specific selection of target proteins, it does not lend itself 
to a widely applicable purification and immobilisation process. In addition, there is a risk 
of protein denaturation if the interaction with the surface is too strong [122].  
Alternatively, a peptide tag with affinity for silica can be genetically appended to the 
target protein. This would enable a range of proteins to be amenable to purification on 
silica, rather than requiring specific characteristics to be present for good retention times 
(as explored in  [89]). In addition, using peptide tags can achieve oriented immobilisation 
that can result in less conformational changes than direct association of the protein and 
the support [88], and generally results in higher activities relative to random 
immobilisation [80]. This might help preserve the function (e.g. enzymatic activity) of 
fusion proteins during immobilisation. There are a range of options for silica binding 
peptides/proteins (SBPs), a review of which will be presented in the next section in order 
to select a tag for inclusion in the fusion proteins.  
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2.1.4 Silica binding peptides  
A variety of SBPs have been used in purification and/or immobilisation applications in 
conjunction with other functional proteins. Given the retention of functionality in the 
fusion protein is key for a diagnostic reagent, this review will focus on those proteins and 
peptides for which genetic fusion to target functional proteins has been demonstrated with 
retention of functionality. These peptides and their sequences can be found in Table 2.1. 
Peptide sequences with affinity for silica (and for driving silica precipitation) have been 
identified from organisms in nature (e.g. L2 protein [122],  CotB1 protein [123], R5 
peptide [124]). L2 is a bacterial 50S ribosomal protein from E. coli [122] and CotB1 is a 
spore coat protein from B. cereus that mediates the accumulation of silica [123]. The R5 
peptide is a synthetic subunit of the silaffin protein from the diatom Cylindrotheca 
fusiformis (one of seven highly homologous repeating units [124]). SBPs have also been 
identified synthetically from combinatorial phage or cell-surface display libraries 
[71,110,111,125] and created through intentional design [126]. The Car9 peptide was 
originally identified through cell-surface display technology for its affinity for graphitic 
materials [127]. The poly-arginine tag, with nine arginine residues (poly-Arg, R9), was 
originally designed as a tag for use with cation exchange chromatography resin given 
arginine was expected to bind strongly to a cation exchanger as the most basic amino acid 
[126]. Both Car9 and poly-Arg have been subsequently shown to have affinity for silica 
[71,128,129].  
The interaction of SBPs with silica is thought to be primarily driven by electrostatic forces 
at physiological pH [102], where their positively charged residues (K and R) interact with 
the silanol/siloxide groups on the silica surface [102,121,130]. For the large SBPs, L2 and 
CotB1, regions rich in positive residues are thought to drive their interaction with silica 
(see Table 2.1 for sequences). Silica binding domains were found at both the N- and C-
terminal regions of L2 (1-60 aa and 203-273 aa) [122] whereas the middle section is 
known to be the RNA binding domain [131]. These protein fragments demonstrated 
dissociation constant (kd) values that were ~20 fold higher than the L2 protein in its 
entirety (when fused to the N-terminus of green fluorescent protein (GFP) in all cases) 
[122]. In the case of CotB1, its C-terminal region with five arginine and three serine 
residues, labelled CotB1p, is expected to drive the interaction with silica [123]. The 
shorter peptide tags (Car9, R5, poly-Arg) are also expected to have similar electrostatic 
interactions of their positive residues with the negative silanol groups.  
Biosensor design utilizing particle-bound enzymes 
18   
While electrostatic forces are expected to dominate, simultaneous H-bonding, van der 
Waals and dipole-dipole interactions are also suggested to be involved, as discussed 
above in Section 2.1.3. For example, hydrophobic contacts between the central 
phenylalanine and siloxane groups were proposed in the interaction of the Car9 peptide 
with the silica surface [71].  
Table 2.1 Silica binding tags and their use cases. 
Tag name Origin Amino acid residues Use case 
L2 
Bacterial 50S 
ribosomal protein of E. 
coli 












(silicon oxidized to 
silica for biosensor) 
[122] 
Purification [132] 




B. cereus spore coat 
protein that mediates 
the accumulation of 
silica 
Total length: 171 residues 
 Silica-binding regions: 
C-terminal (see below for residues)  
Purification [123] 
CotB1p 
C-terminal region of 
CotB1 












appended cargo [135] 
R5 
Repeat unit from 
silaffin polypeptide of 






added cargo [95] 




by encapsulation [140] 
poly-Arg n/a RRRRRRRRR (9) 
Directed adsorption 
onto glass slide [128] 
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Unlike some affinity tags that require proper folding for binding interactions (e.g. maltose 
binding peptide), some SBPs (L2 and Car9) have been used for affinity purification on 
silica under denaturing conditions [129,133] as well as under native conditions [71,132]. 
In addition, the silica binding regions of the L2 were unable to be crystallized, suggesting 
a non-organized structure that interacts with large area of silica surface [122,132]. This 
lack of structure has also been predicted for other tags; modelling in silico of the R5 
sequence gave highly varying models and was unable to predict a meaningful end to end 
distance, indicating that R5 in isolation is highly flexible [141]. Moreover, although Car9 
was originally identified in a disulphide-constrained loop confirmation, a linear version 
has also been shown to have high affinity for silica [71]. Together this suggests that the 
mechanism of binding is generally independent of 3-dimensional structure for the SBPs.  
SBPs have been genetically appended to a variety of functional target proteins for the 
purposes of affinity purification with silica gel, immobilisation on solid surfaces (e.g. 
glass) and/or encapsulation in the presence of silica precursors (See Table 2.1). In some 
cases, the overall pI of the protein may be < 7 after fusion, as in the case of CotB1p (pI 
of 12.6) with fluorescent proteins GFP and mCherry (mCh) (pIs of 5.3-6.8, respectively). 
However, good binding was still observed, which suggested that positive tags can interact 
with negative silica even when the overall charge of the fusion protein is negative [123]. 
This is encouraging for the peptide tag approach to be applicable to a variety of functional 
proteins with a range of pIs. 
The SBPs were observed to retain their affinity for silica and/or silica precursors when 
fused as tags to either the N- or C-terminus of target proteins [71,122,128,129,132,140]. 
Nevertheless, the choice of terminus for the tag will largely depend on the protein of 
interest and how the position of the tag affects function [140]. Functional proteins joined 
with SBPs included fluorescent proteins (GFP, mCh, yellow fluorescent protein (YFP)) 
[122,123,129,140], enzymes (e.g. B-lactamase [129], luciferase [122], RNAase A [128]) 
and proteins with binding capacity for secondary coupling to other proteins (e.g. maltose 
binding protein [129], protein A [132], biotin acceptor protein/AviTag [133]). 
Functionality (e.g. fluorescence, enzymatic activity) was largely retained in the expressed 
fusion constructs. Where tested, functionality was retained after immobilisation of the 
fusion constructs on silica surfaces or after encapsulation, though a slight reduction was 
observed in some cases [122,128]. In general, the interaction of silica and proteins has 
the advantage of mild reaction conditions that enables good retention of activity [94,136]. 
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When used for affinity purification purposes, CotB1/CotB1p, L2, Car9 and R5 were all 
shown to have comparable purity and yield to conventional affinity purification 
techniques, including the His-tag [55], under native conditions. The electrostatic 
interactions of SBPs could be disrupted to release the fusion proteins from the silica gel 
matrix. For example, L2 was released from the silica by ion exchange effect under high 
concentrations (2 M) of the divalent cation MgCl2 [132], while Car9 and R5 were released 
by high concentrations of the amino acid lysine [71,129,140]. Several examples also 
included regions for site-specific cleavage between the SBP and the protein of interest in 
order to release target proteins from the affinity tags in the event that a protein with a 
(near) native sequence is required (e.g. with small ubiquitin-like modifier [123], tobacco 
etch virus and OmpT [71,129] protease-excisable linkers). However, these examples of 
affinity purification presumed removal of the target protein from the solid support was a 
prerequisite for the development of useful purification schemes, unlike the approach of 
simultaneous purification and immobilisation to be considered in this work.  
After purification (either on silica gel or on nickel-charged affinity resin (Ni-NTA) using 
a classical His-tag approach), SBPs have also been used in ‘biomineralisation’ strategies 
to encapsulate proteins in a sol-gel like, ‘one-pot’ process at room temperature [135], 
especially R5 [94,136]. (R5 has also been used in co-precipitation as well as genetic 
fusion strategies, however, ~15 times greater concentration of R5 was needed with the 
co-precipitation approach [139]). SBPs have also been used to immobilise functional 
proteins on solid silica surfaces, mainly glass substrates via simple dropcasting [128] or, 
in one example, via a micro-contact printing process for controlling the pattern of the 
immobilised protein [134]. The enhanced binding (compared to without the tag) enabled 
retention during wash steps. This also enables the removal of any proteins bound through 
non-specific interactions during purification, which will be important for a diagnostic 
reagent.  
Although all of the above SBPs have demonstrated affinity for silica, not all are equal 
when it comes to selection for inclusion in a fusion construct intended for the local 
production of the bio-sensing element for a POCT. For instance, the large size of L2 and 
CotB1 is a disadvantage for expression. Large tags require more metabolic energy during 
overproduction than small tags [142]; for example, higher expression levels were 
observed for CotB1p (14 aa) fused constructs compared to those fused with CotB1 
(171 aa) [123]. Large tags also tend to drive the formation of inclusion bodies when 
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expressed in E. coli, complicating the cell lysis step prior to purification/immobilisation 
step [123]. In addition, L2 is intrinsically expressed by E. coli, which could result in 
competition of the native form with the fusion construct for surface binding sites under 
low levels of induced expression [132]. 
In contrast, poly-Arg, Car9, CotB1p, and R5 are all short peptide extensions that are easily 
added to either terminal of the target functional protein. While poly-Arg does exhibit 
affinity for silica surfaces, the strength of the interaction was 1-2 orders of magnitude less 
than L2 and some slow release was observed, indicating it may not be suitable for the 
intended immobilisation application [122]. Compared to R5, Car9 fused to fluorescent 
proteins (sfGFP-Car9) resulted in an accelerated rate of silicic acid polycondensation 
without causing silica precipitation [135] (when used at the same concentrations as GFP-
R5 by Nam et al. [139]). While this lack of entrapment in precipitated silica was deemed 
beneficial for applications requiring protein release, it may indicate a lower affinity for 
precipitated silica.  
Although Car9 and R5 have a similar pI (11.1) and comparable numbers of basic residues 
(3 Lys / 2 Arg for Car9 versus 4 Lys / 2 Arg for R5), Car9 is lacking the RRIL motif 
which has been proposed to be involved in the silica precipitation process by clustering 
R5 segments through electrostatic interactions [143,144]. CotB1p also lacks this motif. 
Although the interactions with oligomeric silicate species are different to those on 
extended silica surfaces, Patwardan et al. noted a correlation between binding strength 
and precipitation activity for SBPs [100]. This prompts the selection of R5 for inclusion 
in fusion constructs intended for affinity purification and immobilisation. R5 has 
previously been used successfully for affinity purification [140], but direct use of the 
immobilised product has not yet been studied and will be investigated in this work. The 
functional elements to be fused with R5 are described in the next section.  
2.1.5 Selection of fusion elements for visualisation and bio-sensing 
functionality 
As discussed above, SBPs can be fused with a wide-range of functional proteins. In this 
work, the fluorescent protein mCherry (mCh) was used as a first model protein for 
preliminary studies of the interaction between the R5 fusion protein and the silica support 
material. mCh is a monomeric derivative of Dicosoma sp. DsRed (tetrameric) [145] and 
has been used in diverse applications. It has a fast maturation time [146] and has been 
shown to have a higher tolerance to fusions (as the termini lie outside the β-barrel) [147] 
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and photostability against pressure [148] and pH [147,149], making it a good choice as a 
first model.  
As mentioned in Chapter 1, the inclusion of a fluorescent protein in fusion construct could 
potentially facilitate visual monitoring of the protein production and immobilisation 
process without a laboratory infrastructure. In this capacity, a fluorescent protein in the 
red range, e.g. mCh, is preferred to the green range, e.g. GFP, as green fluorescence is 
more difficult to observe by eye in the yellow-coloured media used for culturing E. coli.  
With respect to the functional enzyme (Enz) portion of the R5-mCh-Enz fusions, the 
enzymes sarcosine oxidase (SOx) and horse radish peroxidase (HRP) will be explored as 
first models. HRP in combination with an oxidase is the most used enzyme pair in 
bioassays; HRP detects the peroxide co-product which acts as a good measurand for the 
oxidase’s substrate (sarcosine in the case of SOx). In the multi-enzyme cascade (Figure 
2.3A) combining the two proteins, SOx catalyses the oxidation of sarcosine, yielding 
glycine, formaldehyde and hydrogen peroxide. Subsequently, in the presence of HRP, 
hydrogen peroxide (H2O2) reacts with a chromogenic agent to product a colorimetric or 
fluorimetric response. For applications requiring a very low limit of detection, the high-
sensitivity of the fluorescence approach is generally preferred [30]. It should be noted that 
this scheme requires HRP to have activity in excess of SOx in the assay, so that the 
conversion of sarcosine is the limiting step. Alternatively, the peroxide co-product could 
be detected electrochemically without HRP, using an approach similar to the first-
generation glucose biosensors [150] (Figure 2.3B). Such measurements are carried out on 
an electrode (commonly platinum) at moderate anodic potential [151]. Although it is 
possible to detect peroxide directly, this approach is reliant on the concentration of 
dissolved oxygen in the bulk solution. To overcome this limitation, most oxidase-based 
electrochemical biosensors make use of artificial electron acceptors, known as mediators 
(e.g. ferrocene), to shuttle electrons from the active site of the enzyme to the electrode. 
When held at a constant potential, the current at the electrode correlates with the substrate 
concentration. Both approaches have been successfully incorporated into biosensors for 
a range of oxidase enzymes, including SOx [152–156].  
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Figure 2.3 Reaction schemes for the detection of sarcosine with sarcosine oxidase by (A) 
fluorimetric detection using horse radish peroxidase and a chromogenic agent or by (B) 
electrochemical detection in the presence of a mediator (Med.). 
Given colorimetric and fluorimetric signals have been noted for their utility in POCTs for 
LMICs [21], a fluorimetric signal will be explored in the first instance. This approach 
also offers the potential advantage of using the visualisation protein (e.g. mCh) 
incorporated in the fusion construct as internal reference in the diagnostic. Moreover, 
sarcosine levels in urine have recently been studied as a potential marker of early-stage 
prostate cancer, when the level rises over 5 µM [157,158], giving the model system 
potential NCD relevance. 
 Experimental 
2.2.1 Materials 
Materials sourced from Sigma-Aldrich: sarcosine, horseradish peroxidase (HRP, Type 1, 
P8125), isopropyl β-D-1-thiogalactopyranoside (IPTG), sodium chloride (NaCl), sodium 
phosphate dibasic (Na2HPO4), potassium phosphate monobasic (KH2PO4), sodium 
hydroxide (NaOH), lysozyme (from chicken egg white), Triton X-100, sulfuric acid 
(H2SO4 95 %), bovine serum albumin (BSA), 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS), Coomaisse Brilliant Blue, phosphoric acid, L-ascorbic acid, 
glucose, glycine, silica gel 150 250-500 µm, benzonase nuclease, imidazole, 2-
mercaptoethanol, calcium chloride (CaCl2). Materials sourced from Melford 
Laboratories: LB agar (L1706), LB media (L1704), kanamycin (K0126), carbenicillin. 
Materials sourced from Acros Organics: potassium chloride (KCl), uric acid, L-alanine, 
L-proline, creatinine. Materials sourced from alternate suppliers: AmplexTM UltraRed 
(Invitrogen), commercial silica gel 60 (<63 µm / mesh <230 (Fluka), 6-35 µm (Fisher 
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Scientific), 40-63 µm (Merck), 63-210 µm (YMC), 200-500 µm (Macherey Nagel)), 
glycerol (Fisher Scientific), hydrogen peroxide (30 % w/v in H2O, Fisher Bioreagents), 
dopamine salt (LKT laboratories Inc.), N-methyl-L-alanine (Alfa Asear), 5-
aminolevulinic acid (Cayman Chemical Company). 
2.2.2 Extraction of SiO2 from sand  
Sand was identified as natural resource from which silica is commonly extracted and 
which could be available locally to enable an in-country production process. The protocol 
for silica extraction from sand followed previously published methods with some changes 
[75,77] (Figure 2.6). Small amounts of sand (< 5 g) and NaOH were combine and 
crushed. The mixture was transferred into a Pyrex glass test tube and heated over a flame 
for 3-5 min. After cooling, water was added and it was filtered through filter paper QL100 
(Fisherbrand). H2SO4 (95 %, 0.25-1 mL) was added carefully, drop by drop, to the filtrate. 
The white precipitate was collected, centrifuged (13 k rpm for 1 min) (Biofuge pico, 
Heraeus Instruments) and washed with water three times (1 mL). The white precipitate 
was dried at room temperature for 5+ days, collected and ground manually to a powder.  
2.2.3 Characterisation of extracted silica 
Original sands and dried precipitates were imaged by light microscopy (Optiphot 2 EFD-
3, Nikon) and analysed by attenuated total reflectance - Fourier-transform infrared 
spectroscopy (ATR-FTIR, SpectrumOne, Perkin Elmer). N2 gas adsorption/desorption 
studies were used to characterise porosity (3Flex, Micromeritics), ~100 mg tested. 
Thermogravimetric analysis (TGA, Pyris, Perkin Elmer) results were obtained with a 
heating rate of 10 ⁰C/min from 30 ⁰C to 850 ⁰C in air and nitrogen.  
Both laser diffraction analysis (LDA, Mastersizer 3000, Malvern Instruments) and image 
analysis using light microscopy (Morphologi G3, Malvern Instruments) were used to 
investigate particle size. Under light microscopy analysis, greyscale thresholding was 
used to define particles from surroundings and circle equivalent (CE) diameter calculated 
for the resulting shape. Filters were applied (CE diameter < 1.80 µm, elongation > 0.6, 
circularity < 0.7) to remove noise related to contaminants (e.g. dust fibres) and greyscale 
variation in the background. Calculations for these parameters can be found in the 
equipment manual. For LDA measurements, a refractive index of 1.45 and an absorption 
index of 0.01 were used.  LDA measurements were also used to calculate silica surface 
area (SA) per kg of silica particles using surface areas and volumes as determined for 
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spheres with smooth sphere equivalent diameters from the volume distribution collected 
by LDA. 
Silica extracts and sands were analysed by x-ray fluorescence (XRF, Avaatech) for their 
relative elemental compositions, under the following conditions: 30 s collection time for 
50 kV and 15 s for 30 kV and 10 kV with irradiation of the surface in a sample window 
of 12 mm × 5 mm and a step of 2 mm. Post-processing of the XRF spectra using the 
Canberra WinAxil software with standard software settings and spectrum fit models was 
used to obtain element area counts. The element area counts for chlorine (Cl), potassium 
(K), tin (Sn), and silver (Ag) were removed from analysis as components of the system 
(detector, sample tray, etc.) raise artificial peaks. A one-way analysis of variance 
(ANOVA) was conducted with a α = 0.05, followed by multiple pairwise two-tailed t-
tests for those elements showing a significant difference by the overall F-test (Fvalue > 
Fcrit). The t-tests were conducted with a Bonferonni correction, namely αadjusted = α/k, 
where k is the number of comparisons made. In the case of the two extracted silica 
variants compared together with the commercial silica gel 60, k = 3. 
Densities of silica extracts and commercially available silica were obtained using a 
pycnometer. In brief, the weight of the pycnometer alone was measured (mb), then silica 
or sand sample added and the weight taken again (mb+s). The remaining volume of the 
pycnometer was filled with ultra-high purity water and the weight taken again (mb+s+H2O). 
The pycnometer was emptied and water added to full and the weight taken (mb+H2O). The 
silica density, ρs, was calculated by Eq. (2.1), where the density of water, ρf, was adjusted 
for temperature based on reference tables. 
 𝝆𝒔 =
𝒎𝒃+𝒔 − 𝒎𝒃






2.2.4 Recombinant protein expression 
Fusion protein design and transformation into hosts was completed by previous members 
of the Cambridge Analytical Biotechnology group and glycerol stocks were provided 
(60 % (v/v) glycerol stored at -80 ⁰C). Their methods are recorded in brief in Appendix 
A. Constructs for mCh-6H, R5-mCh-6H and R53-mCh-6H were designed and provided 
by Dr. Shah Abbas [141], for mSOx-R5-6H and mSOx-6H by Dr. Si Chen [159], for R52-
mCh-mSOx-R5-6H by Elizabeth Pumford, and for 6H-R5-mCh-HRP and HRP-mCh-R5-
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6H by Dr. David Bailey and Ziyan Zhao. The DNA and amino acid sequences for the 
proteins can be found in [37]. All the provided constructs in E. coli strains were grown 
and induced to express proteins which were purified and analysed as described below.  
2.2.4.1 mCh-6H, R5-mCh-6H, R53-mCh-6H, and R52-mCh-mSOx-R5-6H 
One Shot® BL21(DE3) E.coli competent cells (Novagen, F-ompT hsdSB (rBmB-) gal 
dcm (DE3)) were used for expression of recombinant proteins. Before inducing the 
expression of proteins, BL21 (DE3) E. coli containing expression vector pET-24a (+) 
with the insert were grown overnight in a starter culture of 20 mL lysogeny broth (LB) 
media with kanamycin. The culture was then scaled up to 200 mL by inoculating fresh 
LB media, containing 50 µg/mL kanamycin, with 10 % inoculum (20 mL) from starter 
culture. It was grown at 37 °C with shaking (225 rpm) to mid-log growth phase 
(OD600 ≈ 0.6) (not more than 0.8) and induced with 1 mM IPTG at 37 °C with shaking for 
4-5 h. Induced cells with expressed proteins were separated into 50 mL aliquots and were 
centrifuged at 4.3 k rpm and 4 °C for 30 min using a centrifuge (Megafuge 1.0R, Heraeus 
Instruments), and the resulting pellets were stored at 4 °C or -20 °C.  
For lysis, 5 mL of lysozyme (1 mg/mL) in H2O was added to each cell pellet and 
incubated on ice for 30 min, followed by probe sonication (30 cycles, 10 s on / 5 s off). 
The resultant lysate was split into 1 mL aliquots and centrifuged at 13 k rpm for 30 min 
in a microcentrifuge (Biofuge pico, Heraeus Instruments). The supernatant was either 
purified on nickel resin for reference following manufacturer’s instructions (Section 
2.2.5) or immobilised directly onto silica (Section 2.2.6) . 
2.2.4.2  HRP-mCh-R5-6H and 6H-R5-mCh-HRP 
HRP expression, purification and reactivation was done in collaboration with Ziyan Zhao 
and Dushanth Seevaratnam. The HRP-mCh-R5-6H was expressed in the BL21 Rosetta II 
E. coli cells and the 6H-R5-mCh-HRP was expressed in E. coli pLysS. pTTQ18 (Addgene 
69122) was used as the expression vector. The cells were grown in 5 mL LB media 
supplemented with carbencillin overnight at 37 °C for 12-16 hours. The starting culture 
was diluted 1:100 in 200 mL LB media with carbencillin and incubated at 37 °C with 
shaking at 225 rpm until an OD600 of 0.6 - 0.8 was reached. The inoculated culture was 
then supplemented with 2 mM 5-aminolevulinic acid and 1 mM CaCl2 and induced with 
1 mM IPTG. The culture was incubated further at 30 °C with shaking at 225 rpm for 8 
hours.  
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The cells were harvested by centrifuge at 6 k rpm for 20 min. The supernatant was 
discarded and the cell pellet was re-suspended in 35 mL buffer A (300 mM NaCl, 2.7 mM 
KCl, 10 mM phosphate buffer solution pH 7.5, 10 mM 2-Mercaptoethanol, 0.1 % 
protease inhibitor cocktail, 20 % glycerol) supplemented with 20 mM imidazole and 2 % 
Triton X-100 per 200 mL of cell culture. The lysis was achieved by freezing the re-
suspended solution at -80 °C for 15 min. Lysozyme was added to a final concentration of 
5 mg/mL after the solution was thawed. Another two repeats of freeze and thaw were 
carried out. The lysed solution was supplemented with 250 units of benzonase nuclease 
and was incubated on ice for 1 hour, before centrifugation at 13.5 k rpm for 45 min. The 
supernatant was collected for protein purification (see Section 2.2.5). 
The purified protein was desalted using a desalting column to exchange the elution buffer 
with the desired protein storage buffer (10 mM sodium phosphate buffer, pH 7.5). 
Reactivation of the protein was achieved by reconstitution with 6 µM of hemin following 
published method [160], either before or after immobilisation on silica. The hemin 
solution was added drop by drop from a 1 mM stock solution in 0.1 M KOH.  In the case 
of activation prior to immobilisation, the activated protein was desalted again after 
incubation with hemin for 1 hour at 4 °C. Post-immobilisation activated protein was 
desalted via repeated centrifuge at 4 k rpm for 3 min, followed by replacing the 
supernatant with protein storage buffer. The final desalted immobilised activated protein 
was suspended in protein storage buffer at a ratio of 20 µL of buffer per 1 mg of silica. 
2.2.5 Protein purification 
Protein purification was performed using Nickel His-Bind Resin (Novagen). The 
purification columns were prepared as recommended by the manufacturer. The column 
was first washed by 5X bed volume of equilibration buffer (20 mM sodium phosphate, 
500 mM NaCl, 20 mM imidazole, pH 7.8), followed by loading the supernatant of the 
cell suspension. The impurities were removed by washing with 3X bed volume of binding 
buffer (buffer A with 20 mM imidazole), 5X bed volume of wash buffer (buffer A with 
50 mM imidazole). The target protein was then eluted with 5X bed volume of elution 
buffer (buffer A with 250 mM imidazole). 
The purified proteins were confirmed using size analyses of denatured proteins on sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 8 % SDS) in 
collaboration with Dushanth Seevaratnam and Ziyan Zhao. The presence of the R5-
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silaffin tag was confirmed by protein sequencing using liquid chromatography coupled 
mass spectroscopy. The yield for R5-mCh-6H was 200 mg/L culture, for R52-mCh-
mSOx-R5-6H was 220 mg/L, for HRP-mCh-R5-6H was 6 mg/L and for 6H-R5-mCh-
HRP was 3 mg/L after Ni-purification.  
2.2.6 Immobilisation of R5-proteins onto silica particles and 
characterisation 
All functional proteins were analysed for their fluorescence and binding affinity to silica 
after Ni-purification and/or from crude lysate.  
A suspension of silica particles (10 mg/mL, 5 mg in 0.5 mL) was prepared in buffered 
saline (100 mM Na2HPO4, 150 mM NaCl, pH 7.5). The mixture was sonicated for 1 h 
(water bath FB15056, Fisher Scientific) and a volume of either purified protein or lysate 
was added, as specified in the text where relevant. The final concentration of the Ni-
purified proteins was between 0.05-0.5 mg/mL. After mixing by vortex (VariMix, 
SciEquip), the suspension was rotated (SB1 tube rotator, Stuart Science) for 1 h and left 
at room temperature to precipitate. The particles became pink and the supernatant 
colourless. The protein-modified silica was centrifuged at 13 k rpm for 5 min. The 
particles were washed several times with water and no leaching of the protein from the 
particles to the solution was observed, as measured by fluorescence. This immobilisation 
process was completed with a range of commercial silica particles as well as extracted 
silica. The selectivity of R52-mCh-mSOx-R5-6H for silica against other materials such 
as alumina, calcium carbonate, and cellulose was tested following the same protocol. 
The percentage of R5-protein immobilised was calculated by measuring the fluorescence 
intensity characteristic of mCh, i.e. excitation 587 nm / emission 607 nm (Cary Eclipse 
Fluorescence Spectrophotometer, Varian) of the supernatant at the beginning and end of 
the immobilisation.  
A Bradford assay was used to determine the total protein immobilisation. In brief, 20 µL 
of supernatant following the first spin-down after incubation was added to 100 µL 
Bradford reagent (Coomassie Brilliant Blue in phosphoric acid) in a well plate. 
Absorbance at 595 nm was measured with a UV spectrophotometer and compared with a 
standard curve made with bovine serum albumin (BSA) (Figure 2.4). Elution of the 
proteins off silica was achieved by incubation in 0.5-1 M lysine for 30-120 min.  
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Figure 2.4 Standard curve for Bradford assay, showing linear relationship of Abs. 595 nm (blank 
subtracted) with BSA concentrations from 0 to 125 µg/mL. 
Absorbance (Infinite M200, Tecan) and fluorescence readings were taken of both 
functionalised particles and soluble proteins to identify any changes in absorbance or 
fluorescence spectra as a result of R5-peptide fusions or immobilisation. Confocal 
microscopy images were obtained using Leica TCS SP2 spectral confocal microscopy. 
Z-stack images were taken for multiple particles and intensity profiles for emission 
609 nm analysed across particle cross-sections. 
A quartz crystal microbalance (QCM, openQCM) was used to estimate binding 
coefficients for the fusion proteins with silica in collaboration with Dr. Neus Jornet-
Martínez. The gold chips were first cleaned with piranha solution for 20 min. They were 
then immersed into 5 mM (3-mercaptopropyl)trimethoxysilane solution in ethanol 
overnight. Under these conditions, the thiol group is expected to interact with the gold 
surface [161] and the remaining alkoxy side groups are expected to undergo self-
condensation and hydrolysis reactions to form siloxane bridges and silanol groups [162–
164], forming a layer on the surface of the chip. The modified chip was rinsed with 
acetonitrile and dried before use. Measurements were conducted at 10 MHz and a flow 
rate of 3.6 mL/h. Buffer (phosphate buffered saline, pH 7.4, PBS) was flown through the 
system (~ 60 min), followed by the Ni-purified proteins in buffer (10 and 5 µg/mL of R5-
mCh-6H and mCh-6H), then buffer again, each time until the frequency stabilised. Plots 
of frequency over time were used to determine the equilibrium dissociation constant KD 
as measure of protein’s affinity for a surface. KD (M) is the ratio of the dissociation rate 
constant, kd (s
-1), to the association rate constant, ka (M
-1s-1), i.e. KD = kd / ka. The 
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association portion of the frequency over time curves were fitted to a function for 
exponential growth (Eq. (2.2)) and the dissociation portion to an exponential decay (Eq. 
(2.3)) using Origin Pro9.1 software, following convention for protein affinity isotherms 





(𝒆−((𝒌𝒂𝑪+𝒌𝒅)×(𝒕−𝒕𝟎)) − 𝟏) + 𝑭𝟎 
(2.2) 
 𝑭𝒕 = 𝑭𝟎𝒆
−𝒌𝒅(𝒕−𝒕𝟎) (2.3) 
Where Ft is frequency at time t, F0 is frequency at the start of association/dissociation, t0 
is the time at the start of association/dissociation, C is concentration of the protein, and 
Fmax is the frequency shift observed from F0 to the plateau. The mass of protein (Δm) 









where Δf is the frequency change, f0 is the resonant frequency of the chip, ρq is the density 
of quartz (2.648 g/cm3), μq is the shear modulus of quartz (2.947 × 10
11 g/cm/s2) and a is 
the active area between the electrodes.  
2.2.7 Determination of sarcosine and H2O2 
Sarcosine or H2O2 was detected by functional R5 proteins (R52-mCh-mSOx-R5-6H 
and/or HRP-mCh-R5-6H or 6H-R5-mCH-HRP, respectively) in combination with the 
dye AmplexTM UltraRed (AR) for both soluble and immobilised proteins. There are a 
variety of chromogenic substrates to choose from with HRP, but AR is reported to have 
stability across a range of pH by the manufacturer and is the dye typically included in 
commercially available enzyme kits for sarcosine detection in plasma/serum.  
For the detection of sarcosine in well plates with Ni-purified protein in solution, 10 µL of 
Ni-purified R52-mCh-mSOx-R5-6H (1.9 mg/mL) was added to 0-10 µL volumes of 
sarcosine solution (100 µM), 10 µL of wild-type (WT) HRP (0.4 mg/mL) and 10 µL of 
AR (1 mM). For the detection of H2O2, 4.8 µg of Ni-purified HRP-mCh-R5-6H or 6H-
R5-mCh-HRP (40 µL of 0.12 mg/mL or 80 µL of 0.06 mg/mL, respectively) was added 
to 10 µL of AR (1 mM) and final concentration of 0-168 µM H2O2. The final volume in 
each well was adjusted to 100 µL with water. The fluorescence was measured, after 
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reaction for 20 min at room temperature (in the dark), at ex. 530 nm / em. 582 nm, 
photomultiplier tube (PMT) voltage 800 V, excitation slit 5 nm. Emission slit was 10 nm 
for mSOx, 5 nm for HRP. The fluorescence intensity of the sample (I) with respect to the 
blank (I0) was plotted against the concentration of substrate (sarcosine or H2O2). A similar 
protocol was conducted with silica-immobilised protein for the detection of sarcosine, 
replacing soluble protein with 1 mg of R52-mCh-mSOx-R5-6H on silica extracted from 
SC sand (~90 µg protein / mg silica). Figure 2.5 shows the calibration curve for the AR 
assay using WT HRP following the protocol described above (100 µL total volume).  
 
Figure 2.5 Calibration curve for the detection of H2O2 with AR dye at 100 µM using WT HRP 
(0.04 mg/mL) and the indicated concentration of H2O2. Ex. 530 nm / ex. 580 nm, slits 5 nm, PMT 
voltage 800 V, blank subtracted. 
Endpoint assays for sarcosine were conducted in well plates, 50 µL each assay with 
50 µM AR, 0.04 mg/mL WT HRP, 3.75 mg silica-immobilised R52-mCh-mSOx-R5-6H 
and various final concentrations of sarcosine. 
For any calibration curves, the limit of detection (LOD) was determined based on the 
slope of the linear regression (b) and the standard deviation of the blank response (SD) 
using the following formula:  
 𝑳𝑶𝑫 = (𝟑. 𝟑 × 𝑺𝑫)/𝒃 (2.5) 
For evaluating the effect pore size of commercial silica gel particles on activity, detection 
of 10 µM sarcosine was performed using the AR assay as described above. Quantity of 
silica added was adjusted based on immobilisation efficiency in order to maintain 
equivalent enzyme concentration. The microcentrifuge tubes were rotated for 60 min 
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before fluorescence intensity was measured at ex. 530 nm / em. 582 nm, PMT voltage 
800 V, excitation/emission slits at 5 nm.  
2.2.8 Determination of specific activity  
For the fusion proteins to potentially have utility as biosensors, they must show activity 
in the presence of the target substrate. Trinder’s colorimetric assay was adapted to 
measure specific activity of sarcosine oxidase. 4-aminoantipyrine (50 µL, 4.7 mM), 
phenol (50 µL, 20 mM), sarcosine (50 µL, 2 M), HRP (50 µL, 0.4 mg/mL) was added to 
300 µL of 10 mM sodium phosphate buffer (pH 7.5). After 5 min, 10 µL of enzyme was 
added to the mix (either R52-mCh-mSOx-R5-6H, in solution (1.9 mg/mL) or immobilised 
on silica (0.1 mg silica, ~90 µg protein/mg silica), or WT sarcosine oxidase (0.5 mg/mL)). 
After 5 min, 2.5 mL of ethanol was added to stop the reaction and the absorbance was 
registered at 480 nm.  
Specific activity for HRP constructs was measured using a colorimetric assay with 
indicator ABTS (2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium 
salt). The enzyme (in solution or immobilised, 0.25 mg) was added to ABTS solution 
(4.83 mM final) to a total volume of 295 µL and allowed to equilibrate for 5 min. Then, 
5 µL of hydrogen peroxide solution was added and the absorbance at 405 nm was 
measured every 5 s over 2 min.  
For both assays of specific activity, total protein immobilised on the silica was measured 
by Bradford assay, as described above. Change in absorbance over time was converted to 










Where ΔA is rate of change of absorbance over time, l is pathlength of the cell, v is the 
final volume of the assay, m is the mass of protein added to the reaction mix and ε is the 
millimolar extinction coefficient (17.14 for quinoneimine dye at 480 nm and 36.8 for 
ABTS at 405 nm). The variable x is a multiplier for depending on the ratio of moles of 
substrate to product, e.g. two moles of H2O2 produces a mole of quinoneimine dye. 
Pathlength, l, for the well plate was determined by the difference in absorbance of water 
at 977 nm and 900 nm for an equivalent volume (Eq. (2.7)), where 0.18 is a reference 
value for this difference in a 1 mL cuvette. Pathlength values of 0.624 cm and 0.912 cm 
were used for 200 and 300 µL samples, respectively. 
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2.2.9 Determination of selectivity and pH effect 
Selectivity is an important component in a biosensor to avoid false positive signal from 
other interfering substances that may be present in the sample. The selectivity of fusion 
constructs was evaluated by the generation of AR fluorescence in the presence of potential 
interferents. The AR assay was conducted following the protocol described above for well 
plate assays of sarcosine/H2O2 but with the following changes.  
For the selectivity of sarcosine oxidase, stock solutions of potential interfering substances 
N-methyl-L-alanine, L-alanine, glycine, L-proline, and creatinine were prepared at 
concentration of 1 mM. The solutions were diluted to final concentrations of 10 µM in 
the assay. L-alanine and creatinine were also tested at final concentrations of 10 mM and 
20 mM, respectively, to compare with expected levels in urine [169,170]. Either 1 mg of 
R52-mCh-mSOx-R5-6H on silica extracted from SC sand in 10 µL buffer (~90 µg 
protein/mg silica), 10 µL of crude lysate or 10 µL of 0.1 mg/mL WT SOx was added to 
potential interferents along with 5 µL of AR (1 mM) and 10 µL of WT HRP (0.4 mg/mL).  
For the selectivity of HRP, stock solutions were prepared of dopamine HCL, L-ascorbic 
acid, glucose and uric acid, and diluted to final concentration of 50 µM in the assay. Either 
0.5 mg of immobilised 6H-R5-mCh-HRP on SC extract in 5 µL buffer (10 µg protein/mg 
silica) or 10 µL of 0.01 U/mL WT HRP was added to potential interferents along with 
5 µL of AR (1 mM).  
For both SOx and HRP, the effect of pH was evaluated using the same protocol as the 
selectivity well plate assay but using buffers of various pH (determined by Jenway 3510). 
In all cases, fluorescence was measured at 20 min with an emission slit of 5 nm for SOx 
and 10 nm for HRP. A standard (Istandard) of sarcosine (10 µM) or H2O2 (50 µM) and a 
blank (I0), all at pH 7.5, were used as a references to calculate relative responses. 
 Results and Discussion 
2.3.1 Silica extraction and characterisation 
As mentioned above, sand can be a good natural source for silica (silica content > 90 % 
for some sands). Silica extraction from sands followed an alkali treatment and subsequent 
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acidification process, adapted from published examples of silica extraction from sand 
[75,77], as outlined in Figure 2.6. Here, the sand is mixed with NaOH in a dry process 
and heated under flame. After filtration, acidification and wash steps, the resulting 
precipitate is dried at room temperature (~20 ⁰C).  
 
Figure 2.6 Schematic illustration of the extraction process of silica (SiO2) from sand.  
A variety of beach sands from diverse locations (Table 2.2 and Figure 2.7A) were used 
to evaluated the performance of the extraction process across a range of sand 
compositions. Sand is a class of material defined by size, rather than by composition; The 
Unified Soil Classification System defines sands as those soils containing 50 % of their 
material larger than No. 200 sieve (> 74 µm in diameter) where > 50 % of this is smaller 
than No. 4 sieve (< 4.76 mm diameter)[171]. The composition of sand varies significantly 
as it is dependent on the local rock sources and conditions, so the variability in yield from 
the extraction process was unsurprising. Not all sands tested had sufficient yields of silica 
from this process. For example, no silica was able to be extracted from sand obtained 
from the Caribbean (CB) and yields from Hong Kong (HK) and Santorini (ST) sands 
were < 1 % weight. In contrast, yields of 11.5 ± 1.4% and 4.7 ± 0.9% weight were 
obtained for beach sands from South Carolina (SC) and Ghana (GH), respectively. Yield 
could potentially be increased with more control over the heating step, e.g. use of a 
hotplate rather than flame, or reduction in initial grain size through milling [76]. 
Nonetheless, yields from SC and GH were sufficient to carry forward for additional 
characterisation (below) and evaluation of binding capacity for fusion proteins (Section 
2.3.2 and 2.3.3).  
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Figure 2.7 Bright field optical microscope images for both (A) the sands and (B) the resulting 
precipitates (from GH, SC, and UK sands).  
Table 2.2 Sand sources and corresponding silica yields after extraction 
Sand source location Abbreviation Silica % yield (w/w) 
South Carolina, U.S.A. SC 11.5 ± 1.4 % 
Accra, Ghana GH 4.7 ± 0.9 % 
Southwold, U.K. UK ~1 % 
Sharp Island, Hong Kong HK < 1 % 
St. Lucia, Caribbean CB n/a 
Santorini, Greece ST < 1 % 
 
The variability in yield across the sand sources is likely related to their variability in 
overall silica content, as shown by XRF analysis. Although elemental counts derived from 
XRF spectra (Figure 2.8) are dependent not only on the concentration of the element but 
also on matrix effects, physical properties, sample geometry and the hardware settings of 
the scanner [172,173], intersample variability in a single element can be used for a relative 
comparison between samples (Figure 2.9). Analysis of XRF results showed that sands 
from ST, HK, and CB had relatively less silica (Si) as compared to the sands from SC, 
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GH and UK, with HK exhibiting the lowest counts. CaCO3 is another common component 
in sands from broken shells and differences in sand composition were also observed for 
calcium (Ca); HK and CB sands show relatively higher counts for calcium (Ca) than GH, 
SC, UK or ST sands, with SC and UK showing the lowest counts. Other variances in 
composition were also visible between the sand variants with this analysis technique. HK 
sand also shows the highest counts for strontium (Sr) and rubidium (Rb). CB and ST 
sands show higher levels of iron (Fe), zinc (Zn), and cobalt (Co). ST also shows higher 
levels of aluminium (Al), barium (Ba) and titanium (Ti). The remaining elements showed 
limited variance across the sands.  
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Figure 2.8 Normalized and offset elemental intensities from XRF plotted across sample position for 
sand sources. 
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Figure 2.9 Mean element intensity counts across individual samples for sand sources. 
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For those sand sources with sufficient silica content to yield a precipitate (SC, GH, UK), 
the FTIR spectra of these extracted products show characteristic symmetric and 
asymmetric stretching modes for Si-O-Si (804-805 cm-1 and 1079-1088 cm-1, 
respectively) and the symmetric Si-OH mode (952-953 cm-1), which overlay with 
commercially available silica gel (Figure 2.10). Similar features are observed in the 
corresponding unprocessed sands, albeit at a lower % transmission. Comparing the 
relative intensities of the symmetric vibrations indicates that the silica extracts have 
slightly higher ratio of Si-OH groups relative to the Si-O-Si groups compared with 
commercial silica gel (Figure 2.10C and Table 2.3). Given the area density of silanol 
groups on the silica surface can influence binding affinity [100], this may have an effect 
on binding capacity of the silica and will be discussed further in Section 2.3.4.  
 
Figure 2.10 Fourier-transform infrared (FTIR) spectra of (A) sands and (B) extracted silica, with 
sand from (1) South Carolina, U.S.A. (2) Southwold, U.K. (3) Accra, Ghana. Curves are offset. 
Results are also shown in (B) for commercial silica gel 60 <63 µm. (C) Magnified region of (B) 
showing peaks of characteristic peaks for SiO2, highlighting the difference in the ratio of Si-OH and 
Si-O-Si symmetric stretching modes between extracted silica and commercial silica gel. 
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Table 2.3 Ratio of the peaks for symmetric stretching of Si-OH (950 cm-1) over Si-O-Si (800 cm-1). 
Silica type Ratio Si-OH / Si-O-Si groups (950/800) 
Silica gel 60 <63 µm 0.84 
UK extract 1.27 
GH extract 1.44 
SC extract 1.43 
 
Given their higher yields, SC and GH sand sources were selected for further 
characterisation including size, porosity and density. Figure 2.11 shows the 
heterogeneous size distribution of the precipitate and Table 2.4 lists the density of sands 
and extracts alongside commercial silica gel variants (60 and 150 refer to pore size in Å). 
Size distributions of commercial silica with discrete size classes (Figure 2.39) are shown 
later in Section 2.3.4 with respect to the effect of particle size on fusion protein binding. 
Table 2.4 Characterisation of sand and silica 
Source Type Particle size range (µm) Density (g/cm3) 
Commercial silica 60 <63 1.87 
Commercial silica 60 6-35 2.07 
Commercial silica 60 40-63 2.04 
Commercial silica 60 63-210 1.96 
Commercial silica 60 200-500 2.03 
Commercial silica 150 200-500 2.05 
SC silica extract See Figure 2.11 2.18 
GH silica extract See Figure 2.11 2.02 
SC sand 100-500 2.75 
GH sand 300-700 2.66 
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Figure 2.11 Particle size distribution of the silica extract from SC and GH and of commercial silica 
gel 60 <63 µm as measured by (A) laser diffraction and (B) microscopy. Resolution limit for 
microscopy was diameter of 1.8 µm.  
Despite the similarity in FTIR spectra (Figure 2.10), the N2 gas adsorption/desorption 
isotherms (Figure 2.12) suggest that the silica precipitated from sand-processing is 
nonporous or macroporous (> 50 nm pore diameter) and undergoes a nearly reversible 
multilayer adsorption (type II isotherm). In contrast the commercial silica gels 
demonstrate mesoporous (type IV isotherm) behaviour, which is typical of mono-
layer/multilayer adsorption followed by capillary condensation in the mesopores. This is 
also consistent with the higher density for silica extracted than commercial silica gel 
(Table 2.4). Figure 2.12E also shows that N2 adsorption on unprocessed sand is very low.  
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Figure 2.12 N2 isotherms for commercial silica 60 (A) <63 µm and (B) 63-210 µm in diameter, for 
silica extracted from sand from (C) SC and (D) GH and for (E) sand, SC.  
During the extraction process, it is expected that the NaOH primarily reacts with SiO2 to 
form sodium silicate, however, there may be some side reactions occurring with other 
components present in the sand. Although the FTIR spectra primarily shows the presence 
of SiO2 (Figure 2.10), other components from these side reactions may also be present in 
low concentration in the extracted silica. Comparative thermogravimetric analysis (TGA) 
against a reference material, e.g. commercial silica gel, can be used to identify if this is 
Chapter 2: Silica-immobilised fusion proteins 
   43 
the case (Figure 2.13 and Table 2.5). TGA is a method of materials characterization 
through analysis of characteristic decomposition patterns. Some weight loss is expected 
for silica gel due to the loss of water. Indeed, the pattern of weight loss for the commercial 
silica gel follows the expected shifts where the first loss between 50-150 ⁰C is attributed 
to physically absorbed water, the second loss between 150-400 ⁰C to strongly held water, 
and the final loss between 400-900 ⁰C attributed to the condensation of silanol groups on 
the surface [174] (Figure 2.13). A similar pattern is observed for the both extracted silica 
variants, but with additional overall weight loss. This suggests that there may be 
components other than silica present in the extracts. Minimal difference in weight loss 
was observed between heating in air or in nitrogen, which suggests that the mass loss 
from organic matter is small and the other components may be inorganic.  
 
Figure 2.13 TGA of commercial silica gel and extracted silica in (A) air and (B) nitrogen.  
Table 2.5 Weight loss of silica variants during TGA in air and nitrogen. 
Silica type Air Nitrogen 
Silica gel 60, <63 µm 3.7 % 3.9 % 
SC extract 14.7 % 13.9 % 
GH extract 19.3 % 20.8 % 
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To identify potential differences in inorganic components in the extracts, element counts 
from XRF analysis of extracted silica variants were tested for statistically significant 
differences using a one-way ANOVA with α of 0.05 followed by multiple pairwise two-
tailed t-tests with a Bonferonni correction of αaltered of 0.017. The extracted silica variants 
were compared to each other and to commercial silica gel 60 (<63 µm) as a reference. 
This analysis showed that the two extracted silica variants have more sulphur (S) than the 
commercial silica gel, which is likely a residue from the final acidic precipitation step, 
with GH extract showing higher levels than SC. This could potentially be removed with 
further wash steps as done by Lazaar et al. for Cl- ions after HCl precipitation [96].  
Statistically significant differences are also observed in other elements. Both silica 
extracts show lower counts for calcium (Ca) and aluminium (Al) than commercial silica 
gel, but no difference to each other. SC shows higher counts for titanium (Ti), but lower 
counts for silicon (Si) and rhodium (Rh) when compared to either GH or commercial 
silica gel. SC extract also shows higher counts for iron (Fe) than the other two at 10 kV 
and 30 kV. Fe counts at 30 kV are also higher for GH as compared to commercial silica 
gel. However, Fe counts at 50 kV show SC is only significantly different from GH extract 
and neither different from commercial silica 60. This pattern at 50 kV is also observed 
for Ba counts. While some elements are counted in more than one energy band in order 
to make the deconvolution most effective, one energy band is usually recommended for 
each element. For Fe, the 10 kV band is recommended, while for Ba, the 50 kV band is 
recommended. GH shows higher counts for zinc (Zn) than either SC or commercial silica 
gel.  It also shows higher counts for bromium (Br), but lower counts for zirconium (Zr) 
and nickel (Ni) when compared to commercial silica 60 but only in the 30 kV energy, not 
at the 50 kV. However, the 30 kV energy band is recommended for these elements so the 
differences are likely significant between the materials. There were no statistically 
significant differences between samples for the other elements analysed here.  
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Figure 2.14 Normalized and offset elemental intensities from XRF plotted across sample position 
for silica extracted from SC and GH sands and for commercial silica gel 60, <63 µm. 
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Figure 2.15 Mean element intensity counts across individual samples for silica extracted from SC 
and GH sands and for commercial silica gel 60, <63 µm. 
Some of these variances reflect variances in the sand sources (Ti, Fe, Zr), however, the 
majority are uncorrelated. XRF analysis does not provide a quantitative measure, 
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however, the FTIR results confirm the precipitate is primarily silica and suggest that these 
are likely trace elements. If significant variance is observed in the purification and 
immobilisation ability of the silica extracts, explored in Section 2.3.2 and 2.3.3, then 
future work may need to consider the role of these trace elements and/or ways to remove 
them (e.g. pre-treatment of sand with HCl [76],  increased time soaking the precipitate in 
acid [75] or additional wash steps [96]). 
In general, the results discussed above indicate that the implementation of a local 
production process including silica extraction will require analysis of the available sand 
to determine if silica content is high enough to yield silica extract with the simple method 
explored here. Of those sands tested in this work, SC sand had the highest yield with 11.5 
± 1.4%. The presence of silica in the extracted products was confirmed by both FTIR and 
XRF. Although extracted silica was shown to have a different porosity and density to 
commercially available silica gel 60 particles and may have some traces of other 
elements, the utility of the extracted silica to a local manufacturing process for diagnostics 
will ultimately depend on its performance with respect to integrated purification and 
immobilisation of fusion proteins. This will be explored in the next section.   
2.3.2 Proof-of-concept: Immobilisation of R5-tagged mCherry on silica 
particles 
To test the feasibility of immobilisation onto particulate silica through the R5-tag, the 
fluorescent protein mCh was used as a first model in fusion constructs.   
As discussed in Section 2.1.3, general protein adsorption on silica is a combination of 
both electrostatic interactions of the ionized silanol groups with positively charged 
residues on the surface of the protein and weaker interactions of H-bonding, van der 
Waals interactions and structural flexibility [89,100,102]. However, the R5 peptide in the 
fusion protein is expected to provide an affinity site for silica, thereby incorporating a 
more selective immobilisation capability for the protein without requiring additional 
chemical coupling reagents. R5 belongs to the proteins involved in silica precipitation in 
diatoms that are rich in arginine and lysine (silaffins [70,124,175,176]). These positively 
charged residues interact with the negative charge of silica surface that results from 
deprotonated hydroxyl groups on the surface (-SiO-,  at pKa > 3-4) [102,177]. By adding 
the 19-amino acid R5 sequence (SSKKSGSYSGSKGSKRRIL) to mCh the estimated pI 
for the protein shifts positive by ~1 unit for each R5 peptide unit added [140,178]. Table 
2.6 shows the estimated pI for the fusion sequences used in this work. It should be noted 
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that pI is only an average indication of charge on macromolecules and significantly 
positively charged regions might exist on proteins even when overall charge is negative, 
as is likely the case for R5-mCh-6H. These regions can still exhibit good binding to silica 
even with the overall charge of the fusion is negative, as previously shown for other SBPs 
[123,140]. Thus, the addition of the R5-tag should increase the affinity of the fusion 
protein for binding to silica.  







Although the intended process for use in local production is direct immobilisation of 
proteins from crude lysate onto silica, R5-mCh-6H and mCh-6H were purified via a 
conventional Ni-column for preliminary studies. Figure 2.16 shows the immobilisation 
efficiency on both commercial silica gel and extracted silica (SC) for R5-mCh-6H and 
mCh-6H. Greater than 90 % immobilisation, as measured by built-in fluorescence, was 
observed on either silica substrate for R5-mCh-6H. (Although silica is present in sand, 
the sand variants showed little to no immobilisation of R5-proteins (less than 1 %).) Good 
efficiency of adsorption at this low concentration (0.05 mg/mL) correlates with 
electrostatic interaction as the driving mechanism (as observed for the cationic peptide 
sequence investigated by Puddu et al. [102]). However, the improvement in 
immobilisation efficiency compared to the control without the R5 tag (mCh-6H) is small 
(~10 %). The interaction of mCh with silica without the R5-tag is unsurprising; 
fluorescent proteins, especially those in the red family, have been reported to have 
susceptibility to adsorption on silica [179]. Yang et al. observed some acceleration of the 
sol-gel gelation process with green-fluorescent protein (GFP) alone without the Car9 tag; 
however without the Car9 tag, GFP leaked out much faster at higher pH [135], indicating 
possibly more hydrophobic interactions involved in its binding [100,102]. This may also 
be the case for the interaction of mCh and particulate silica. 
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The small difference in immobilisation efficiency of mCh with and without the R5-tag is 
in line with previous in situ observations of binding behaviour for these constructs on 
silica surfaces using a quartz crystal microbalance with dissipation monitoring (QCM-D) 
[141]. Here the chip was functionalised by dipping it in the reaction mix for silica 
polymerisation following the Stӧber method (a solvent mixture of 15 % aqueous 2-propanol 
solution containing 2 % NH4OH, as a catalyst, with a mixture of organosilanes 
(octyltriethoxysilane and Bis[3-(trimethoxysilyl)-propyl]amine), followed by dipping in a 
mixture with tetraethylorthosilicate. Under these conditions the silanes are expected to 
undergo self-condensation and hydrolysis to form a silica layer on the chip.  Only a slight 
difference in the change in frequency (ΔF) caused by the adsorption of the protein was 
observed between mCh-6H and R5-mCh-6H. However, increasing the number of R5 tags 
(to R53-mCh-6H) was observed to significantly increase ΔF. This indicates that the R5 
peptide tag can increase affinity of a target protein for silica surfaces. Increasing the 
number of R5 tags has also be shown in increase the efficiency of immobilisation for 
larger target proteins (unpublished results from D. J. Seevaratnam, Dept. Chemical 
Engineering and Biotechnology, U. of Cambridge). Nevertheless, in the presence of the 
R53-tag, mCh fluorescence was reduced, possibly due to interactions of the longer tag 
inhibiting chromophore maturation. The solubility of mCh was also reduced, resulting in 
the formation of inclusion bodies (IBs) [141]. Together, this suggests that the increase in 
immobilisation efficiency must be balanced against other undesirable effects, and that 
appending more than three R5-tags is likely to be a disadvantage for protein production 
and retention of functionality. 
 
Figure 2.16 Immobilisation efficiency of R5-mCh-6H and mCh-6H (0.05 mg/mL) on silica gel 60 
(<63 µm) powder (grey) and extracted silica (red) (5 mg), as measured by mCh fluorescence.  
The effect of the addition of the R5-tag was also observed when comparing the interaction 
of the proteins with a silane-modified gold surface using a QCM (example curve shown 
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in Figure 2.17). While there may be some unreacted alkoxygroups present, the silanol and 
siloxane groups formed through hydrolysis and self-condensation of the organosilane 
used to functionalise the gold chip provide a silica-like surface [163,164]. This 
functionalised surface is likely similar to the modified chip used in the previously 
described QCM experiments, although the thickness of the layer and the surface density 
of silanol groups may be different. Interaction of the R5-tagged proteins with these 
surfaces can provide an estimate of their binding affinities with silica particle surfaces.  
Without the R5-tag, the quantity of the mCh-6H immobilised at saturation on the silane-
modified chip was four times less than that of R5-mCh-6H (100 ng for R5-mCh-6H 
compared with 24 ng for mCh-6H calculated by the Sauerbrey equation, Eq. 
(2.4)(2.4)(2.4)(2.4) [167,168]). This fits with reported observations that, when added at 
the same concentration, a higher percentage of peptide is adsorbed for those peptide-silica 
interactions dominated by electrostatic interactions than for those of hydrophobic 
interactions [102], again indicating the electrostatic nature of the interaction of R5 with 
the silica surface compared to more hydrophobic interactions in the case of the fluorescent 
protein alone. Equilibrium dissociation constants (KD) previously obtained for mCh-6H 
and R5-mCh-6H using QCM-D also show an increase in binding affinity with the addition 
of the R5-tag (1.34 × 10-6 M and 0.427 × 10-6 M, respectively) [141]. A similar KD was 
obtained for R5-mCh-6H by fitting to the frequency plots obtained in this work (0.34 ± 
0.03 × 10-6 M). This KD is similar to those reported for other silica binding tags in the 
literature (e.g. 1 × 10-6 M  for Car9 with silica particles [71]) and for the interaction of 
His-targeted proteins and Ni-NTA-coated surfaces [180], which suggests the R5-peptide 
may be able to function as an affinity tag for purification where silica is the stationary 
phase.  
Chapter 2: Silica-immobilised fusion proteins 
   51 
 
Figure 2.17 QCM frequency over time, showing (a) stabilisation in buffer, (b) introduction of R5-
mCh-6H at 10 mg/mL, and (c) return to buffer. 
Although the increase in binding affinity was small with the addition of a single R5-tag, 
the results of R5-mCh-6H and mCh-6H adsorbed on to silica thin layer chromatography 
plate clearly demonstrate the benefit of oriented attachment over general adsorption. R5-
mCh-6H maintained > 60 % of its fluorescence over one month at room temperature 
while mCh-6H lost the majority of its fluorescence within a day [181]. This stability will 
be important given the intention to use the fusion constructs in their immobilised state, 
rather than elute them from the stationary phase (as is classically done in protein 
purification).  
For the R5-peptide to function as a combined purification and immobilisation tag for 
silica, the fusion construct should remain bound during wash steps. No significant 
leaching (< 5 %) was observed over several washes of the silica nor after a one-hour 
incubation as shown in Figure 2.18 for of R5-mCh-6H (as measured by fluorescence). 
For analysis of the bound fraction, R5-mCh-6H was eluted off the silica by incubation in 
concentrated lysine solution (1 M), as demonstrated previously for the Car9 tag [71,129] 
and for R5 tag [140]. Arginine has also been shown to be effective as an eluting agent for 
proteins bound to silica, as demonstrated for the release Car9-fused cargo proteins in 
silica sol-gels [135] and for the purification process using silica with un-tagged proteins 
[89]. The R5-tagged protein can also be eluted by using a buffer with acidic pH, as shown 
previously for R5-mCh constructs [181]. This protein release behaviour adheres to the 
current understanding that the molecular interaction between the R5 tag and silica is 
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dominated by electrostatic interactions. At acidic pH, the hydroxyl groups are protonated 
or partially protonated (-SiOH, pKa 3-4) and the negative charge on the silica surface 
decreases; hence, the R5-tagged protein is partially released from the silica under such 
conditions. In the case of lysine or arginine, at neutral or basic pH the protonated amines 
(-NH3
+) interact with the negative charge on silica surface (-SiO-). This competition 
between the positively charged R5 peptide and free amino acid for the ionized silanol 
groups, or binding sites, on the silica surface produces the release of the R5-tagged 
protein.  
 
Figure 2.18 Release of proteins after incubation in H2O, as measured by fluorescence intensity of 
the supernatant. 
Despite encouraging immobilisation results, correlation with protein activity needs to be 
established. In this proof-of-concept, the mCh fluorescence serves as an initial marker of 
immobilised protein activity. Fluorescent lifetimes of mCh-6H and R5-mCh-6H are 
similar and are comparable with the reported lifetime for mCh (1.46 ns) [182] (Table 2.7), 
and therefore suggest that the secondary structure (and the chromophore) is retained. 
Olmez et al. observed retention of fluorescence characteristics of a C-terminal R5-tagged 
mCh, but the N-terminal variant was untested given an observed shift in the excitation-
emission maxima of N-terminal tagged GFP [140]. No shift with R5 as an N-terminal tag 
was observed here. Figure 2.19A and Table 2.8 show that the soluble and immobilised 
R5-mCh-6H protein exhibited nearly identical red fluorescence to mCh-6H with 
excitation/emission peaks at 587/608 nm. Spectral analysis of individual silica particles 
with confocal microscopy confirmed an emission peak around 608 nm (Figure 2.19B). 
For all of the above, no significant difference was observed when extracted silica was 
used as the stationary phase in place of commercial silica gel. 
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Figure 2.19 (A) Emission (solid), excitation (dots) and adsorption (dash) spectra comparing mCh-
6H in solution (green) to R5-mCh-6H in solution (black) to R5-mCh-6H immobilised on silica 
extracted from sand (red). (B) Confocal spectral analysis for immobilised R5-mCh-6H (n=10) 
showing retention of mCherry emission peak around 608 nm on either commercial silica gel 60 
<63 µm (solid) or extracted silica (SC, dash). Resolution is limited by the discrete emission bands of 
the confocal microscope. 
Table 2.7 Fluorescence lifetime values (ns) for constructs. Measured in solution and immobilised on 
silica (commercial or extracted from sand). 
Constructs Free in solution Immobilised on  silica Immobilised on sand extract 
mCh-6H 1.61 1.58 1.60 
R5-mCh-6H 1.68 1.55 1.55 
 
Table 2.8 Peak fluorescence (max. λem) values for mCh constructs. Measured in solution and 
immobilised on silica (commercial Si60 <63 µm or extracted from sand), excitation 587 nm.  
Construct Condition Max. λem (nm) 
mCh-6H 
Ni purified 608 
immobilised – Si60 608 
immobilised - SC 608 
R5-mCh-6H 
Ni purified 608 
immobilised – Si60 608 
immobilised - SC 608 
 
These results with R5-mCh-6H demonstrate successful immobilisation and retention of 
fluorescence with this approach and prompted the progression towards the inclusion of 
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functional enzymes in the fusion construct. Moreover, it was decided to retain mCh in 
subsequent fusion constructs, as mCh expression in E.coli produces a pink culture that 
allows for simple visual monitoring of the successful production of the protein. For 
example, Figure 2.20 demonstrates the increase in the inbuilt fusion protein fluorescence, 
as a function of protein expression after induction for R53-mCh-6H. It can be followed 
semi-quantitatively (visual colour matching – Figure 2.20B) or checked against a colour 
card (Figure 2.20C), depending on available resources. The inclusion of mCh also allows 
for visual tracking of the success of the subsequent purification and immobilisation 
process as the functionalised silica becomes pink in colour as the R5-mCh-6H becomes 
adsorbed and the supernatant becomes colourless. Together this could enable in-country 
production and purification of the fusion proteins by making the process suitable for use 
in a laboratory with minimal infrastructure. 
 
Figure 2.20 (A) Fluorescence intensity at ex. 587 nm / em. 607 nm for the (blue) induced and 
(orange) un-induced culture over growth period for 5 h at 37 ⁰C for R53-mCh-6H and (B) 
corresponding cuvette samples to show visual change in colour. Expression levels can be checked 
semi-quantitatively against a colour card (C). 
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2.3.3 Silica immobilisation with functional R5-mCh-Enzyme proteins 
As discussed in Section 2.1.5, mSOX and HRP were used as first models of functional 
enzyme units in R5-mCh-Enz fusions. These enzymes can be used in conjunction for the 
detection of sarcosine (Figure 2.3), a potential biomarker for prostate cancer [183], as a 
first example of a gene-to-diagnostic production process potentially amenable to 
resource-limited settings.  
The increase in the inbuilt fusion protein fluorescence, as a function of protein expression 
after induction, was also observed for R5-mCh-Enz fusions, as demonstrated for the 
fusion containing mSOx (R52-mCh-mSOx-R5-6H) in Figure 2.21. A slight delay in the 
growth curve was observed as compared to R53-mCh-6H (Figure 2.20), which could be 
due to the increased size of the SOx construct, as an increase in peptide length is 
associated with more metabolic energy requirements during expression [123,142]. 
Tracking these expression patterns visually for each construct could be used to help 
identify the correct expression time for each construct under the conditions of each local 
production facility. 
 
Figure 2.21 (A) Fluorescence intensity at ex. 587 nm / em. 607 nm for the (blue) induced and 
(orange) un-induced culture over growth period at 37 ⁰C for R52-mCh-mSOx-R5-6H and (B) 
corresponding cuvette samples to show visual change in colour.  
R5-mCh constructs with HRP were also expressed under similar conditions. Despite 
being widely used in bioassays, either as a label or to detect peroxide as co-product, 
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recombinant HRP is a difficult protein to express [160,184–186]. (Many commercially 
available peroxidases remain largely an isoenzyme mixture from plant extracts, requiring 
normal downstream processing purification and isolation steps.) Recombinant HRP has 
a tendency to form IBs with low yield of active protein [186]. However, both HRP-mCh-
R5-6H and 6H-R5-mCh-HRP (type C HRP) were transformed and expressed in E. coli 
without IB formation. This is possibly the result of the R5 sequence and the change in pI 
of the protein improving its solubility (Table 2.9). The protein could therefore be isolated 
from the soluble cell fraction.  
Table 2.9 Theoretical pI for fusion sequences with functional proteins (calculated using ExPASy 








Again, fusion proteins were purified via a conventional Ni-column for preliminary studies 
of binding affinity for silica. Good immobilisation efficiency (> 85 %) was observed for 
the R5-mCh-Enz constructs on both extracted silica and commercial silica gel (Figure 
2.22A). It was previously shown that mSOx-R5-6H also exhibited > 90 % immobilisation 
efficiency on silica gel but SOx-6H showed only 32.3 ± 2.6 % (as measured by Bradford 
assay) [37,181]. Thus, it is expected that the R5 sequence is primarily responsible for the 
affinity for silica in these fusion proteins rather than mCh.  
As expected, when immobilisation was done with proteins pre-purified on Ni-resin, total 
(measured by the Bradford total protein assay) and selective (measured via the built-in 
mCh fluorescence) protein immobilisation were similar (Figure 2.22B). However, 
immobilisation of the R5-tagged proteins onto the silica from crude cell lysate results in 
30-50 % uptake of total protein, but this corresponds to 85-95 % selective uptake of the 
R5-mCh-Enz fusion proteins (as shown for R52-mCh-mSOx-R5-6H on SC extract) 
(Figure 2.22B). This is consistent with selective immobilisation via the R5 tag and 
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demonstrates the potential for a reliable immobilisation process directly from lysate. R5-
tagged HRP constructs could be also be isolated directly from the cell lysate with silica. 
 
Figure 2.22 Immobilisation efficiency of the (A) Ni-purified R5-mCh-Enz proteins on silica gel 60 
<63 µm (grey) and extracted silica (red) (5 mg), as measured by mCh fluorescence. (R52-mCh-
mSOx-R5-6H 0.4 mg/mL, HRP-mCh-R5-6H 0.12 mg/mL, 6H-R5-mCh-HRP 0.06 mg/mL). (B) 
Immobilisation efficiency of R52-mCh-mSOx-R5-6H on silica extracted from SC sand when added 
as Ni-pure or from lysate (30 µL lysate/mg silica, ~5 mg/mL protein), assessed by (dark blue) 
fluorescence for target protein amount or by (green) Bradford assay for total protein. 
The immobilisation process from lysate to R5-mCh-Enz on silica can be followed step by 
step in the SDS-PAGE gel shown in Figure 2.23. The R5 protein band (R52-mCh-mSOx-
R5-6H at 73 kDa), visible in the crude lysate (Lane 1), almost completely disappears from 
the supernatant (Lane 2) in contact with the silica, as the silica turns pink.  The identity 
of the protein on the silica was confirmed in the eluent after elution in non-physiological 
conditions from the silica (Lane 3). While there is some decrease in purity compared to 
the His-tag approach (Lane 4), no wash steps were conducted on the silica prior to elution. 
Other purification approaches on silica matrices with SBPs observed similar purity to 
His-tag approaches after washing in buffers containing NaCl (0.5-2 M) and detergents 
such as Tween-20 or Triton X-100 (0.5 %) to reduce non-specific interactions 
[122,129,132], showing that higher purity could be achieved if deemed necessary. 
However, the addition of the detergents can also reduce the target protein loading [123] 
and add cost and complexity to the process. In addition, in many cases diagnostic products 
can function without high levels of purity [40].  Thus, the utility of the end product with 
minimal wash steps was explored throughout this work.  
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Figure 2.23 Immobilisation process from crude lysate as shown by (A) SDS page gel for R52-mCh-
mSOx-R5-6H, showing in lane (1) crude lysate, (2) supernatant after immobilisation of silica, (3) 
eluent off silica and (4) eluent from Ni-resin.  Purification pathway shown in (B). The band 
corresponding with the R52-mCh-mSOx-R5-6H (73 kDa) is significantly diminished in the 
supernatant after immobilisation on silica and reappears in the eluate from the silica, along with a 
small amount of other proteins. L indicates molecular weight ‘Ladder’. The lower molecular weight 
band seen in the purified proteins indicates that the mCherry has undergone a partial hydrolysis of 
its chromophore acylimine bond  [141] during SDS-PAGE analysis. 
Even from lysate, the immobilisation process is quick; Most of the immobilisation 
happens within five minutes, as shown for R52-mCh-mSOx-R5-6H immobilised from 
lysate at concentration of 45 µg of total protein per mg of silica (Figure 2.24). This is 
similar to rates observed in the literature for other SBPs; for instance, 85 % of both CotB1 
and CotB1p-tagged constructs were immobilised within the first minute of incubation, 
reaching a plateau at ~95 % at 15 min [123]. These rates support the strong affinity of the 
R5-tag for silica. 
 
Figure 2.24 Immobilisation over time of R52-mCh-mSOx-R5-6H from crude lysate on silica 
extracted from sand (SC). 
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Specific immobilisation (as measured by mCh fluorescence) of R5-tagged proteins from 
lysate on silica was twice that of other substrates tested (alumina, calcium carbonate, and 
cellulose, Figure 2.25), demonstrating the selective affinity of the R5 sequence for silica. 
As discussed, the silica-protein interaction is expected to be primarily driven by 
electrostatic forces at physiological pH [102], where the positively charged residues (K 
and R) interact with negative surface of the silica. Zeta-potential is a relative indicator for 
the surface potential of the particle (one of the major forces mediating particle-protein 
interactions [86,187]) and can be used to compare the materials investigated here.  
 
Figure 2.25 Immobilisation efficiency of R52-mCh-mSOx-R5-6H from crude lysate on various 
support materials, assessed by (dark blue) fluorescence for target protein amount or (green) by 
Bradford assay for total protein. 
Like silica, alumina has hydroxyl groups on its surface, whose protonation and 
deprotonation is dependent on the environment [188]. However, at pH 7.5, silica has been 
shown to have a zeta-potential of approximately -30 mV, while alumina’s is +30 mV 
[189]. This makes alumina positively charged at pH 7 [190], so the specific 
immobilisation of the fusion construct observed (as indicated by fluorescence) could be 
due to surface accessible negative amino acid residues in other parts of the fusion 
construct rather than through the R5 tag. In contrast, at pH 7.5 cellulose has been shown 
to have a slight negative surface charge, approximately -12 mV [191]. Unmodified 
cellulose is known for its low unspecific protein absorption [192], which is also observed 
in Figure 2.25, however, the increased specific adsorption of the R52-mCh-mSOx-R5-6H 
observed here may be a result of this slight negative charge electrostatically interacting 
with the positive amino acid residues of the R5 sequence. Finally, calcium carbonate 
particles have been shown to be close to neutral at pH 7.5 [193], indicating hydrophobic 
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interactions may be the driving force for protein binding to this material. Minimal 
difference is observed between the specific and non-specific protein adsorption for this 
substrate material.  
With the differences in surface charge across these materials, it is likely that there is some 
variance in which proteins adsorb generally from the lysate, as shown by the range of 
total protein adsorption results (measured by Bradford assay). The lysate contains many 
other proteins from the expression cell line, which are expected to be largely negatively 
charged [128], as well as the lysozyme from the lysis technique. These proteins will vary 
in their spatial surface potential distribution and total charge at a given pH [194], and this 
will affect their interaction with the substrate surface. For example, lysozyme is positively 
charged while bovine serum albumin (BSA) is negatively charged at pH 7, resulting in 
more lysozyme immobilised on negative surfaces and vice versa for BSA [190]. 
Nevertheless, the target protein is the dominant protein binding to the surface of the silica, 
as shown by the SDS-PAGE results above (Figure 2.23). Having demonstrated that the 
R5-tag can function as a tag for affinity purification of the R5-mCh-Enz fusions on silica, 
the next step is to ensure the retention of functionality in the fusion constructs. 
2.3.4 Functionality of R5-mCh-Enzyme proteins  
The retention of enzymatic activity in the fusion constructs is essential for their utility as 
diagnostic reagents. However, both fusion of additional peptide sequences and 
immobilisation on silica have the potential to disturb native protein folding and 
correspondingly the characteristics of fluorescence and enzyme subunits. Fusion proteins 
were first evaluated for fluorescence, as an initial marker of correct protein folding, and 
subsequently for enzymatic activity, selectivity, performance in a range of pH 
environments and stability.   
2.3.4.1 Fluorescence 
The inbuilt fluorescence of mCh was checked against the reference standard (mCh-6H) 
to provide an indication of any changes in protein folding as a result of the incorporation 
of enzyme units into the fusion. Fluorescent lifetimes between 1.45-1.68 ns were 
measured in all the cases (Table 2.10), again comparable with the reported lifetime for 
mCherry (1.46 ns) [182]. The fluorescence spectra for each of the R5-mCh fusions also 
exhibited nearly identical red fluorescence with the mCh-6H standard (Figure 2.19), as 
shown for HRP-mCh-R5-6H and R52-mCh-mSOx-R5-6H in Figure 2.26. Silica-
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immobilised versions of these constructs exhibited identical fluorescence spectra to their 
solution counterparts, including the small shift observed for R52-mCh-mSOx-R5-6H in 
lysate. These results provide an indication that the protein is folded properly both after 
the fusion and after immobilisation on silica.  
 
Figure 2.26 Characterization of the free (black) and immobilised (red) R5-mCh proteins. Emission 
(solid), excitation (dots) and adsorption (dash) spectra for (A) HRP-mCh-R5-6H and (B) R52-mCh-
mSOx-R5-6H immobilised on extracted silica.  
Table 2.10 Fluorescence lifetime values (ns) for R5-mCh-Enz constructs. Measured in solution and 
immobilised on silica (commercial silica gel 60 <63 µm or extracted from sand). 
Constructs Free in solution Immobilised on silica Immobilised on sand extract 
R52-mCh-mSOx-R5-6H 1.60 1.59 1.55 
HRP-mCh-R5-6H 1.42 1.52 1.45 
6H-R5-mCh-HRP 1.65 1.53 1.51 
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Table 2.11 Peak fluorescence (max. λem) values for R5-mCh-Enz constructs. Measured in solution 
and immobilised on silica (commercial Si60 <63 µm or extracted from sand (SC)), excitation 
587 nm. Reference max. λem for mCh-6H = 608 nm. 
Construct Condition Max. λem (nm) 
R52-mCh-mSOx-R5-6H 
Ni purified 608 
lysate 605 
immobilised – Si60 605 
immobilised - SC 605 
HRP-mCh-R5-6H 
Ni purified 608 
immobilised – Si60 608 
immobilised - SC 608 
6H-R5-mCh-HRP 
Ni purified 607 
immobilised – Si60 607 
immobilised - SC 607 
 
2.3.4.2 Enzyme activity  
Given fluorescence measurements showed no change after fusion or immobilisation, the 
next step was to evaluate the effect of these on enzyme activity. Specific activity of an 
enzyme is defined as the amount of substrate the enzyme converts (reactions catalysed), 
per mg protein in the enzyme preparation, per unit of time. Table 2.12 shows the specific 
activity for sarcosine and H2O2 for WT and R5-mCh-Enz fusion constructs of SOx and 
HRP, respectively.   
A similar order of magnitude of specific activity was observed for Ni-purified R52-mCh-
mSOx-R5-6H as compared to the WT SOx. Although, the apparent activity of the 
immobilised R52-mCh-mSOx-R5-6H is lower than that of the Ni-purified, the total 
protein here also includes some non-specific adsorption (See Lane 3 of the SDS-PAGE 
gel in Figure 2.23A). Notably, more specific activity is retained by this R5-immobilised 
SOx than by SOx immobilised on silica particles via chemical coupling with an NH2 
activated surface (~0.4 U/mg) or via the classical glutaraldehyde coupling method for 
protein crosslinking (~0.09 U/mg) [181]. Despite some reduction in activity, previous 
work in the Cambridge Analytical Biotechnology group has shown that Km for the silica-
R52-mCh-mSOx-R5-6H was 16.5 ± 0.9 mM (compared with 16.5 ± 0.4 mM, 
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16.3 ± 0.3 mM, and 16.1 ± 0.4 mM for R52-mCh-mSOx-R5-6H, R5-mSOx-6H and 
mSOx-6H, respectively, in solution) [37,159], which suggests that there has been minimal 
conformational impact on the sarcosine binding site due to the protein fusion or 
immobilisation. 
Table 2.12 Specific activity for R5-mCh-Enz constructs and WT variants. Measured in solution and 
immobilised on silica (commercial or extracted from sand). SOx was measured for sarcosine and 
HRP for hydrogen peroxide. 
Construct Condition U/mg protein 
WT SOx in solution 4.75 ± 0.30 
R52-mCh-mSOx-R5-6H 
Ni purified 7.06 ± 1.54 
crude lysate 0.50 ± 0.01 
immobilised – Si60 3.80 ± 0.22 
immobilised - SC 3.07 ± 0.20 
HRP-mCh-R5-6H 
Ni purified 0.142 ± 0.008 
immobilised – Si60 0.029 ± 0.010 
immobilised - SC 0.033 ± 0.0088 
immobilised pre-activation 0.037 ± 0.0061 
6H-R5-mCh-HRP 
Ni purified 0.229 ± 0.012 
immobilised – Si60 0.097 ± 0.028 
immobilised – SC 0.053 ± 0.0088 
immobilised pre-activation 0.020 ± 0.0023 
WT HRP in solution 386.0 ± 4.0 
 
The HRP constructs required re-folding with heme to activate the enzyme. After 
incubation with heme, a Km of 3.8 mM and 1.6 mM was measured for soluble 6H-R5-
mCh-HRP and HRP-mCh-R5-6H, respectively. These are consistent with the range of 
values reported in the literature for different HRP isoenzyme preparations [195], 
compared with a Km of 8 µM for the commercially available mixture of acidic and 
basic isoenzymes.   
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Figure 2.27 Reaction rate versus substrate concentration for (A) HRP-mCh-R5-6H and 6H-R5-
mCh-HRP constructs (Type C) and (B) WT HRP (mix of isomerases), showing Km of 1.62 mM, 
3.8 mM and 8 µM, respectively. 
Figure 2.28B shows that the response curve for both the N- and C-terminal recombinant 
HRP are similar, as are their specific activities (Table 2.12), with the C-terminal variant 
only showing a slight increase in activity of the Ni-purified protein. No significant 
difference was observed in the specific activity of HRP-mCh-R5-6H if activation with 
heme occurred before or after the protein was immobilised on silica, however, a decrease 
was observed in the specific activity of 6H-R5-mCh-HRP if activation was done after 
immobilisation (Table 2.12). In addition, the immobilisation of the Ni-purified protein 
was less efficient when it occurred prior to reactivation; only 60 % of total protein was 
immobilised as compared to > 75 % total protein when it followed activation. Although 
the constructs retained some activity, both the soluble and immobilised versions only 
showed minimal activity when compared to the commercially available WT HRP. 
Nevertheless, silica-immobilised HRP was shown to work in tandem with R52-mCh-
mSOx-R5-6H (see Chapter 4). However, their low activity may ultimately limit their use 
in a diagnostic platform. 
To have potential as a quantitative diagnostic, the fusion constructs must demonstrate a 
response correlated with substrate concentration; Figure 2.28 shows the calibration curves 
for the fusion constructs in solution. R52-mCh-mSOx-R5-6H was used in conjunction 
with WT HRP to test its performance independently of the low activity of the HRP fusion 
proteins. While it is possible to elute the R5-mCh-Enz proteins off the silica, as would be 
done in a classical protein purification with Ni-resin and has been done with various 
silica-affinity tags, the functionalised silica can also be used directly in bioassays without 
any further processing. This eliminates the need for the elution step using costly L-lysine 
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or other eluting agents as well as reducing post-purification cleaning and concentrating 
steps that are often necessary. 
 
Figure 2.28 Calibration curves for free proteins in solution for (A) R52-mCh-mSOx-R5-6H and (B) 
HRP constructs, fluorescence intensity (ex. 530 nm / em. 582 nm) plotted against concentration. The 
isolated HRP showed a linear response to H2O2 in the range 0-200 µM, while mSOx is linear in the 
range of 0-10 µM when used with WT HRP. 
Direct use is shown for R52-mCh-mSOx-R5-6H, collected on silica from the lysate 
(Figure 2.29). Here a linear relationship is observed between sarcosine and the 
fluorescence intensity of the reporter dye AR at 20 min over a range relevant to the 
detection of prostate cancer (0-10 µM) [157,158] with a limit of detection (LOD) similar 
to the soluble protein. In this example, R52-mCh-mSOx-R5-6H on silica extracted from 
sand had been stored dry for three months at 4 °C, suggesting the potential long-term 
stability of the reagent. This will be explored further in Section 2.3.4.5.  
 
Figure 2.29 AR fluorescence (ex. 530 nm /em. 580 nm) with respect to final concentration of 
sarcosine in an assay using R52-mCh-mSOx-R5-6H on silica extracted from sand after 3 months of 
dry storage at 4 °C. 
While these results showcase intensity of signal after 20 min which is still within the 
linear region of signal development, an end-point assay can also be designed that uses a 
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smaller sample. For example, with 50 µL total sample and increased amount of silica-
enzyme, consumption is achieved within circa 40 mins, again producing a linear 
relationship with sarcosine concentration (Figure 2.30).  This assay can be extremely 
sensitive and valuable where only very small samples are available.  While these results 
are promising, more characterisation of these fusion reagents, including selectivity, 
optimum pH and stability, is necessary to determine if they are fit for purpose and how 
such assays might be optimised.   
 
Figure 2.30 Endpoint assay for 50 µL sample showing (A) consumption of sarcosine with time, with 
completion by ~40 min. (ex. 530 nm / em. 580 nm) and (B) fluorescence intensity at 60 min showing 
a linear relationship of intensity with sarcosine concentration. 
2.3.4.3 Selectivity 
To function as a biosensor, the fusion proteins must not only have activity but also 
selectivity for their substrate to avoid false positive signals from other substances. 
Recombinant variants were compared against the commercially available reagent for their 
selectivity against known cross-reactants and potential interferents that may be present in 
a urine sample, given the potential application of the sarcosine assay (Figure 2.31). 
Substrates known to show reactivity with SOx include other secondary amine substrates 
(N-methyl-L- or D-alanine and L- or D-proline [196,197]). Glycine, which is the 
downstream product of the oxidative demethylation of sarcosine catalysed by SOx, has 
also been shown to be a substrate for SOx with low activity. Both glycine and proline 
show little reactivity with either recombinant or WT SOx at 10 µM (Figure 2.31). In 
contrast, N-methyl-L-alanine results in 50-60 % relative fluorescence for R52-mCh-
mSOx-R5-6H compared with 10 % cross reactivity with the WT SOx. Similar turnover 
rates for N-methyl-L-alanine compared to sarcosine have previously been reported for 
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mSOx [197]. However, the concentration of N-methyl-L-alanine in urine samples is not 
well characterised in the literature, so it is difficult to determine the effect this change 
would have on sarcosine detection in urine (the target sample matrix).  
Alanine, on the other hand, is present in urine. The concentration of alanine in urine is 
approximately 1000 fold higher than sarcosine [170,198], so 10 mM final concentration 
of L-alanine was also tested, but minimal cross-reactivity was observed. This suggests 
that an enzymatic approach could be a good alternative for selective measurements of 
sarcosine in urine. Creatinine is another potential interferent also present in urine. Males 
40+ years of age (the group most likely to be tested for prostate cancer) have a mean 
urinary creatinine concentration of 150 mg/mL or 13.2 mM [169]. Hence, creatinine was 
tested at a final concentration of 20 mM (2000X [sarcosine]), but minimal cross-reactivity 
was observed.  
 
Figure 2.31 Selectivity of (A) R52-mCh-mSOx-R5-6H  and WT SOx and (B) 6H-R5-mCh-HRP and 
WT HRP. Fluorescence intensity (ex. 530 nm/ em. 580 nm) recorded at 20 min after addition of the 
substrate. In the case of sarcosine oxidase, substrate final concentrations were 10 µM unless 
otherwise noted. For HRP, substrate concentrations were 50 µM. 
The selectivity of one of the recombinant HRP (6H-R5-mCh-HRP) and WT HRP was 
evaluated against dopamine, L-ascorbic acid, glucose and uric acid [199], with minimal 
cross reactivity observed for either variant (Figure 2.31B). For both, HRP and SOx, those 
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substrates that appear to give negative signals are likely to have some direct interaction 
with the AR dye that is reducing the background fluorescence [200].  
2.3.4.4 Effect of pH on activity 
Enzymes are known to be affected by pH so this effect was evaluated for recombinant 
and WT variants of SOx and HRP to determine their optimum pH for the detection of 
sarcosine and hydrogen peroxide, respectively. The reported optimal pH is 8.0-9.0 for 
WT SOx of Bacillus sp. origin [201,202] (the mSOx sequence used here is of Bacillus sp. 
origin). Both immobilised and crude lysate R52-mCh-mSOx-R5-6H show greater 
retention of activity in the lower pH range than WT SOx (obtained commercially). In 
contrast, the reported optimal pH by the supplier is 6.0-6.5 for WT HRP. Experimentally, 
WT HRP showed similar activity across the range of 5.0-7.5, consistent with its 
composition of a mixture of basic and acidic isoenzymes. In comparison, the optimal pH 
of immobilised 6H-R5-mCh-HRP (type C HRP) is shifted to higher pH range, 7.0-8.0, 
which matches better with the optimal pH of R52-mCh-mSOx-R5-6H.  
 
Figure 2.32 Effect of pH on the detection of sarcosine and H2O2 with (A) R52-mCh-mSOx-R5-6H  
and (B) 6H-R5-mCh-HRP, respectively. Fluorescence intensity (ex. 530 nm/ em. 580 nm) recorded 
at 20 min after addition of the substrate. In the case of sarcosine oxidase, substrate final 
concentrations were 10 µM. For HRP, substrate concentrations were 50 µM. 
2.3.4.5 Stability of bio-recognition element  
Given the intended use of the constructs is in POCTs in resource-limited settings where 
storage at -20 ⁰C or even 4 ⁰C may be unavailable, the stability of the fusion constructs 
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was evaluated after storage at 20-22 ⁰C (room temperature in the lab, RT) and at 37 ⁰C 
(the expected room temperature in some target locations). 
The free 6H-R5-mCh-HRP retained 60-80 % of its activity for more than two weeks, even 
at room temperature (the WT enzyme lost 90 % of its activity in 4 days, Figure 2.33).  
Given the specific activity of HRP constructs with R5-mCh was several orders of 
magnitude lower than the WT (Table 2.12), further improvements are needed to the 
protein design and hence, the stability of these constructs were not explored in depth.  
 
Figure 2.33 Stability of the WT HRP and the HRP-mCh-R5-6H over 4 weeks at 4 °C and ambient 
temperature, based on ABTS measurements of reaction rate. 
Preliminary studies showed that for R52-mCh-mSOx-R5-6H on silica > 95 % of the 
activity remained after two months of storage at room temperature, compared with 
< 20 % for the protein in solution [37]. However, this activity was benchmarked after the 
drying process so further investigation was required. Both wet (in buffer) and dry storage 
states were investigated with regard to the stability of R52-mCh-mSOx-R5-6H on silica. 
The WT SOx control was stored in the lyophilized form provided commercially and 
rehydrated just prior to use at each time point. 
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Figure 2.34 Relative enzymatic activity of WT SOx in a lyophilized form and R52-mCh-mSOx-R5-
6H on silica overtime, in both wet and dry storage states at 20-22 ⁰C (RT) and 37 ⁰C, as measured 
by Trinder’s assay. 
The drying process for R52-mCh-mSOx-R5-6H on silica resulted in a significant loss of 
activity, over 85 % loss as compared to activity just after immobilisation (Figure 2.34).  
Addition of sugars or other stabilizing agents during the drying process or using 
lyophilization could help retain more of the initial activity [203] and should be further 
investigated as part of any future developments of this process. However, once dry (and 
after the significant drop in activity occurs), there is little difference between storage at 
20-22 ⁰C versus 37 ⁰C. This suggests the dry form would not require storage at a specific 
temperature. When stored at 4 ⁰C, the dry storage state maintains ~90 % for up to 
3 months, but some decline in activity is seen after this point (Figure 2.35). This decline 
is observed for both commercial silica gel and silica extracted from sand. 
 
Figure 2.35 Relative activity of R52-mCh-mSOx-R5-6H on silica overtime in a dry storage state at 
4 ⁰C. 
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The wet storage states were kept in microcentrifuge tubes, however, significant 
evaporation occurred over the length of the study, especially for the 37 ⁰C storage state 
(which was dry by the end of the 16-week study). This effect was compensated for in the 
activity results by a control study of evaporation at both temperatures (Figure 2.36). 
Storage at room temperature maintained more activity (80 % after 16 weeks) as compared 
to storage at 37 ⁰C (~40 % at 16 weeks). A similar trend was observed for the lyophilized 
WT SOx. While wet storage states provided greater activity retention as compared to dry, 
aggregation of the particles was observed for the wet storage states. This aggregation 
could be driven by interactions of the protein immobilised on the surface, and may affect 
the dispersion of these functionalised particles in a sample, limiting their ability to 
consume substrate throughout the sample.  
 
Figure 2.36 Percent weight loss due to dehydration overtime for 500 µL samples stored at 20-22 ⁰C 
(yellow) and 37 ⁰C (red). 
The mCh portion of the fusion construct serves as a built-in visual marker for both the 
protein production and immobilisation processes. It was hypothesized that it could also 
serve as a marker of quality assurance for the stability of the protein and indicate retention 
of enzymatic activity. mCh retained more of its fluorescence when stored at 20-22 ⁰C 
(room temperature) than when stored at 37 ⁰C in either storage condition (Figure 2.37). 
While dry storage samples at room temperature visually appeared white, they regained 
their pink colour upon rehydration in the initial weeks of storage. After two weeks, all 
storage states apart from wet storage at room temperature lost over 50 % of their 
fluorescence intensity.  
Although a loss of fluorescence and activity was observed for all storage states over time, 
there is no direct correlation between the two. For example, fluorescence retention is 
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comparable at day 1 for the wet and dry storage states at room temperature (after 
rehydration of the dry state), but < 20 % activity is retained after drying. In contrast, wet 
storage at 37 ⁰C results in the retention of ~ 75 % enzymatic activity, but < 30 % 
fluorescence activity. The lack of correlation between fluorescence intensity and activity 
suggests that mCh may not be well-suited as an internal quality assurance measure of 
enzymatic activity. Nevertheless, it still has utility as a visual indicator for monitoring of 
the earlier steps of the production process (see Figure 2.20 and Figure 2.21).  
 
Figure 2.37 Relative fluorescence activity of R52-mCh-mSOx-R5-6H on silica overtime in both wet 
and dry storage states at 20-22 ⁰C (RT) and 37 ⁰C, ex. 587 nm / em. 607 nm. 
In summary, R5-mCh-Enz fusions retained enzyme activity in both their soluble and 
immobilised forms. Although the drying process should be improved to prevent loss of 
activity, the dry reagent retained activity for over two months at room temperature. This 
is an advantage compared to the soluble reagents. Given a similar limit of detection can 
be achieved with immobilised reagents as with soluble protein, as shown for R52-mCh-
mSOx-R5-6H (Figure 2.29 and Figure 2.28, respectively), this suggests directly 
immobilised reagents could be used in the development of POCTs. In light of this, it is 
important to investigate how particle characteristics affect the interaction of the of R5 
peptide with silica in order to select the optimum stationary phase for both purification 
and immobilisation.  
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2.3.5 Effect of particle characteristics on immobilisation efficiency 
Silica particle characteristics including diameter, pore size and silica type have previously 
been shown to affect the interaction of SBPs [99,100,129]. The effect of each of these 
was investigated for R5-tag mediated immobilisation directly from lysate with R52-mCh-
mSOx-R5-6H.  
2.3.5.1 Effect of particle diameter  
Z-stacks acquired through confocal microscopy of the immobilised R5-mCh-Enz fusion 
proteins suggest that immobilisation is largely on the surface of the irregular silica 
particles; slices through the centre of the particles show a reduction in fluorescence in the 
middle of their intensity plots (Figure 2.38 shows this for R52-mCh-mSOx-R5-6H on 
silica extracted from SC). This would suggest that immobilisation efficiency should 
decrease with an increase in particle diameter. 
 
Figure 2.38 Confocal microscopy z-stack images of R52-mCh-mSOx-R5-6H immobilised on 
extracted silica showing emission at 609 nm and corresponding intensity plots along the position 
indicated by the dashed line. 
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To investigate this effect, commercial silica gel of discrete size classes but of the same 
pore size (60 Å) were tested. The size distribution of each of these classes is shown in 
Figure 2.39; Figure 2.40 shows the resulting fluorescent particles after immobilisation for 
each of the size classes. 
 
Figure 2.39 Particle size distribution of the commercially sourced silica gel 60 as measured by (A) 
laser diffraction and (B) microscopy. 
Chapter 2: Silica-immobilised fusion proteins 
   75 
 
Figure 2.40 (top) Fluorescence and (bottom) corresponding light microscope images of  (A) silica 
gel 60 <63 µm, (B) silica gel 60, 6-35 µm (C) silica gel 60 40-63 µm, (D) silica gel 60, 63-210 µm, (E) 
silica gel 60, 200-500 µm and (F) silica gel 150, 250-500 µm. 
Figure 2.41 shows that as particle size increased, immobilisation efficiency decreased 
(where the same volume of crude lysate was added per weight of silica) (Figure 2.41). As 
particle diameter increases, the surface area to volume ratio decreases significantly, 
resulting in a reduced surface area for each 5 mg aliquot of silica. An estimated total 
surface area per unit mass (SA) can be calculated based on the sphere-equivalent 
diameters of the distributions determined by laser diffraction analysis (Table 2.13). As 
expected, the relative decrease in immobilisation efficiency follows closely with the 
decrease in total SA (Figure 2.41B). This trend was also observed in the Car9-tag 
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purification of a GFP variant [129]. Thus, the decrease in immobilisation efficiency for 
the larger size classes is likely due to this decrease in available surface area. If this is the 
case, increasing the weight of larger silica added to same protein concentration, should 
improve immobilisation efficiency. This was observed for the silica variants with larger 
diameters (Figure 2.41C), and indicates that protein concentration may be above 
saturation for available surface area of these size classes at 5 mg of silica. 
Table 2.13 Median diameter from imaging results and total surface area (SA) calculated for 
spherical equivalent diameters of the size distribution by LDA. 
Silica size class (µm) Median diameter (µm) SA (m2/kg silica) 
<63 11 579 
6-35 25 201 
40-63 39 100 
63-210 73 43 
200-500 285 11 
 
 
Figure 2.41 Immobilisation efficiency across (A) various silica gel 60 size classes. 75 µL of crude 
lysate for R52-mCh-mSOx-R5-6H (estimated 6.6 mg/mL) added to 5 mg of each silica type in 500 
µL buffer. (B) Immobilisation efficiency and silica surface area (SA) normalized to silica gel 60 
<63 µm. (C) Immobilisation efficiency across weight of silica 60 added for particle diameter size 
classes of 40-63 µm and 63-210 µm. 
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2.3.5.2 Effect of pore diameter  
The results above suggest that the protein is immobilised largely on the surface for 
commercial silica gel with pore size 60 Å and extracted silica (observed to be non-
pourous/macroporous, Figure 2.12). However, increasing the average pore size of 
commercial silica gel from 60 Å to 150 Å increases the immobilisation efficiency for the 
same size class of particles (Figure 2.42). This suggests that at 150 Å average pore 
diameter some of the protein is immobilising inside the pores. A similar increase in 
binding capacity when switching from 60 Å to 150 Å was observed by Soto-Rodruiguez 
et al. in their study of the use of the SBP Car9 as tag for affinity purification of proteins 
[129]. Correspondingly, pore sizes of 50-100 Å are typically used in biocatalyst materials 
to keep the entrapped enzymes from leaching into the surrounding fluid [204]. This 
difference in immobilisation between the pore sizes is in line with the expected size of 
the proteins, as the unit cell of mSOx alone is reported as 71 × 69.7 × 72.9 Å3 (RCSB 
Protein Data Bank 3QSE for crystal structure for the complex of substrate-reduced mSOx 
with sarcosine). mCh is reported to have unit cell of 48.8 × 42.9 × 61 Å3 (RCSB Protein 
Data Bank 2H5Q for crystal structure of mCherry) and the dimensions of the native HRP 
(MW: ~ 44 kDa) in a neutral buffer solution were predicted to be 62 × 43 × 12 Å3 by a 
scanning tunnelling microscopy study [205]. Hence, for commercial silica gels of 60 Å 
and the extracted silica variants showing non-porous behaviour, immobilisation is 
expected to be primarily on the surface. 
 
Figure 2.42 (A) Immobilisation efficiency across silica gel 200-500 µm particle diameter with two 
different average pore diameters. 75 µL of crude lysate for R52-mCh-mSOx-R5-6H (estimated 
6.6 mg/mL) added to 5 mg of each silica type in 500 µL buffer. (B) Activity of silica of 200-500 µm 
particle diameter with different average pore diameter in the presence of 10 µM sarcosine 
Although immobilisation efficiency increased with an increase in pore diameter, less 
fluorescent product was generated by functionalised 150 Å pore silica than by 60 Å pore 
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silica when total enzyme (mSOx) added to the reaction was kept constant (based on 
immobilisation rates) (Figure 2.42B). A similar decrease was observed in the apparent 
activity of the immobilised enzyme with the increase in pore size, with 0.041 ± 0.008 
U/mg and 0.152 ± 0.054 U/mg for 150 Å and 60 Å pore size, respectively, after 
dehydration (as determined by Trinder’s assay). This suggests that the enzymes 
immobilised in the pores are not as accessible for the reaction with sarcosine, and hence 
primarily surface immobilisation is desirable. 
2.3.5.3 Effect of silica type  
The binding affinity of proteins for the silica surface in known to be influenced by the 
composition of the silica surface [99,100]. Surface composition includes the degree of 
surface ionisation, the area density of the silanol groups and the prevalence of different 
types (single, vicinal, germinal), and is known to depend on the synthetic origin and 
thermal history of the silica [102,103]. The extracted silica was compared against 
commercial silica gel to determine the effects of the extraction process used here.  
No difference in immobilisation efficiency from lysate was observed between both 
extracted silica variants; however, a decrease in efficiency was observed for commercial 
silica gel 60 when immobilisation was performed under the same conditions (30 µL of 
lysate (~5 mg/mL protein) per 1 mg of silica) (Figure 2.43A). Although similar levels of 
immobilisation were observed for extracted silica and commercial silica gel using Ni-
purified constructs (Figure 2.22), these were at lower total protein concentration than 
found in the lysate. Figure 2.43C shows that by decreasing the volume of lysate added to 
silica gel 60 <63 µm, immobilisation efficiency increases. This indicates that at 30 µL of 
lysate per 1 mg silica, the silica gel surface is likely saturated. In contrast, extracted silica 
saturates with a higher volume of lysate per mg of silica (Figure 2.43B).  
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Figure 2.43 Immobilisation efficiency of R52-mCh-mSOx-R5 -6H from lysate on (A) extracts from 
GH and SC sands and on commercial silica gel 60 <63 µm, as measured by mCh fluorescence. Vol. 
of lysate per mg of silica required to observe saturation for (B) SC extract and (C) silica gel 60 
<63 µm. 
Although an increase in particle size was shown to reduce immobilisation capacity 
(Figure 2.41), extracted silica has a distribution shifted towards the larger particles 
(Figure 2.11). This suggests the difference observed in binding capacity between the 
extracted silica and silica gel 60 is not due to particle size. Instead, it is likely due to the 
differences in silica surface composition, including density of silanol groups and their 
ionisation, the degree of which varies across types of silica [105–109]. An increase in 
ionized silanol groups on the surface would result in a more negative surface charge, 
which would be expected to provide more binding sites for the R5-sequenece. This is 
likely the case here as the silica extracts were observed to have slightly higher ratios of 
Si-OH groups relative to the Si-O-Si groups as compared to commercial silica gel when 
analysed by FTIR (Figure 2.10). Therefore, silica extract not only supports R5 peptide 
mediated binding but is preferred over commercial silica gels when high surface loading 
is desired.   
 Summary 
This chapter explored the feasibility of a simple protein production and purification 
process that could enable in-country manufacture of functional proteins for affordable 
diagnostics. The strategy was to design fusion proteins combining the R5 peptide and a 
fluorescent protein with the target bio-sensing protein for the diagnostic assay and to use 
silica as the low-cost support matrix. Figure 2.44 provides a summary of this ‘gene to 
device’ pathway, including extraction of silica from sand.   
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Silica was investigated as an abundant and low-cost support material for the proteins. It 
was extracted easily from beach sand with simple alkali treatment and subsequent 
acidification. Not all sands tested were sufficient sources of silica but of those that were, 
SC sand had the highest yield with 11.5 ± 1.4%. The precipitate from sand processing 
was shown to be nonporous or macroporous and of a heterogeneous size distribution, and 
the presence of silica was confirmed by both FTIR and XRF. While the material may 
have some traces of other elements, it showed good immobilisation of R5-tagged proteins, 
making applicable to the local production process. Moreover, it was shown to have a 
higher binding capacity than commercial silica gel 60. 
 
Figure 2.44 Schematic illustration of a “gene to device” pathway; 1) Protein engineering to obtain 
R5-mCh-Enz, 2) Bacterial culture growth, 3) Protein expression, 4) Addition of silica (extracted 
from sand) to lysate, 5) Protein purification/immobilisation/stabilisation on silica, before and after 
examples in microcentrifuge tubes shown, 6) Isolation of silica-R5-mCh-Enz, 7) Direct use of the 
silica-R5-mCh-Enz in biosensor platforms, as shown by silica-R52-mCh-mSOx-R5-6H for the 
detection of sarcosine. (mCh structure 2HQ5 and mSOx 3QSE from RCSB Protein Data Bank). 
A proof of concept was demonstrated with R5-mCh-6H. Good rates of immobilisation 
were observed and the binding affinity of the R5 tag for silica was shown to be similar to 
the affinity of His-tagged proteins and Ni-NTA-coated surfaces used in the classical 
method of protein purification. Fluorescence lifetime and maximum λem values suggest 
that the chromophore structure of mCh was maintained after the fusion and after 
immobilisation. 
Fusion proteins were created with two functional enzymes, HRP and mSOx. Together, 
these enzymes can be used to detect sarcosine, a potential biomarker for prostate cancer 
[158,183]. The fluorescent protein mCh was retained in the fusion construct as a tool for 
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simple visual monitoring of both the successful production of the protein and its 
subsequent immobilisation, with the hope that this will help make the process suitable for 
use in a laboratory with minimal infrastructure. The HRP fusion proteins only showed 
minimal activity when compared to the commercially available WT HRP, but the R5-tag 
addition avoided HRP’s tendency form inclusion bodies during recombinant production. 
R52-mCh-mSOx-R5-6H showed comparable specific activity to WT SOx.   
With R52-mCh-mSOx-R5-6H, the potential for a quick, reliable and specific 
immobilisation process directly from crude lysate without additional coupling agents was 
demonstrated. Immobilisation was found to be largely on the surface of both the extracted 
silica and commercial silica gel 60 for fusion proteins of this size. Although increasing 
pore diameter to 150 Å resulted in an increase in immobilisation efficiency, indicating 
that that immobilisation does occur in larger pores, less apparent activity per unit enzyme 
suggested that those enzymes were not as accessible for the reaction with sarcosine in the 
solution; hence, surface immobilisation is desirable.  
While R5-mCh proteins could be eluted off the silica, as would be done in a classical 
protein purification, the functionalised silica can also be used directly in bioassays, 
removing steps and further simplifying the process. This is a new approach with SBPs as 
previous approaches have either shown their utility as a purification tag for later elution 
or their immobilisation/encapsulation ability after elution from column purification. 
Although there was a significant loss of activity during drying, which requires further 
process improvements, once dried, the reagent was shown to be stable for over two 
months. This indicates a potential advantage of immobilised reagents. In addition, by 
using solid components instead of liquid solutions in the biosensor, the time and laborious 
work of solution preparation can be reduced. This could result in increased portability 
and increased simplicity of the assay meaning it can be used by non-specialized personnel 
in remote areas. An assay format that takes advantage of the particulate nature of the 
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3 EXPLORATION OF A FALLING 
PARTICLE BIOSENSOR 
 Introduction 
3.1.1 POCT formats utilizing particle-bound enzymes 
In Chapter 2 it was shown that the silica-immobilised R5-mCh-Enz proteins can be used 
directly for sensing target substrates in solution. While immobilisation can add stability 
and particle-based reagents could simplify assay preparation steps, immobilised enzymes 
experience different mass transport limitations to soluble enzymes, which can affect their 
apparent activity. Particles, even in stirred solution, are usually surrounded by a diffusion 
layer, such that the enzyme at the surface experiences a different local concentration than 
it would experience in the bulk; this surface concentration is typically lower with respect 
to substrate and higher with respect to product. The thickness of this layer varies with 
particle size and the relative movement between the solute and particle phase. For some 
immobilisation strategies (e.g. encapsulation), internal mass transport processes within 
the pores of the support material must be considered in addition to external mass transport 
to the surface; however, for silica-immobilised R5-mCh-Enz constructs, pore diffusion 
can be ignored as primarily surface immobilisation was observed (Chapter 2). A variety 
of strategies have been explored in the past to successfully utilize immobilised enzymes 
in POCTs by optimising the transport phenomena of substrates and products. 
Classical diagnostic platforms have typically used the immobilised protein as the 
stationary phase, where the sample diffuses transversally or laterally into the protein 
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layer. Examples include sample-fill into a glucose test strip, where the enzyme is 
deposited in a matrix of preservative agents, or lateral flow immunoassays, where the 
antibodies are immobilised directly to the nitrocellulose paper. Of those utilizing particle-
bound enzymes, a packed particle bed is the most reported format. Packed beds of 
functionalised beads have been employed in microfluidic devices for both lateral flow 
immunoassays (as shown in a recent publication with collaborators [206] and by others 
in the literature [207–212]) and for small molecule assays (e.g. [213–216]). Although 
microfluidic channels are typically touted for their improved surface area to volume ratio 
compared to other systems, the use of particles in the channel provides further 
improvement of the surface area to volume ratios (as compared to bio-sensing elements 
immobilised directly to channel surfaces) and diffusion distances are significantly 
reduced in the narrow pores through a particle bed [206–208,217]. There is also some 
evidence to suggest that flow through a packed particle bed promotes improved mixing 
in microfluidic channels which typically face mixing challenges due to laminar flow rates 
[213]. However, maintaining these particles in place during microfluidic flow is often 
accomplished through mechanical structures such as weirs or pillars which require 
complex fabrication steps.  
The particle format also allows other biosensor configurations to be explored. In contrast 
to a packed particle bed, where the fluid sample passes the stationary particles, a design 
can be considered where the bio-functionalised particles are moved throughout the 
sample in which they are suspended. ‘Stationary’ fluid concepts are attractive for POCT 
design because they do not require continuous fluid actuation to be integrated in the 
system. Within ‘stationary’ fluid compartments, particle movement can be used to 
homogenise reagents, increase particle-fluid interactions and help overcome diffusion 
limitations.  
‘Stationary’ fluid concepts have often used magnetic particles as they can be conveniently 
manipulated by magnetic fields [218]. For example, magnetic particles have been 
transferred through various processing solutions separated by air gaps in a capillary tube 
by an external magnet for analyte capture. This is in contrast to the typical approach where 
magnetic particles are held stationary during fluid movement, akin to packed bed (e.g. 
[219]). The movement of the magnetic particles through pre-loaded solutions in a 
capillary tube has been used for both nucleic acid and protein extraction from clinical 
samples [220–222]. This approach to nucleic acid extraction has also been coupled with 
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subsequent amplification of the extracts for the detection of infectious diseases [223–
225]. In addition, magnetic particles have a tendency to form chains and other structures, 
due to magnetic dipole-dipole interactions between the particles, which can be used for 
chaotic mixing at the microscale [226]. 
Alternatively, the movement of the particles can be driven by simple gravitational force, 
i.e. particle sedimentation in a fluid-filled chamber (as shown in Figure 3.1). Particle 
sedimentation, and therefore interaction of the immobilised enzyme with the sample, is 
controlled by the density and size of the particles as well as the internal shape and 
dimensions of the chamber. This falling particle biosensor approach achieves dispersion 
of the particles throughout the fluid for a period of time, a feature that is often beneficial 
with respect to the reaction rate for large scale bioreactors using immobilised enzymes 
[227]. In addition, sedimentation allows for the removal of the silica particles from the 
region for fluorescent signal analysis, potentially improving the signal to noise ratio by 
removing background noise due to light scattering by the particles. Moreover, this 
approach requires no additional external components nor the use of expensive magnetic 
particles, making it amenable to use with the R5-mCh-Enz functionalised silica particles 
developed in Chapter 2. Despite the potential advantages of such an approach, no 
examples of POCT formats using the particle-bound enzyme as the mobile phase closely 
resemble the falling particle design proposed here. As such, an initial exploration of this 
format is presented in this chapter. Its performance against other assay formats utilizing 
particle-bound enzymes will be considered in Chapter 4. 
 
Figure 3.1 Schematic of a falling particle biosensor format, where (A) inversion and (B) subsequent 
sedimentation is used to pass the particles though the sample. After sedimentation, (C) fluorescent 
signal from the solution can be measured. Particles are shown in pink to represent R5-mCh-Enz 
immobilised on the surface.  
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To design an effective biosensor using the falling particle approach, it will be necessary 
to understand the interplay between the kinetics of the immobilised enzyme and the mass 
transport of the substrate to the particle surface, as this will ultimate determine product 
formation and thus, signal development.   
3.1.1 Design parameters for a falling particle biosensor  
Various characteristics of the falling particle biosensor design play a role in determining 
the rates of enzyme kinetics and mass transport in such a system. The kinetic reaction rate 
is a result of inherent enzyme characteristics. Enzyme behaviour, especially for those 
reactions involving a single substrate, is classically described by Michaelis-Menten 
kinetics [227,228], which mathematically describes the rate of product formation by the 
set of reactions in Figure 3.2.  
 
Figure 3.2 Reaction sequence for a one-substrate reaction. 
In the first step, the substrate (S) binds reversibly to the enzyme (E) forming an enzyme 
substrate complex (ES). This complex is then assumed to react irreversibly to generate 
product (P) and release the enzyme. The reaction rates are determined by the substrate 
binding (k+1/k-1) and catalytic conversion (k+2). The assumption of irreversibility is 
generally valid when [S] >> [P], such as in the initial stages of reaction (where square 
brackets denote concentration). By making the steady-state assumption that the rate of 
formation of ES equals the rate of ES disappearance and subsequent product formation, 





where Vmax is the maximum rate of reaction of the enzyme when it is under substrate 
saturated conditions and is a measure of enzyme specific activity. Practically, Km is the 
concentration of substrate which permits the enzyme to achieve one-half Vmax, but is also 
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Clearly, both Vmax and Km are important parameters with respect to rate of product 
formation. Km is a characteristic dependent on the relationship between enzyme and 
substrate (i.e. target analyte). Vmax is a rate per unit of enzyme, which means that the 
activity for each particle will be dependent on the enzyme surface coverage (ESC, mg 
enzyme / m2 silica surface) and particle surface area (as determined by particle size). 
When [S] >> Km, the rate of product formation is independent of substrate concentration; 
however, when [S] < Km, product formation exhibits first order kinetics with respect to 
[S]. In the case of an immobilised enzyme, the concentration of substrate at the particle 
surface will be determined by mass transport processes.  
The rate of mass transport of the substrate is determined not only by substrate 
concentration and by substrate diffusivity, which is a function of substrate size and 
polarity, but also by fluid viscosity and by flow around the particle. In the case of the 
falling particle approach, the relative flow experienced at the particle surface is 
determined by the settling behaviour of the particles per inversion of the device and the 
number of inversions. Although there are no examples of POCTs that move particle-
bound enzymes through the sample via particle settling, particle sedimentation has been 
extensively studied in many disciplines, ranging from geologists investigating the 
formation of river beds [229] to chemical engineers looking at the design and operation 
of chemical process equipment such as fluidized bed reactors [230,231]. 
It is well known that the settling behaviour of particles is affected by their inherent 
characteristics, such as size, shape and density, as well as the characteristics of the fluid 
in which they are suspended, such as viscosity and density. Stokes, in his classical work, 
presented an expression for particle settling velocity by equating the effective weight of 
a spherical particle to the viscous resistance of the fluid, also called the drag force [232]. 
Since then, extensive work has combined theoretical and experimental approaches to 
develop relationships that encompass particle-fluid systems beyond a single sphere in a 
viscous fluid. For example, the ratio of the principal axis lengths defining a particle’s 
shape was found to be a significant factor on settling velocity [233]. Particle volume 
fraction also has an effect; as particle fraction increases, the interparticle interactions 
become increasingly important. The motion of an individual particle is affected by the 
relative positions and velocities of nearby particles. Clusters, or small groups of closely 
spaced particles, have been shown to fall together and their velocity well approximated 
by the velocity of a sphere with an effective radius similar to that of the cluster [234]. 
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When the number of particles becomes large, clusters become clouds of particles, and 
their behaviour changes. A cloud of particles can be regarded as an effective fluid drop, 
and thus described by the sedimentation of a heavy fluid in a lighter fluid (as solved by 
Hadamard and Rybezynski). Again, the cloud has a greater settling velocity than an 
individual particle.  Within the cloud, the particles experience a degree of circulation and 
some are observed to ‘leak’ from the cloud and form a vertical tail [235]. 
For both clusters and clouds, the hydrodynamic interaction between particles has a 
cooperative effect, increasing velocity relative to Stokes velocity. However, this assumes 
infinite fluid in the direction of settling (or an experimental vessel long enough that the 
influence of the bottom wall is small). However, for particles uniformly dispersed in a 
viscous fluid in a vessel with vertical side walls and fixed bottom, the mean velocity of 
the particles is found to be hindered, decreasing as particle concentration is increased 
[236]. The presence of a fixed bottom on the vessel requires the fluid to move upward to 
compensate for the settling of the particles, such that the average velocity in the whole 
suspension is zero. This correlation has been extended from uniform spheres to multi-
sized distributions of both large and small particles [237,238]. In addition, for multi-sized 
distributions, as the settling progresses, the faster falling large particles move away from 
the others, changing the concentrations of particles throughout the settling suspension 
[229]. It is clear that the settling behaviour of bio-functionalised silica explored here will 
be complex, especially for the silica extracted from sand given its wide distribution of 
particle size. Hence, experimental observations will be key to defining the relative 
velocity experienced by the particles, to then inform the understanding of reaction rate 
control.  
In summary, there are many parameters for consideration in the initial exploration of a 
falling particle format presented in this chapter. Figure 3.3 shows these parameters 
grouped according to the processes in which they are involved. Both mass transport and 
kinetic rates are also affected by temperature, as it affects fluid viscosity and enzyme 
specific activity, however, temperature will be kept constant for initial exploration of the 
system.  
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Figure 3.3 Parameters with a possible effect on the rate of product formation in an falling particle 
biosensor. 
To determine the process controlling the rate of substrate conversion by enzymes on a 
falling particle, first it will be necessary to assess the relative flow around the particles 
and degree of turbulence in the device through detailed analyses of particle settling 
behaviour (Section 3.3.1 and 3.3.2). Next, this information will be used in conjunction 
with experimentally determined enzymatic parameters from Chapter 2 and reaction 
conditions (e.g. substrate concentration) to assess relative theoretical reaction rates under 
the regimes of kinetic and mass transport control (Section 3.3.3). Finally, these relative 
rates will be used to predict product formation by a range of silica types. These predictions 
will be compared to experimental results to determine validity of a relative reaction rate 
model and the ensuing design implications for a falling particle biosensor (Section 3.3.4).   
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 Experimental 
3.2.1 Materials 
Materials were sourced as described in Chapter 2, with the addition of the following: 
poly(methyl methacrylate) (PMMA, Engineering Design Plastics, UK), PCR plate seal 
(Adhesive PCR Plate Seal, Thermo Scientific).  
Silica nanoparticles made via Stöber synthesis [93] by a former member of the Cambridge 
Analytical Biotechnology group, Dr. Yao Du, were also tested [239]. These nanoparticles 
have a mean dry diameter of 245 ± 49.0 nm as measured by Scanning Electron 
Microscopy and subsequent image analysis by ImageJ [240].  
3.2.2 Falling particle biosensor construction and use 
Falling particle chambers were produced by laser cutting 2 mm thick PMMA and sealing 
both sides with PCR plate seal. Three different designs were explored: a system with a 
parallel sides, as shown in Figure 3.1, and two with central constrictions, or waists, of 
different widths. These are introduced in detail in Section 3.3.1 and shown in Figure 3.7. 
Total volumes were 320 / 240 / 200 µL for the parallel sided / standard waist / narrow 
waist designs, respectively. The sealed device containing bio-functionalised silica in 
solution was inverted for mixing, either by flipping about a central horizontal axis (flip) 
or by rotation in plane (tilt), each time allowing the particles to settle to the bottom 
(schematic of inversion techniques in Figure 3.12). Time between inversions was 60 s 
unless otherwise specified.  
3.2.3 Particle image velocimetry analysis 
Particle settling patterns were observed by obtaining shadows of particles using backlit 
illumination (experimental setup in Figure 3.4). For illumination, a 100 W light-emitting 
diode (LED) array with a light diffuser was placed behind the 'device' and aligned to the 
camera. The resulting shadow was captured by a high-speed camera (Phantom v130) with 
a 12X lens and accessories (Navitar). Videos were captured at 50 fps. Fixtures were 
designed to hold the device and to allow either inversion technique (i.e. rotation in plane 
or flipping about a horizontal axis through the middle of the device). Devices were filled 
with range of silica sizes suspended in buffer and sealed. Silica variants were presented 
and characterised in Chapter 2. Silica concentration in the device was 5 mg/mL unless 
otherwise noted. (For the volumes encased by the devices this is similar to the amount of 
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silica added for each sarcosine assay - 0.875 mg). All silica was functionalised with R52-
mCh-mSOx-R5-6H from lysate following the immobilisation protocol described in 
Chapter 2. Sample videos are provided on a USB drive across the range of silica types 
and inversion techniques, with details recorded in Appendix B. 
 
Figure 3.4 Schematic of experimental set-up for visualisation of particle settling patterns. 
Frames from the videos captured by this setup were converted to greyscale and colour 
inverted using MATLAB [241] (See Appendix C for details). These inverted video 
frames were translated into virtual stacks using ImageJ and Z-projections of the maximum 
pixel value were used to create image overlays. Image overlays were then analysed using 
set level image thresholding to determine percentage of particle passage through the total 
volume using ratio of white to black pixels, where white pixels indicated particle passage.  
Particle image velocimetry (PIV) analysis of particle settling patterns was performed 
using PIVLab v1.41 in MATLAB [242], using Fast Fourier Transform window 
deformation and four successive passes of pixel area (64, 32, 16 and 8) with 50 % step 
overlap, for each pair of images (pairings done 1-2, 3-4, etc.). Images were calibrated 
using an internal reference of chamber height (18.32 mm) and time step determined by 
frame rate (e.g. 20 ms for 50 fps). No observed velocities are reported for particles 
r < 10 µm due to limitations of camera resolution (1 pixel ≈ 20 µm). 
3.2.4 Modelling product formation by the particle-bound enzymes 
A mathematical model was developed to estimate the product formation for each particle 
size class while falling at a given velocity. The model combines the principles of enzyme 
kinetics for immobilised enzymes and corresponding equations [227] with a model for 
mass transfer of the substrate to the particle’s surface based on Fick’s law of diffusion 
[243]. Where the system was under mass transport control (diffusive or convective 
process) rather than kinetic control, the concentration of substrate at the surface was 
assumed to be zero and substrate flux to the surface was equated with product formation.  
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Given the immobilisation of the R5-mCh-Enz fusion proteins was shown to be largely on 
the surface of the particles (Chapter 2), the model does not consider internal diffusion of 
the substrate into the pores. Rather it considers only external diffusion processes where 
the transport of the substrates towards the surface and products away is in series with the 
catalytic conversion of substrates to products occurring at the surface. This surface where 
the enzyme is immobilised is assumed to be equally accessible by the substrate and to be 
a flat impervious support, given the relative scale of protein to particle. (The equivalent 
diameter of the fusion protein is on the order of 5-10 nm (see Chapter 2) while particle 
diameter > 1 µm; similar assumptions have been made regarding particle curvature in 
models of silica-protein interactions [100]). Total surface area per unit weight of silica 
particles (SA, m2 / kg silica) was determined using the distribution of sphere equivalent 
diameters measured by LDA and calculating surface areas and volumes for spheres 
accordingly. Total protein immobilised per weight of silica (TPI, µg protein / mg silica) 
was determined experimentally with a Bradford assay (as described in Chapter 2). TPI 
divided by SA was used to estimate enzyme surface coverage (ESC, mg protein / m2 
silica). Values for TPI, SA, and ESC can be found in Table 3.1 for each of the silica 
variants explored here. As discussed in Chapter 2, silica extract was shown to support a 
higher binding capacity per weight of silica (TPI), so a sample with high loading was also 
included. 
Table 3.1 Model inputs for each size class of silica for total protein immobilised per weight of silica 
(TPI), silica surface area (SA), and enzyme surface coverage (ESC) for immobilisation of R52-mCh-
mSOx-R5-6H. 
Silica size class 
(µm) 
TPI 
(µg protein / mg silica) 
SA 
(m2 / kg silica) 
ESC 
(mg protein / m2 silica) 
 
6-35 14.8 201 74  
40-63 7.4 100 74  
63-210 3.3 43 77  
<63 µm 43 579 74  
SC extract 43 150 286  
SC extract, high loading 86 150 573  
  
The product formation of immobilised enzymes is either controlled primarily by the 
diffusion of the substrate to the enzyme on the particle surface or by the catalytic activity 
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of the immobilised enzyme (as determined by inherent characteristics of the enzyme and 
loading capacity of the substrate). The ratio of catalytic control to mass transport control 
is often characterised by the dimensionless Damköhler number, Da [227,244]. To 
determine Da for the falling particle system, it is necessary to first calculate the rates of 
product formation under each regime. 
When the system is under kinetic control, enzyme behaviour is assumed to follow 
Michaelis-Menten kinetics (Eq. (3.1)) with an absence of product inhibition and of 
portioning or electrostatic effects (sarcosine is not a highly charged substrate). Steady 
state is assumed (ignore variation in S0 with time). In addition, the target concentrations 
for detection (< 10 µM) are significantly less than the Km for R52-mCh-mSOx-R5-6H 
(16.5 ± 0.9 mM [37]). Eq. (3.1) can be re-written such that it is with respect to particle 
surface area, Eq. (3.3), and can be used to calculate the rate of product formation per 
particle (units of mol/s).    





where S0 is the initial concentration of the substrate, ri is the radius of the particle, and 
Vmax_SA and Km are experimentally determined enzyme parameters. This assumes 
S0 < Km, as is true for this case. The surface area term (4πr
2) assumes spherical geometry. 
Vmax_SA is the maximum rate of reaction catalysed by unit of area, as calculated by:  
 𝑽𝒎𝒂𝒙_𝑺𝑨 = 𝑽𝒎𝒂𝒙 × 𝑬𝑺𝑪 (3.4) 
where ESC is the enzyme surface coverage described above. Both Vmax and ESC are 
determined experimentally (with values reported in Table 2.12 and Table 3.1, 
respectively).  
Alternatively, when the system is under mass transport control, the conversion of 
substrate to product is expected to be instantaneous once the substrate reaches the surface-
bound enzyme. Hence, the flux of the substrate to the surface is equal to rate of product 
formation. This flux is controlled by either a diffusion or convection process, depending 
on the flow experienced by the particle. The ratio of advection of a physical quantity by 
the flow over diffusion rate driven by a concentration gradient is given by the Péclet 
number (Pe), as described by:  
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 𝑷𝒆 =
𝒖𝒊 ∗  𝐚
𝑫𝒔
 (3.5) 
where a is the characteristic length, Ds is the substrate diffusivity, and ui is the relative 
velocity of the fluid regarding the particle of radius ri. For Ds, the reported diffusivity of 
glycine, 1.1 × 10-9 m2/s, was used as glycine is an amino acid of similar size and polarity 
to sarcosine [245]. Radius was used as the characteristic length, following convention for 
spherical particles [246].  By attaching the frame of reference to the particle, ui can be set 
equal to the terminal velocity of the particle during fall. After the particles have settled, 
their velocity can be approximated as a zero velocity case.  
The expected terminal velocity was calculated for each size class of particle of diameter 
di, combining theory on particle sedimentation and experimental observation. Only the 
steady-state situation in which velocity is constant was considered given the period of 
time required for the particles to reach their terminal settling velocity is very short (e.g. 
< 10 ms for particles 500 µm in diameter). To do this, the predicted settling velocity was 
first calculated based on the relationship developed by Song Zhiyao et al. for natural 
sediment particles, where the constants are derived from experimental data to account for 









where up is the settling velocity for a single particle, ηf is the dynamic viscosity of the 
fluid and d* is a dimensionless particle parameter as calculated by: 







where g is the gravitational acceleration and ∆= 𝜌𝑠 𝜌𝑓⁄ − 1, and ρs and ρf represent the 
density of the particles and the density of the fluid, respectively. 
This velocity was used to calculate the particle Reynolds number, Rep. 
 𝑹𝒆𝒑 =
𝝆𝒇 ∗ 𝒖𝒑 ∗  𝒅𝒊
𝜼𝒇
 (3.8) 
where ρf is the density of the fluid, ηf is the dynamic viscosity of the fluid, up is the 
velocity of the particle and di is the diameter class of the particle [248]. 
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This was in turn used to calculate the hindered settling velocities, uh, due to particle 
fraction based on the Law of Richardson and Zaki [236] which describes the dependency 
of the settling velocity on the particle fraction: 
 𝒖𝒉 = 𝒖𝒑 × (𝟏 − 𝛉𝒑)
𝒏
 (3.9) 
where θ is the volume fraction of particles in the suspension and n is an exponent 
dependent on Rep (Table 3.2). A particle velocity ui was selected for each diameter di, 
switching from the velocity predicted for natural sediment, up, to hindered settling 
velocity, uh, for a particle fraction of 0.2 at di = ~20 µm, to 0.3 particle fraction at 
di = ~200 µm and to particle fraction 0.4 at di = ~300 µm based on experimental 
observations (Figure 3.9). This velocity function was smoothed using adjacent averaging 
of 150 pts.  
Table 3.2 Corresponding n for specified ranges of Rep. 
Rep 0-0.2 0.2-1 1-500 >500 
n 4.6 4.4(Re-0.03) 4.4(Re-0.1) 2.4 
 
For Pe << 1, diffusion still dominates and thus, the effect of flow on the chemical reaction 
is limited. Assuming a spherical particle in dilute suspension under flow with low 
Reynold’s number and expressing the mass transport problem in the frame of reference 
attached to the sphere, steady state flux under diffusion can be approximated by: 






where ri is the radius of the particle, C∞ is the concentration of the substrate in the bulk, 
Cp is the concentration of the substrate at the surface of the particle, and b is the distance 
from the centre of the particle to the bulk. Cp is assumed to be zero as the substrate is 
expected to be consumed by the enzyme immediately upon arrival in the case of mass 
transport controlled system. C∞ is the initial concentration of the substrate, S0, and b >> ri 
as the bulk is infinitely far away under low flow rates. Eq. (3.10) simplifies to: 
 𝝓𝒅𝒊𝒇𝒇𝒖𝒔𝒊𝒐𝒏 = 𝟒𝝅𝒓𝒊𝑫𝒔𝑺𝟎 (3.11) 
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If Eq. (3.11) is divided by surface area of the particle, this matches the simple model often 
used to represent external diffusion with the assumptions of a boundary layer thickness 
equal to radius and Cp = 0 [86,227]. 
Alternatively, when Pe >> 1, the effect of flow must be accounted for. Eq. (3.12) 
approximates flux under convection (for Rep < 10).   
 𝝓𝒄𝒐𝒏𝒗𝒆𝒄𝒕𝒊𝒐𝒏~𝑷𝒆 × 𝝓𝒅𝒊𝒇𝒇𝒖𝒔𝒊𝒐𝒏 = 𝟒𝝅𝒓𝒊
𝟐𝒖𝒊(𝑪∞ − 𝑪𝒑) (3.12) 
Again, Cp can be approximated as zero and C∞ is the initial concentration of the substrate, 
S0. Eq. (3.12) becomes: 
 𝝓𝒄𝒐𝒏𝒗𝒆𝒄𝒕𝒊𝒐𝒏 = 𝟒𝝅𝒓𝒊
𝟐𝒖𝒊𝑺𝟎  (3.13) 
Both relationships for substrate flux (Eq. (3.11) and Eq. (3.13)) were multiplied by a 
factor of 1000 L/m3 to convert units to mol/s. At the transition between diffusive and 
convective regimes, these process are likely to be additive rather than a discrete switch 
between the two regimes, as described by:  
 𝝓𝒅𝒊𝒇𝒇𝒖𝒔𝒊𝒐𝒏 + 𝝓𝒄𝒐𝒏𝒗𝒆𝒄𝒕𝒊𝒐𝒏 = 𝟒𝝅𝒓𝒊𝑫𝒔𝑺𝟎 + 𝟒𝝅𝒓𝒊
𝟐𝒖𝒊𝑺𝟎 =  𝟒𝝅𝒓𝒊𝑺𝟎(𝑫𝒔 + 𝒓𝒊𝒖𝒊) (3.14) 
Dividing Eq. (3.3) and Eq. (3.14), the relative ratio of kinetic controlled product formation 
to mass transport, or the Damköhler number for the system, Da, is described by: 














When Da << 1, the system is under kinetic control and the rate of product formation is 
described by Eq. (3.3). When Da > 1, the system is expected to be under mass transport 
control and Eq. (3.14) describes the flux of substrate to the surface (and correspondingly, 
the rate of product formation).  
To determine the product formation by individual particles during one inversion, either 
rate of product formation (kinetic or mass transport controlled) can be multiplied by the 
total time of inversion (tinver., e.g. 60 s). This approach assumes that particles continue 
reacting at the same rate after they have reached the base of the device. This assumption 
will be discussed further in Section 3.3.3.4. 
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In order to predict product formation by a known mass of particles of a certain distribution 
(e.g. 5 mg), the predicted amount of product formed per particle of diameter di can be 
multiplied by the number of particles at each di. (Particle number distributions were 
collected by imaging on a morphology microscope, see Figure 2.11 and Figure 2.39). A 
summation of the resulting product formed by each particle size class across the 
distribution of sizes gives the expected reaction rate over one inversion for the specified 
mass and size distribution of silica. These predictions can be compared to experimental 
results. A summary of the variables used in this model is provided in Table 3.3. 
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Table 3.3 Variables used as model inputs. 
Constant Variable Value Units 
Device height h 18.32 mm 
Substrate diffusivity Ds 1.10 × 10-5 cm2/s 
Initial substrate concentration S0 0-10 µM 
Density, fluid ρf 1000 kg/m3 
Density, particle ρs 1860-2180 kg/m3 
Dynamic viscosity ηf 0.001 Pa s 
Gravitational acceleration g 9.81 m/s2 
Particle volume fraction θp 0.2-0.4  
Particle diameter di 1-1000 µm 
Michaelis constant Km 1.65 × 10-2 M 
Total protein immobilised TPI See Table 3.1 µg total protein/mg silica 
Silica surface area SA See Table 3.1 m2/kg silica 
Enzyme surface coverage ESC See Table 3.1 
mg total protein/m2 silica surface 
area  
Maximum reaction rate Vmax 0.3 
U/mg or µmol substrate/min/mg 
enzyme  
(for dried R52-mCh-mSOx-R5-6H) 
Max. reaction rate per unit 
surface area 
Vmax_SA See Eq. (3.4) 
mol substrate/s/m2 silica surface 
area 
Time of between inversions tinver. 60 s 
3.2.5 Experimental comparison to model predictions 
Falling particle sensors were constructed as described above in Section 3.2.2 and rate of 
product formation in the device experimentally determined by the fluorescent signal from 
2-enzyme coupled assay for sarcosine (as presented in Chapter 2). Both silica extracted 
from SC sand and a range of sizes of commercial silica gel 60 were functionalised with 
R52-mCh-mSOx-R5-6H from crude lysate following the protocol described in Chapter 2. 
The silica was suspended in buffer (4.17 mg/mL silica, protein loading per 1 mg silica 
specified in Table 3.1) and loaded into the device with dye AR (4.17 µM), WT HRP 
(0.016 mg/mL) and sarcosine (0-10 µM). After a number of inversions and subsequent 
particle settling, the device was laid on fluorescence flatbed scanner (FFEI) with 505 nm 
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LED for excitation and a CCD RGB linear sensor for detection (Figure 3.5) and 
fluorescence intensity was recorded.  The spectra for the LED and CCD sensor, as 
specified in the equipment manual, can be found in Appendix D. Final concentration of 
sarcosine and number of inversions are specified in the text for each assay. 
 
Figure 3.5 (A) Custom, flatbed fluorescence scanner, with (B) a diagram of signal detection 
elements housed within the scanner.  
The fluorescence images were analysed for grey scale intensity of the red channel in the 
chamber area using ImageJ software. Selection of one particular colour component for 
quantification has been known to give better sensitivity [249] and the red channel has the 
most overlap with the emission spectra of the AR dye (as reported by the manufacturer). 
Fluorescent signal was determined by measuring the average intensity in the device. 
Figure 2.4 shows the calibration curves of fluorescence intensity for known 
concentrations of H2O2 in the presence of WT HRP following the protocol outlined above 
(200 µL total volume), as measured in both the falling particle chamber using the 
fluorescence flatbed scanner and in well plates using the fluorimeter (ex. 530 nm / 
em. 580 nm, slits 5 nm, PMT 800V). A similar LOD was observed with either 
measurement technique.   
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Figure 3.6 Standard curve for AR assay, showing linear relationship of fluorescence intensity 
(blank subtracted) with H2O2 concentrations as indicated, as measured by (A) fluorimeter and (B) 
fluorescence scanner.  
 Results and Discussion 
3.3.1 Design of a falling particle biosensor  
Ultimately, the falling particle devices are intended for use as low-cost diagnostics so 
they should be able to be constructed with low-cost materials and using simple 
manufacturing equipment. Devices were cut from PMMA using a benchtop laser cutter, 
potentially allowing for a wide range of chamber shapes. To explore the feasibility of a 
design utilizing particle sedimentation, three chamber designs were explored (Figure 
3.7A-C). In addition to the parallel sided design presented in Figure 3.1, two designs with 
central constrictions or ‘waists’ were explored, with increasing degree of constriction; 
baffled tubes with similar constrictions have been shown to exhibit efficient mixing in 
oscillatory flow reactors [250] and mixing may be advantageous for increasing signal 
production as it can reduce mass transport limitations [227,243]. The overall aspect ratio 
was preserved across the designs in order to provide consistency in the settling time, as 
determined by the height, and in the depth of the settled particle bed prior to inversion, as 
determined by the width at the top/base and silica volume. However, a better 
understanding of the reaction dynamics of the system may prompt further optimisation of 
the chamber shape in the future. 
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Figure 3.7 Dimensions of the chip designs for the (A) parallel sided, (B) standard waist and (C) 
narrow waist design. All dimensions are in mm. Actual physical dimensions of the chamber varied 
slightly as laser cutting results in some melting.  
After the chambers were cut from PMMA, the seals were adhered by hand to each side 
but considering the intended application of the devices, it was envisioned that they could 
eventually be applied by a desktop laminator for consistency and increased throughput 
while keeping simplicity of manufacture. PMMA with a thickness of 2 mm resulted in a 
robust device that still could allow for sealing with a desktop laminator in the future, 
while 1 mm thick PMMA showed increased susceptibility to accidental flexing, and in 
some cases fracture, which compromised the seal and resulted in leakage. 200-300 µL 
was selected as the initial target volume range for the devices such that they would be 
large enough to handle without requiring significant sample volumes. Although urine, the 
target clinical sample for a prostate cancer test [183], is typically collected in greater 
volume than a finger prick of blood used for some POCTs, larger sample volumes likely 
require larger reagent volumes which would increase total assay cost.  
For initial studies of particle settling behaviour, bio-functionalised silica extracted from 
sand was suspended in buffer within each sealed chamber. To initiate the movement of 
the particles, the device was inverted and the particles are allowed to sediment/settle for 
60 seconds (the majority of the particle mass was observed to settle within this time). The 
settling patterns of the bio-functionalised silica extracted from sand suspended in the 
PMMA / adhesive tape chambers can be seen visually in Figure 3.8 for the (A) parallel 
sided (B) standard waist, and (C) narrow waist designs, flipped about a central horizontal 
axis. For all three designs, immediately following inversion of the device, plumes of 
closely grouped particles are observed. As these plumes contact the bottom wall of the 
chamber they create additional fluid displacement in the system. The larger particles are 
too heavy to become entrained in this fluid displacement and continue their fall 
undisturbed but some smaller particles are redistributed in the fluid as a result. After the 
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fall of the largest particles within the first 6-7 s, the smaller particles continue to fall in a 
more laminar fashion. As discussed above, the relative velocity of the particles with 
respect to their surrounding fluid may influence the rate of product formation by the 
immobilised enzyme as it can affect the diffusion of the substrate to the particle surface. 
Particle image velocimetry (PIV) analysis was used to estimate the falling speeds of the 
particles and thus determine the degree of turbulence within the system and the possible 
effect on reaction rate.  
PIV is a common technique to visualise flows within a fluid and measure velocities of 
those flows. Typically, the fluid is seeded with small particles, selected such that they are 
of a similar density to the fluid. These neutrally buoyant particles are assumed to follow 
the fluid dynamics of the system, becoming entrained in any fluid movement; hence, their 
motion can be used to calculate the speed and direction of the flow. In contrast, the 
particles of extracted silica in the system described here are generally of a larger size and 
of a higher density than the fluid; thus, they cannot be expected to follow fluid patterns. 
Rather, as previously mentioned, their movement causes additional fluid displacement in 
the system. However, conducting PIV on the videos of particle settling in the devices can 
provide estimates of particle velocity during their fall after inversion, making PIV 
analysis a useful tool for an initial understanding of the particle behaviour in the falling 
particle biosensor. 
Factors affecting the settling velocity of sediment particles through fluids are well known 
(e.g. particle size, shape and density; fluid density, fluid viscosity). Theoretically, particle 
settling velocity is determined by equating the effective weight of a particle to the viscous 
resistance of the fluid or drag force, as first presented by Stokes for a sphere in viscous 
fluids with very small Reynolds number [232]. The drag coefficient is an intricate 
function of the flow conditions, as described by the Reynolds number, as well as the 
particle shape [230,235]. In the system described here, the particles are polydisperse, non-
spherical and suspended in a fluid of low viscosity, so it is likely that a relationship 
beyond that of Stokes’ Law will be needed to describe their settling velocity.  
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Figure 3.8 Colour-inverted stills of particle sedimentation for selected time points after flipping for 
the (A) parallel sided, (B) standard waist and (C) narrow waist design. 
Biosensor design utilizing particle-bound enzymes 
104   
Those particles settling in the initial plumes with effective radii in the range of 100-
250 µm fall with a maximum terminal velocity estimated from the PIV data of 1.3-
10.2 × 10-3 m/s (Figure 3.9 and Table 3.4).  At these velocities and particle sizes, the 
particle Reynolds number (Rep, as calculated by Eq. (3.8)) is not in the region in which 
Stokes’ Law is in good agreement with experimental findings (Rep < 0.1) but in the 
transitional regime (1 < Rep < 100). For all three chamber designs, the experimental 
velocities, recorded near the base of the chamber, are lower than the terminal velocity 
expected for a smooth, spherical particles of the same diameters (calculated according to 
the numerical equation developed by Guo that combines the three classical equations for 
settling velocity under laminar flow (Stokes’ Law), intermediate flow and turbulent flow 
(Newton’s Law) [251]). This is anticipated considering the irregular shape of silica 
extracted from sand and resulting frictional forces. Zhiyao et al. [247] proposed a formula 
for the terminal velocity of natural sediment that adjusts for the effect of particle shape, 
however, this does not fully account for the observed decrease in terminal velocity for the 
larger particles.  
 
Figure 3.9 Plot of terminal velocity with respect to particle radius showing both (blue points) 
experimentally observed velocities and (grey curves) theoretical terminal velocities. Predicted 
velocity for the spherical particle is plotted using the relationship defined by [251] and that of 
natural sediment by [247]. 
To account for this discrepancy, the action of the fluid displacement is considered during 
sedimentation. The equations developed by both Guo and Zhiyao et al. disregard 
interactions with other particles or the fluid; however, despite an overall volume fraction 
of particles in the device < 0.003, the local volume fraction of particles in the plumes is 
much higher. Immediately after inversion, hindered settling, from the upward motion of 
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the displaced fluid interacting with the particle(s) [252], can thus result in lower 
velocities.  As can be seen from  Figure 3.9 and Table 3.4, the experimental data of the 
particles falling in the initial plumes of r > 50 µm are comparable with an apparent 
particle fraction of 0.2 - 0.4, as calculated by relationship proposed by Richardson and 
Zaki [252]. Smaller, more dispersed particles falling after the initial plumes, on the other 
hand, show less hindered settling and behave more like smaller volume fraction natural 
sediment. In Table 3.4, light green boxes indicate when the predicted velocities closely 
match the observed velocities in the first row (in grey). The maximum velocity of the 
particles (but not particle position along the x-axis) as they cross the indicated location 
near the base of the device is nearly independent of the design, highlighted in Figure 3.10. 















OBSERVED -- 0.20×10-3 1.13×10-3 5.31×10-3 7.02×10-3 1.02×10-2 
spherical particle 2.57×10-6 2.50×10-4 5.79×10-3 1.96×10-2 3.69×10-2 5.49×10-6 
natural sediment  1.91×10-6 1.90×10-4 4.41×10-3 1.49×10-2 2.78×10-2 4.06×10-2 
particle fraction 
0.2 
6.86×10-7 6.82×10-5 1.60×10-3 6.20×10-3 1.26×10-2 1.90×10-2 
particle fraction 
0.3 
3.71×10-7 3.69×10-5 8.82×10-4 3.70×10-3 7.81×10-3 1.23×10-2 
particle fraction 
0.4 
1.83×10-7 1.82×10-5 4.45×10-4 1.99×10-3 4.51×10-3 7.42×10-3 
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Figure 3.10 Characterization of particle sedimentation for three basic chamber designs of (A) 
parallel sided, (B) standard waist and (C) narrow waist. Plot of the maximum velocity of the 
particles over time as they cross the indicated position near the base of each design (blue line), 
where t = 0 is the time at which the first particle crosses. Bold blue lines show 10 pts moving 
average while grey shows raw data. 
Although terminal velocity of the particles was shown to be nearly independent of 
chamber design (Figure 3.10), the influence of the funnelling waist on particle trajectory 
was evident. Overlaying the frames of the video into a single image shows the combined 
trajectories of the particles through the device, as shown in Figure 3.11. Image 
thresholding analysis of these trajectories predicts that 80-90 % of the chamber volume 
is ‘sampled’ on each inversion by particles passing through the chamber. However, this 
analysis does not consider the fluid movement within the system as a result of the fluid 
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displacement caused by the falling particles, which would likely result in the 
redistribution of the fluid in the region that appears ‘un-sampled’ back into the path of 
the particles falling behind the initial plumes. Without additional buoyant tracer particles 
in the fluid, it is difficult to precisely quantify the impact of this fluid displacement on the 
overall ‘sampling’ of the volume by the particles. In addition, although the waisted 
designs have some areas where the passage of particles was limited, especially when 
compared to the parallel sided design, these trajectories are only for one inversion and the 
device can be inverted multiple times. The multiple inversion approach also allows for a 
longer dispersion time of the particles with the sample while keeping device dimensions 
small and amenable to a POCT. Dispersion of the particles throughout the fluid is often 
beneficial with respect to the reaction rate for large scale bioreactors [227] and may also 
be true in this small scale design.   
 
Figure 3.11 Image overlays showing particle trajectories over time for the (A) parallel sided, (B) 
standard waist and (C) narrow waist design. Images here are compilations of video frames from 2-
14 s after inversion. 
The waisted nature of the design also had an impact on the final resting position at the 
end of sedimentation. For all patterns observed above, the device was “flipped” over 
central horizontal axis; however, the device could easily also be inverted by rotation in 
plane (“tilt”). The initial movement of the chamber also produces fluid movement in the 
system, affecting the sedimentation patterns of the particles. Figure 3.12 shows that the 
positioning of the particles after settling depends on this axis of inversion of the device 
and on the dimensions of the waist of the chamber. It is seen that by narrowing the waist 
of the chamber, the bio-functionalised particles are guided to a resting position beneath 
the central channel, independent of inversion technique. In contrast, the parallel sided and 
standard waist chambers achieve little focusing of the particle settling. By defining the 
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final position of the particles in a central area irrespective of inversion axis, the narrow 
waist shape creates a reproducible inversion pattern with the particles always starting 
from the same location for each inversion. This is not seen in the other designs. Since an 
enzyme linked assay is a dynamic reaction process, this reproducible sedimentation helps 
to ensure that a reproducible process occurs and thus the narrow waist chamber design 
lends itself to a biosensor platform.  
 
Figure 3.12 Effect of shape and inversion technique on particle sedimentation patterns, showing  
(A) rotation in plane (“tilt”) or (B) “flip” over central axis. 
3.3.2 Effect of particle size on falling behaviour 
Although additional processing steps to size-select the silica extracted from local sand 
would increase time and cost, a significant increase in signal generated in a biosensor 
design could justify the additional steps. For example, assuming constant enzyme 
coverage per unit surface area and a system under kinetic control, smaller particles would 
be expected to produce more signal per unit mass. In contrast, a system under mass 
transport control might favour larger, faster falling particles which increase the turbulence 
in the system and reduce diffusion restrictions. To investigate the potential effects of size 
on signal output, an understanding of the effect of size of on settling behaviour in the 
device is first required. Four discrete size classes of commercial silica gel 60 of were 
added separately to narrow waisted devices and their behaviour observed: 6-35 µm, 40-
63 µm, 63-210 µm and 200-500 µm in diameter. These silica size classes were used 
previously in Chapter 2 to investigate the effect of particle size on immobilisation 
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efficiency and their particle distributions can be seen in Figure 2.39. Silica nanoparticles 
produced in house (average diameter of ~250 nm, [239]) were also tested.  
For all size classes of commercial silica, particle positioning ability of the narrow waisted 
design was maintained and they all initially exhibited similar plume falling behaviour to 
the heterogeneous silica extract (Figure 3.13A), followed by distributed settling of the 
remaining particles. Size has a clear impact on the speed of settling; as the median 
diameter of the particle size distribution decreased, it took longer for the first particle or 
cluster of particles to reach the bottom of the device and the velocity was reduced (Figure 
3.14 and Table 3.5). This is expected given the relationships describing particle settling 
velocity include a component for particle size. 
 
Figure 3.13 Particle sedimentation patterns for various silica gel 60 particle size distributions (6-35, 
40-63, 63-210 and 200-500 µm) in the narrow waisted chamber showing images of (A) initial plume 
behaviour and (B) centralised position of the particles (at 15 s). Images in (A) are selected frames at 
2 s, 0.5 s, 0.25 s and 0.5 s, respectively. 
For the smaller size distributions (6-35 µm, 40-63 µm and 63-210 µm), settling times for 
the initial plumes were faster than those predicted by the model by Zhiyao et al. for 
terminal velocity for single natural sediment particles (as calculated for the median 
diameter of each distribution, Table 3.5). In these cases, the smaller particles were 
observed to travel in clouds for which an increase in velocity is expected [235]. For the 
largest silica distribution tested (200-500 µm), the observed initial settling time was 
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slower than the model would predict. This hindered settling behaviour is similar to that 
observed for the largest particles in the extracted silica. Again, the hindrance of the larger 
particles is likely a result of the increased local fraction for those first particles and 
resulting fluid displacement that results in a decreased settling velocity.  
 
Figure 3.14 Characterization of particle sedimentation for various silica gel 60 particle size 
distributions (6-35, 40-63, 63-210 and 200-500 µm) in the narrow waisted chamber, showing plots of 
the maximum velocity of the particles over time as they cross the indicated location the base (blue 
dashed line) of the chamber. Curves shown are smoothed with 10 pts adjacent averaging.  
Table 3.5 Predicted and observed settling times for silica gel 60 size distributions. Green box 
indicates a faster time than predicted, red indicates a slower time. Median diameter values are 
drawn from morphology imaging results. 
Particle size class (µm) 6-35 40-63 63-210 200-500 
Median diameter observed (µm) 25 57 73 339 
Expected settling time for a single natural 
particle (Eq. (3.6) from [247]) 
62 12.3 7.5 0.54 
Time of first plume reaching base (s) 10.88 2.68 1.64 1.36 
 
In addition to changing the settling time of the initial plume, the choice of size distribution 
also alters the overall time period required for the particles to settle out of solution.  Given 
dispersion is predicted to be beneficial to signal development, a longer settling time is 
likely desirable. In the case of the commercial silica 60 of 200-500 µm in diameter, the 
majority of these large particles have fallen in less than 10 s. Although there are some 
smaller particles in this distribution (likely fragments broken off the larger particles) that 
continue to fall for the remainder of the 60 s observed, these are few in comparison with 
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the particles that remain falling for an equivalent mass of silica extracted from sand 
(Figure 3.8). To achieve a level of continued dispersion with the larger commercial 
particles would require almost constant flipping, making this distribution an impractical 
choice for the current design of the falling particle biosensor.  
With each decrease in particle size class, the length of time for the majority of particles 
to settle increased (e.g. with the 63-210 µm distribution most of the particles have settled 
after 25 s). To increase time in suspension, the use of silica nanoparticles (median 
diameter of 245 ± 49.0 nm) in the falling particle device was explored. The silica 
nanoparticles were smaller than the resolution of the high-speed imaging set-up, so no 
PIV analysis was performed on the videos of particle fall. It was observed (Figure 3.15) 
that although the nanoparticles are suspended in a single fluid, after inversion the 
sediment laden portion and the remaining portion form pseudo-immiscible fluids, passing 
each other in separate laminar fronts in the central channel. Here, the upward fluid 
movement in response to the particle stream is clear. The plumes of the two portions of 
the fluid follow the evolution of single-mode Raleigh-Taylor instabilities at the interface 
of a light and heavy fluid in the presence of gravitational acceleration, including the 
development of mushroom-like shapes at later times caused by secondary Kelvin-
Helmholtz instabilities [253]. Here, the sediment laden fluid has an average density higher 
than that of the surrounding ambient fluid and hence, the driving buoyancy force behind 
the plumes is the gravity acting on the higher density of the particles temporarily 
suspended within a fluid. The interface of the two fluid portions is defined by the jump 
in value of particle concentration. The position of the sediment laden fluid front within 
the channel is determined by the initial fall of a few clumps of aggregated particles. (It is 
well known that silica nanoparticles have a tendency to form aggregates [254,255]). This 
laminar behaviour and lack of mixing of the two portions of the sample would limit the 
potential of the immobilised enzymes to sample all of the fluid within the chamber. In 
addition, the smallest particles in this nanoparticle distribution are almost neutrally 
buoyant and thus, do not settle out in a reasonable amount of time (< 10 min) for a POCT, 
and could lead to light scattering challenges for detection of the fluorescent product in 
solution. The settling ability of the particles is also important for the collection of the R5-
mCh-Enz coated particles during the previous step of purification from crude lysate, as 
discussed in Chapter 2. Combined, these characteristics of the silica nanoparticles settling 
behaviour make them a suboptimal choice for the aims of this work.  
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Figure 3.15 Video frames from selected time points for a suspension of silica nanoparticles in the 
narrow waisted chamber design. 
Interestingly, the addition of a few large silica particles (of 200-500 µm in diameter) in 
with the silica nanoparticles changes these sedimentation patterns (Figure 3.16). The 
device in Figure 3.16A was loaded only with the silica nanoparticles. Despite a small 
plume of clustered particles resulting from a higher number of nanoparticle aggregates in 
this suspension, the pseudo-immiscible fluid behaviour was still observed (as shown in 
the final image). However, this behaviour was not observed when several larger particles 
were subsequently added to the same device, indicating a greater degree of mixing in the 
device in the presence of these larger particles (see the final frame at 48 s in Figure 
3.16B). These larger particles also entrain the smaller nanoparticles in their wake, driving 
faster settling. This effect is evident in the plume of aggregated nanoparticles reaching 
the base of the device more quickly in the presence of the larger particles (14.8 s instead 
of 23.8 s) and the correspondingly increased velocity of the nanoparticle plume as it 
crosses a location near the base of the device (Figure 3.17).  
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Figure 3.16 Video frames from selected time points for a suspension of silica nanoparticles in the 
narrow waisted chamber design, (A) without and (B) with a few larger particles (200-500 µm). 
  
Figure 3.17 Characterization of particle sedimentation patterns for a suspension of silica 
nanoparticles in the narrow waisted chamber design, with (dark blue) and without (red) a few 
larger particles added (200-500 µm), showing (A) plot of the maximum velocity of the particles over 
time as they cross the indicated position near the base of the device (dashed blue line) and (B) the 
velocity profile across that line when the plume of aggregated particles first crosses (14.8 s and 
23.8 s with and without large particles, respectively). Bold lines in (A) show 10 pts moving average 
while grey shows raw data. 
The entrainment of the smaller particles by larger ones is also visible in the settling 
behaviour of both the silica extracted from sand and the commercial silica gel < 63 µm 
in diameter, both of which have broad heterogeneous distributions of particle size (see 
Figure 2.11 for size distributions). Figure 3.18 shows the maximum velocity plots over 
time for these particles in the narrow waisted device. The commercial silica gel < 63 µm 
lacks the largest particles observed in the extracted silica. Correspondingly, the maximum 
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velocity observed during the initial period of particle fall (< 10 s) decreased for the 
commercial silica gel and the time at which the first particle or cluster of particles reached 
the bottom increased (from 1.1 s to 2.2 s). The remaining particles fall in a dispersed 
fashion for both silica distributions.  
 
Figure 3.18 Characterization of particle sedimentation for (A) silica gel 60 <63 µm and (B) 
extracted silica in the narrow waisted chamber, showing images of selected time points during 
particle sedimentation. (C) Plot of the maximum velocity of the particles over time as they cross 
near the base of the chamber for (red) silica gel 60 <63 µm and (black) extracted silica. Bold lines 
show 10 pts moving average while grey shows raw data. 
A particle distribution that settles in a reasonable time, enabling purification in the earlier 
stages of the enzyme production process and removing scattering effects from the final 
signal processing would be advantageous (unlike the nanoparticles explored above). 
Moreover, given the particles are intended to be collected by sedimentation in the 
purification stage, the smallest particles in a mixed distribution that fail to settle would 
be lost at this stage. On the other hand, very large particles (d > 200 µm) do not remain 
in suspension for long, and a distribution consisting of only these would require constant 
flipping to achieve dispersion. Hence, a particle distribution largely within these 
boundaries is desirable. In addition, the combination of large particles with smaller 
particles enables high surface area per unit weight from the smaller particles in 
conjunction with faster settling rates, driven by the larger particles. The increased mixing 
resulting from these large particles is potentially also an advantage for signal 
development. While these characteristics potentially enable a more appropriate device 
from a use perspective, the effect of particle size distribution on rate of product formation 
by the immobilised enzyme (and thus signal generation) is a critical parameter that must 
be evaluated before a selection of carrier particle can be made. Understanding this will 
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involve understanding the interplay between kinetic or mass transport rates in a falling 
particle system.  
3.3.3 Modelling product formation by particle-bound enzymes  
3.3.3.1 Determining reaction control: kinetic versus mass transport 
The reaction efficiency of immobilised enzymes is either controlled primarily by the 
catalytic activity of the immobilised enzyme (as determined by inherent characteristics of 
the enzyme and loading capacity of the substrate) or by the mass transport of the substrate 
to the surface of the particle (Figure 3.19). For a falling particle, the mass transport is 
affected by the flow conditions around the particle, which is in turn determined by the 
settling behaviour of the particle. The ratio of the product formation rates for each regime, 
the Damköhler number, Da, can be used to determine the ratio of catalytic control to mass 
transport for each falling particle (Eq. (3.15)). When Da << 1, the system is under kinetic 
control and well-known Michaelis-Menten reaction kinetics for enzyme turnover can be 
used to calculate rate of product formation. In contrast, when Da >> 1, the formation of 
product is limited by the rate of mass transport of the substrate to the surface, with all 
substrate expected to be converted to product by the enzyme immediately upon arrival. 
Calculating Da provides a first look at the driving forces for product formation by the 
immobilised enzyme on the falling particles in this system. 
 
Figure 3.19 Schematic showing the two regimes of reaction control – mass transport and kinetic. 
(mCh structure 2HQ5 and mSOx 3QSE from RCSB Protein Data Bank). 
Biosensor design utilizing particle-bound enzymes 
116   
In chemical engineering, the first Damköhler number is typically reaction rate with 
respect to convective mass transport rate and the second Damköhler number is with 
respect to diffusive mass transport rate [244]. In Da described by Eq. (3.15), the 
convective and diffusive rates are combined to provide a better estimate of the mass 
transport rate in the transition region where these processes are likely additive (Pe ≈ 1). 
When either process is dominating, the Da described here becomes equal to the relevant 
conventional Damköhler number (Figure 3.20).  
 
 Figure 3.20 Ratio of predicted product formation rates by kinetic and mass transport processes, 
Da, as determined by Eq. (3.15) (green) and by conventional descriptions of Da (blue). Plotted for 
silica extracted from sand with R52-mCh-mSOx-R5-6H and 6 µM sarcosine.    
The rates of mass transport are related to hydrodynamic conditions experienced by each 
particle, which can be approximated by its velocity relative to the surrounding fluid. The 
experimentally observed particle settling behaviour was combined with theoretical 
models to assign a velocity to each particle diameter (d) class (discussed in detail in 
Section 3.2.4). This approach was used for all silica types, given similar settling behaviour 
was observed (plumes followed by dispersed particles). Figure 3.21A shows the ensuing 
velocity relationship for each silica type, accounting for their respective densities (as 
reported in Table 2.4 – 2180 kg/m3, 2000 kg/m3 and 1860 kg/m3 for silica extracted from 
sand SC, silica gel 60 discrete size classes and silica gel 60 <63 µm, respectively). 
Terminal velocity increases with an increase in density (Eq. (3.6) and Eq. (3.7)) so the 
extracted silica is predicted to fall faster for an equivalent diameter particle.  At these 
velocities and particle sizes, Rep < 10 for particles of d < 500 µm and Rep < 1 for particles 
of d < 200 µm, indicating that relationships for substrate flux developed under the 
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assumption of low Reynolds number, as described by Eq. (3.11) and Eq. (3.13), still apply 
for the majority of particles (Figure 3.21B). 
 
Figure 3.21 Particle velocity and associated dimensionless numbers with respect to particle 
diameter, showing (A) velocity assigned to each silica type based on experimental data and the 
corresponding plots of (B) Rep and (C) Pe. (D) shows the region of (C) where Pe ≈ 1. 
Combining these velocities with experimentally determined parameters for R52-mCh-
mSOx-R5-6H on silica (as determined in Chapter 2 and specified in Table 3.3 and Table 
3.1), Da << 1 for all particle sizes and silica types (Figure 3.22). This suggests that the 
system is reaction rate limited by several orders of magnitude. Nonetheless, it is important 
to test the sensitivity of this result to changes in the assumptions and inputs. Discussion 
of the changes in Da with silica type will be included in this sensitivity analysis.  
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Figure 3.22 Ratio of predicted product formation rates by kinetic and mass transport processes, 
Da, plotted against particle diameter for the silica types tested in the falling particle biosensor.   
Looking at Eq. (3.15), for Da > 1, it would require one or more of the following changes: 
 decrease in the flow experienced by the particle (ui) 
 increase in enzyme surface coverage (ESC) 
 decrease in the diffusivity of the substrate (Ds) 
 increase in specific activity of the enzyme (Vmax)  
 increase in affinity of the enzyme for the substrate (corresponding to a decrease 
in Km)  
All the above components of Da are constant across all particle sizes with the exception 
of particle velocity, ui. The falling speed of the particle determines the ratio of advection 
of the substrate by the flow over diffusion rate driven by gradient, as characterised by Pe 
(Eq. (3.5)). Higher flow rates are associated with an increased rate of mass transport as 
flow helps overcome limitations of diffusion by decreasing the effective distance from 
the surface to the bulk solution (i.e. diffusion boundary layer). Under slow flow or the 
zero velocity case, the effect of flow on the chemical reaction is limited. Figure 3.21C 
shows the corresponding Pe for each particle size class. For the smallest particles, Pe < 1 
and therefore diffusive flux is the dominant process in mass transport of the substrate and 
a decrease in flow is unlikely to change Da for these particles. However, for larger 
particles (d > ~20 µm), Pe > 1 and flow is predicted to increase rate of mass transport, 
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thus making the enzyme on these larger particles more likely to be under kinetic control 
(Da << 1). The diameter at which diffusion is no longer expected to dominate and flow 
must be considered (Pe ≈ 1) shifts slightly for each silica type (Figure 3.21D), as the 
variance in their density changes the relationship between the particle velocity with 
respect to diameter (Figure 3.21A). Thus, to probe a change in ui that could result in 
Da > 1 for those larger particles, one can consider the extreme scenario where the 
particles are a very slow flow or at zero velocity, such that flow no longer has an effect 
and the rate of mass transport is determined only by diffusion processes. Indeed, this no 
flow scenario is reflective of the particles once they have reached the base and are 
stationary (at least initially before it would be necessary to account for restricted access 
to the bulk solution and ensuing local depletion of the substrate – as discussed in Section 
3.3.3.4). Nonetheless, assuming all other system parameters remain unchanged, even this 
scenario does not result in Da > 1 for the size range of particles studied here (1-1000 µm 
in diameter, see blue dashed line in Figure 3.23).  
The remaining parameters are subject to changes in enzyme characteristics (Vmax, Km), 
substrate properties (Ds) or silica surface-protein interactions (ESC). In the case of Vmax 
and ESC, the increase in Da will be proportional. For Km, the relationship is inversely 
proportional. The same is true for Ds when Pe < 1, i.e. mass transport is diffusion limited. 
In the system described here with R5-mCh-Enz proteins immobilised on silica, the 
surface coverage (ESC) is dependent on the ionisation of the silanol groups, the degree 
of which varies across types of silica [105–109]. The difference in Da for the various 
silica types in Figure 3.22 is largely a result of this variance in ESC (Table 3.1) rather 
than the slight variation in particle velocity (Figure 3.21A). Nonetheless, an increase of 
several orders of magnitude in surface coverage is unlikely as the silica surfaces are close 
to saturation with the enzyme for the immobilisation conditions explored here (as 
discussed in Chapter 2, see Figure 2.41 and Figure 2.43).  
With respect to substrate diffusivity, a decrease is expected if the substrate is larger in 
size or the viscosity of the solution increases (assuming operation at a constant 
temperature). However, a significant change in substrate diffusivity is unlikely even if the 
system were to be used with other enzymes as many substrates are similar in size to 
sarcosine and have diffusivities of a similar order of magnitude. With respect to possible 
changes in viscosity, a switch to a more viscous clinical sample type (e.g. blood serum) 
over buffer would only be expected to double the viscosity. As observed for glucose in 
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cell culture medium as compared to phosphate buffer, doubling the viscosity produced 
less than double an increase in the diffusivity [256]. 
A substantial change in specific activity (Vmax) or affinity (Km) is unlikely for any batch 
to batch variation of the silica-immobilised R52-mCh-mSOX-R5-6H given the 
consistency observed experimentally, but a large degree of change is likely when 
considering the range of other enzymes with which this system could be used. For 
instance, SOx belongs to the same family of enzymes as the ubiquitous glucose oxidase, 
which has a specific activity ranging from 172-300 U/mg; however, the specific activity 
for the one electron process with SOx is known to be an order of magnitude lower in 
comparison with the two electron oxidation mechanism involving glucose oxidase. This 
is consistent with the fusion SOx explored here, which has an apparent specific activity 
of only ~3 U/mg immediately after immobilisation, which decreases to 0.3 U/mg after 
drying, as used in the falling particle sensor (Table 2.12 and Figure 2.34). 
Given the proportionality of Da with respect to the parameters Vmax, Km, and ESC, the 
magnitude of their combined effect on Da can be evaluated by investigating an equivalent 
magnitude of change in one, as demonstrated in Figure 3.23 with enzyme activity (Vmax) 
for both scenarios of flow (solid lines) and no flow (dashed lines). In this analysis of 
change in Vmax, the value used for ESC is the highest observed as it was the most likely 
to support a change in Da (573 mg total protein/m2 silica surface area for silica extracted 
from sand, Table 3.1). For particles falling at the speeds observed experimentally for SC 
extract (solid lines), even when the activity of the enzyme has increased by three orders 
of magnitude to 300 U/mg (similar to that of glucose oxidase), the system is not predicted 
to be under mass transport control (solid red line). In the case of slow or no flow when 
diffusion would dominate the mass transport process (dashed lines), the particle diameter 
at which the system becomes mass transport limited decreases with the increase in 
enzyme activity. Where Da ≈ 1, the system is in the transitional regime so additional 
simulation would be required to control for the non-valid assumptions, e.g. dilute 
particles. However, the falling particles under observation here are not in a scenario of 
limited flow (except once they have reached the base –this will be discussed further in 
Section 3.3.3.4). Moreover, no significant changes are expected in the values of the 
remaining parameters for silica functionalised with R52-mCh-mSOX-R5-6H (Vmax, Km, 
ESC, Ds), so kinetic control is predicted across all particle sizes.  
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Figure 3.23 Ratio of predicted product formation rates by kinetic and mass transport processes, 
Da, plotted against particle diameter for a range of enzyme activity values for (solid lines) particles 
falling at velocities estimated by experimental observation and (dashed lines) particles in a very 
slow or no flow scenario.   
The ratio Da can also be plotted using the experimental parameters for the HRP-mCh-
R5-6H construct immobilised on silica extracted from SC sand (where 
Vmax = 0.018 U/mg, Km = 1.6 mM, as reported in Chapter 2, and Ds = 1.43 × 10
-9 m2/s for 
H2O2 [257]). In this case, the protein was not immobilised at saturation given the low 
expression level and correspondingly low concentration of the purified protein, so ESC 
is reduced as compared to immobilisation with R52-mCh-mSOx-R5-6H 
(ESC = 128 mg protein/m2 silica surface area). Under these conditions, particles of all 
diameters are still predicted to be under kinetic control (purple line in Figure 3.23).  
In contrast, plotting Da for WT HRP parameters, as determined for the soluble enzyme 
(Km = 8 µM and Vmax = 386 U/mg, see Chapter 2), shows that the system is expected to 
be under diffusion control for all particle sizes (black line in Figure 3.23). This 
hypothetical case assumes no loss of enzyme activity or substrate affinity due to 
immobilisation and that immobilisation can be achieved with similar ESC to R52-mCh-
mSOx-R5-6H on SC extract (ESC = 573 mg protein/m2 silica surface area). The predicted 
rates of product formation for different silica size classes under this hypothetical case can 
be compared with the predicted rates for a kinetically controlled system in the next section 
and both compared against relative ratios of product formed experimentally (Section 
3.3.3.3).  
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3.3.3.2 Predicting product formation for silica particle distributions 
Since kinetic control is predicted for particle-bound R5-mCh-Enz across all particle sizes, 
even while they are settled at the base (barring significant changes in local substrate 
concentration – see Section 3.3.3.4 for discussion on this), the rate of product formation 
per particle is described by Eq. (3.3) (assuming steady state Michaelis-Menten reaction 
kinetics where S0 < Km). In the hypothetical case of particle-bound WT HRP where 
diffusion control is predicted, the rate of product formation per particle is described by 
Eq. (3.14). Figure 3.24 shows the predicted rates of product formation per silica size class 
based on these relationships and the experimental parameters defined for each of the silica 
types explored here (including their respective densities (Table 2.4) and enzymatic 
parameters (Table 3.3)).  
 
Figure 3.24 Predicted rate of product formation per silica size class for (A) silica functionalised 
with R52-mCh-mSOx-R5-6H under kinetic control (parameters in Table 3.3) and for (B) the 
hypothetical case of mass transport control using WT HRP enzyme parameters (equivalent to 
parameters in (A) apart from Km = 8 µM and Vmax = 386 U/mg). In both cases, S0 = 6 µM and 
Ds = 1.1×10-9 m2/s.  (C) Region of (B) showing the change in rate as a result of density for larger 
particles where Pe > 1 and flow affects substrate flux. 
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Under kinetic control (Figure 3.24A), predicted product formed during an inversion 
varies with silica type due to the variance in ESC (or lack thereof as in the case of 
commercial silica gel 60 of 6-35 µm and <63 µm in diameter, see Table 3.1). In contrast, 
under mass transport control (Figure 3.24B), variance in ESC is no longer a factor and 
the predicted rate of product formed varies slightly instead with density only for the larger 
particles (where Pe > 1 and velocity affects substrate flux). Increased relative flow as a 
result of higher density decreases the thickness of the boundary layer and increases the 
substrate flux to the surface. 
Multiplying either of these predicted reaction rates for a particle by the time between 
inversions (tinver, i.e. 60 s) produces the expected product formed by the particle during a 
single inversion. These relationships are plotted with respect to particle diameter in Figure 
3.25A and B for commercial silica gels with discrete size ranges (6-35, 40-63 and 63-
210 µm). The differences in their ESC and densities are small so the curves appear 
essentially equivalent. 
 
Figure 3.25 Predicted product formed per individual particle during one inversion across particle 
diameter for commercial silica gel 60 particle distributions (in the presence of 5 µM sarcosine), 
under (A) kinetic control and (B) mass transport control.  
The predicted product formation by individual particles of diameter di during one 
inversion can be multiplied with a size distribution of particles to predict the total product 
formed by a mass of particles with a known distribution; Figure 3.26 shows the number 
distributions of the silica types explored here for a known mass (0.875 mg). Valencia et 
al. demonstrated the importance of considering total particle distribution as input rather 
than considering average particle size in their theoretical model of immobilised enzyme 
reactor performance [258]. They predicted a lower conversion rate when using the 
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distribution as compared to the average particle size, suggesting that the positive effect 
of smaller size particles did not compensate for negative effect of particles of larger size. 
The magnitude of the difference depended on the standard deviation of the distribution, 
with a wider distribution resulting in a larger decrease in conversion rate when compared 
to predictions made using average particle size as the input. Thus, silica size distribution 
rather than average particle size was used to predict product formation in the analysis 
presented here.  
 
Figure 3.26 Number of particles of each di in the distribution for 0.875 mg for (A) discrete size 
classes of silica gel 60 and (B) heterogeneous silica distributions of commercial silica gel 60 <63 µm 
and silica extracted from sand.  
Figure 3.27 shows the resultant plots from the multiplication of product formation during 
one inversion (Figure 3.25) and particle distribution (Figure 3.26) for the commercial 
silica gel with discrete size ranges. The product formation in the hypothetical case of mass 
transport control is also included. Figure 3.28 shows similar plots of product formation 
corresponding to the characteristics determined experimentally for silica extracted from 
sand and commercial silica gel <63 µm. Predicted total product formed during one 
inversion of the device with the known mass (0.875 mg) and distribution of particles is 
found by summing the predicted products for each size class di as formed by all the 
particles of that size (approximately equivalent to area under the curve (AUC)). It should 
be noted that these predictions assume no change in product formation rate by the 
particles once they have settled to the base, an assumption which will be discussed further 
in Section 3.3.3.4. 
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Figure 3.27 Predicted product formed in one inversion by 0.875 mg of commercial silica gel 60 
particle distributions (in the presence of 5 µM sarcosine), showing product formation under (A) 
kinetic control and (B) mass transport control.  
 
Figure 3.28 Predicted product formation by silica extracted from SC sand and silica gel 60 <63 µm 
(in the presence of 6 µM sarcosine), showing product formed per (A) individual particle during one 
inversion across particle diameter and (B) by 0.875 mg of respective distributions.  
The total product produced per inversion by the particles (area under the curve) can be 
multiplied by number of inversions to calculate predicted total product formed after said 
inversions. Figure 3.30 shows the theoretical product (H2O2) produced by the various 
silica types over time (assuming kinetic controlled system in all cases), plotted as product 
concentration in the 200 µL assay volume of the narrow waist falling particle chamber. 
Notably, for SC extract and silica gel 60 <63 µM, product levels are expected to be above 
the limit of detection for the scanner (Figure 2.4B) after 5 min (in the presence of 6 µM 
sarcosine). The same is true for the silica gel 60 discrete size ranges when they are allowed 
to react for longer (~30 min). These predictions of product formed by silica size classes 
and types were compared to experimental results to determine the validity of the model. 
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Figure 3.29 Theoretical product produced over time by R52-mCh-mSOX-R5-6H on (A) silica gel 60 
<63 µm and silica extract (with two different loadings) in the presence of 6 µM sarcosine and on (B) 
silica gel 60 discrete size ranges (6-35, 40-63 and 63-210 µm) in the presence of 5 µM sarcosine 
(where the device is inverted every 60 s).  
3.3.3.3 Comparison of predictions with experimental results 
The predicted product formation by the falling particles during one inversion (and 
correspondingly substrate consumption) is < 0.5 % of the total substrate in the device for 
all silica variants functionalised with R52-mCh-mSOx-R5-6H, so the steady state 
assumption regarding bulk concentration of the substrate should be valid. Figure 3.30 
follows the increase in fluorescence with inversions of bio-functionalised silica extracted 
from sand, revealing a linear relationship with time, even for 30 inversions (= 30 min), 
and confirming experimentally the steady state assumption.  
 
Figure 3.30 Fluorescence increase with device inversions/time in the narrow waisted chamber in the 
presence of 6 µM sarcosine and R52-mCh-mSOx-R5-6H immobilised on silica extracted from sand 
at ESC of 573 mg protein/m2 silica surface area. Time between inversions was 60 s.  
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For a kinetically controlled system, one of the driving forces for product formation is the 
quantity and activity of the enzyme added. In this system, the immobilisation of the R5-
mCh-Enz constructs was shown to be largely on the surface of the particles (Chapter 2). 
In addition, the enzyme coverage on the surface (ESC) is expected to be consistent across 
particles within a distribution as immobilisation efficiency was shown to be closely 
related to surface area for silica of the same type under saturated conditions (Figure 2.41). 
Hence, total enzymatic activity for a distribution of particles should be correlated with 
total surface area and thus, a mass of smaller particles is expected to produce product at 
a greater rate than the same mass of larger particles with the same enzyme loading. 
These predictions can be tested against experimental results. The same mass (0.875 mg) 
of three discrete size classes of commercial silica gel with minimal overlap in size ranges, 
each functionalised with R52-mCh-mSOx-R5-6H, was added to separate narrow waisted 
devices with substrate (sarcosine, 5 µM final) and other necessary reagents (AR dye and 
soluble WT HRP) (Figure 3.31). The number distributions across particle size for each 
silica mass can be seen in Figure 3.26A. Fluorescent signal was measured at 40 minutes 
with an inversion every minute. Table 3.6 shows the experimental fluorescence intensity 
and expected product formation based on the area under the curve (AUC) for either a 
kinetically or mass transport limited system, all normalized to the result of the 6-35 µm 
silica. The predicted results for a system under kinetic control match the trends observed 
experimentally when comparing the different size classes. In contrast, under mass 
transport limited conditions, the particle distributions of larger size are predicted to 
perform better, diverging from experimental trends. This is in line with expectations given 
the system was predicted to be under kinetic control (Da < 1) for the experimental 
conditions of R52-mCh-mSOx-R5-6H on silica particles and that the mass transport 
control is a hypothetical case using the enzyme parameters for soluble WT HRP. The 
predicted results for the kinetic controlled regime are within experimental standard error 
for the 40-63 µm size class, however, the model predicts slightly higher product 
formation than observed from the 63-210 µm size class. It was observed during video 
analysis of particle fall that a small fraction of these particles were sticking to the seal 
used to create the chamber. This would limit their movement through the sample as well 
as their accessible surface area (and thus accessible enzyme), which may help explain the 
difference between experimental and predicted results. This sticking behaviour was not 
observed for the other size classes tested.  
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Figure 3.31 Comparison of silica gel 60 size classes in the narrow waisted device for the detection of 
sarcosine (5 µM) via AR fluorescence, shown (A) visually and (B) by the corresponding change in 
average signal intensity at 40 minutes. 
Table 3.6 Comparison of experimental and predicted results for various silica gel 60 size classes in 
the narrow waisted device for the detection of sarcosine (5 µM) via AR fluorescence, normalised to 




fluorescent signal  
Predicted signal (AUC) 
Kinetic control 
Predicted signal (AUC) 
Mass transport control 
6-35 1 ± 0.07 1 1 
40-63 0.45 ± 0.06 0.45 1.42 
63-210 0.17 ± 0.05 0.34 1.72 
 
While the predictions for narrow size distributions of silica gel 60 were matched well 
with experimental results, a similar comparison can be done between commercial silica 
<63 µm in diameter and extracted silica.  Like the silica extracted from sand, silica gel 60 
<63 µm has a size distribution with higher heterogeneity, albeit without the largest 
particles observed for the extracted silica. For this comparison, 0.875 mg of each silica 
was used with 6 µM final sarcosine in the narrow waisted chamber. Reaction time could 
be decreased from 40 minutes used above to seven minutes as these distributions have 
more enzyme per unit mass due to the presence of smaller particles and the increased 
enzyme loading capacity (ESC) of extracted silica (Table 3.1). Both are predicted to be 
above the LOD for the scanner after reaction for > 5 min (Figure 3.29). Again, the 
predicted results for a kinetically controlled system reflect the trends observed 
experimentally; extracted silica produces more signal in the same number of inversions, 
despite having a distribution shifted towards the larger particles. Given the system is 
expected to be primarily reaction rate limited, the superior performance of the extracted 
silica is likely related to its higher loading capacity.  
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Figure 3.32 Comparison of signal intensity at 7 minutes for silica gel 60 <63 µm and SC extract 
(ESC = 286 mg protein / m2 silica surface area) in the narrow waisted device for the detection of 
sarcosine (6 µM) via AR fluorescence. 
Table 3.7 Comparison of experimental and model predicted results silica gel 60 <63 µm and SC 
extract in the falling particle device for the detection of 6 µM sarcosine via AR fluorescence, 
normalised to SC extract.  
Particles Measured fluorescent signal Predicted signal (AUC) 
SC extract 1 ± 0.10 1 
Si60, <63 µm 0.70 ± 0.10 0.68 
 
It is also possible to compare the best performing across both of narrow and wide particle 
size distributions: extracted silica versus silica gel 60 6-35 µm. Experimentally, seven 
inversions of extracted silica produced 72 ± 6.7 % of the signal observed for 40 inversions 
of the 6-35 µm silica gel 60, compared to 66 % predicted by the model. Again, the 
predicted results reflect experimental trends. Overall, the match of model predictions with 
experimental results supports not only the prediction that the system is kinetically 
controlled for all particle sizes but also supports the use of the model as a tool to help 
optimise sensor design using a falling particle approach.  
3.3.3.4 Limitations of the model 
Although the predictions of product formation match well with experimental trends, it 
should be noted that the model does not fully reflect the behaviour observed in the falling 
particle devices. For instance, the particles are considered to be in dilute suspension, 
which does not reflect the situation of those particles the initial plumes. Those particles 
inside the plumes would experience less relative motion with respect to their surrounding 
fluid. This decrease in relative velocity could shift the reaction towards diffusion control, 
and hence the model could again be overestimating their signal contribution. However, 
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given that particle-bound R5-mCh-Enz were still predicted to be under kinetic control in 
a zero flow condition, this is unlikely. In addition, within the plumes, the local 
concentration of the substrate is more likely to decrease over time. Given S << Km and 
the system is expected to be under kinetic control, local substrate concentration will affect 
the rate of reaction, which means the product formation rate could be overestimated for 
these particles. This decrease in local substrate concentration could also occur for those 
particles falling directly behind another particle. However, the redistribution of fluid 
caused by the falling particles could help alleviate depletions in local substrate 
concentration for these particles and is also unaccounted for in the current description of 
product formation for this system.   
Depletion of the local substrate should also be considered with respect to those particles 
within the bed of settled particles at the base of the device. As mentioned in Section 
3.3.3.1, once settled, the particles are essentially in the scenario of slow or no flow. 
Considering the system is expected to be under kinetic control even in this scenario (see 
blue dashed line in Figure 3.23), the particles were predicted to consume substrate at the 
same rate while settled. This assumed minimal changes in the local concentration of the 
substrate, however, for those particles within the settled bed, substrate from the bulk 
would be required to diffuse through a porous network to reach the buried enzymes. Thus, 
depletion should be accounted for when the settled particles are expected to consume a 
significant portion of the substrate in their immediate vicinity, as access to the bulk is 
reduced.  
The void volume of the settled bed can be used to estimate the local substrate available 
for consumption. Micro-computed tomography (micro-CT) imaging of packed beds made 
with the silica extract and the silica gel 60 <63 µm indicated a void fraction, θv, of ~25 % 
(see Chapter 4). With this information, void volume (Volvoid) can be calculated using the 
relationship: 
 𝑉𝑜𝑙𝑣𝑜𝑖𝑑 = 𝑉𝑜𝑙𝑠𝑏
𝜃𝑣
(1−𝜃𝑣)
  (3.16) 
where Volsb is the total volume of the particles expected to settle in 60 s and thus, form 
the settled bed. Volvoid can be multiplied by starting concentration of substrate (S0) to get 
total molar amount of substrate in the local zone. This can be compared to the predicted 
product formation by the particles over the time they spend in the settled bed to indicate 
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if it would be necessary to account for a local depletion zone in the modelled rates of 
product formation.  
Predicted product formation by each particle in the settled bed can be estimated by 
multiplying rate of product formation (Eq. (3.3)) by time spent in the settled bed. For each 
particle size class, it is possible to estimate their time in the settled bed by subtracting 
their time of fall from the time between inversions (60 s). The time spent falling for each 
particle is determined by particle velocity and device dimensions, as described by: 
 𝒕𝒊 = 𝒉 𝒖𝒊⁄   (3.17) 
where h is the height of the chamber (Table 3.3). Those particles not expected to settle 
within one inversion period have their falling time capped to the time between inversions. 
Figure 3.33 shows the assigned falling time for each size class. 
 
Figure 3.33 Assigned reaction time for each particle size based on estimated velocity, shown here 
for silica gel 60 size classes with a density of 2000 kg/m3.  
Combining Eq. (3.3) with Eq. (3.17), the quantity of product formed by each particle after 
settling is described by Eq. (3.18). 




𝟐)(𝟔𝟎 − 𝒕𝒊) (3.18) 
Again, Eq. (3.18) can be multiplied a known particle distribution and area under the curve 
calculated to estimate predicted total product formed by the settled bed of that silica size 
distribution. Table 3.8 shows this for each silica class compared with the estimated 
substrate available for consumption in the void volume (Eq. (3.16) and S0). Where the 
predicted product formed is only a small portion of the substrate available in the void, 
local depletion is not likely to be significant (e.g. silica gel 60 < 63 µm).  
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In contrast, where the predicted product formed is a significant portion of or greater than 
the void substrate available, this indicates that a local depletion zone should be taken into 
consideration when predicting rates of product formation for those particles in the settled 
bed. This is the case for silica extracted from sand, especially when ESC is increased 
close to saturation at 573 mg protein / m2 silica. Under these conditions, the available 
substrate in the void would be consumed before the next inversion if the particles in the 
settled bed continued producing product at the initial rate. Thus, for the silica extract, the 
particles in the settled bed are likely to experience a local depletion zone during the 
inversion period. 
Table 3.8 Void substrate available for consumption compared to expected product formation by the 







in the void (mol) 
Product formed by 
the particles while 
settled (mol) 
Ratio of the 
predicted product 
to void substrate  
6-35 74 5 1.44 × 10-13 1.67 × 10-14 0.12 
40-63 74 5 7.07 × 10-13 1.49 × 10-13 0.21 
63-210 77 5 7.27 × 10-13 1.57 × 10-13 0.22 
<63  74 6 4.14 × 10-14 3.49 × 10-15 0.08 
SC extract 286 6 6.52 × 10-13 5.56 × 10-13 0.85 
SC extract 573 6 6.52 × 10-13 1.10 × 10-12 1.69 
 
For those particles within the bed that are likely to face local substrate depletion, their 
rate of product formation would be expected to decrease accordingly. For example, 
considering a single particle with its corresponding portion of the void volume (25 % of 
particle volume), Figure 3.34 shows the estimated decrease in product formation rate as 
a result of the decrease in local substrate concentration. This clearly indicates that a local 
depletion zone would reduce the contribution of the settled particles to the total product 
formation over time.  
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Figure 3.34 Product formation by a single particle (d = 100 µm) over time where S0 = 6 µM and 
ESC = 573 mg protein / m2 silica and Vmax = 0.3 U/mg, assuming a local depletion zone equal to 
25 % particle volume, as shown in (B), that has no access to the bulk solution and continuous 
redistribution of the substrate in this zone. 
This finding is supported by experimental results comparing a change in protocol for 
inverting the device when loaded with the silica extract at high enzyme loading 
(ESC = 573 mg protein / m2 silica). Figure 3.35 compares the result of two different 
protocols: (A) regular inversions every 60 s (as done for comparison of the various silica 
classes) and (B) two inversions of the device with 60 s in-between and five minutes of 
stationary position. In each case the fluorescence is measured at seven minutes from 
addition of the substrate (6 µM sarcosine), either by measuring average intensity in the 
top chamber (Figure 3.35B) or by calculating the AUC of a central intensity profile 
(Figure 3.35C). Assuming the same rate of product formation by both falling and settled 
particles, the model would predict Protocol B with only two inversions to have 100 % of 
the signal of Protocol A with seven inversions; however, experimentally Protocol B 
shows 50 % of the signal from the multi-inversion protocol. This confirms that substrate 
is being turned over inefficiently by the particles while they are settled at the bottom of 
the chamber and that the efficiency increases during settling as the particles pass through 
the fluid. Further simulation and experimental validation could help quantify the 
contribution to the signal from the settled particles and support the development of a 
model where particles switch between falling and settled states. 
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Figure 3.35 Comparison of two flipping protocols for the detection of sarcosine via AR fluorescence 
in the narrow waist device, shown (A) visually, (B) by the corresponding change in average signal 
intensity in the top portion of the chamber and (C) by the change in intensity profile throughout the 
device, plotted along a central line perpendicular to the base. Blank is subtracted for both (B/C). 
Overall, a better understanding of not only the settled bed, but also those particles falling 
in plumes through simulation and experimental validation would help optimize the design 
of a falling particle chamber and selection of silica size distribution. For instance, the 
reduced contribution of the settled particles after some time suggests that a more 
consistent time in suspension per particle by using particles of similar size would be 
advantageous compared to a distribution where some portion of the particles settles out 
quickly. However, even with more homogenous size distributions than the extracted 
silica, the falling behaviour of the initial plumes is complex and has an effect on the 
overall fluid movement within the system. The design of accurate numerical algorithms 
for these complex behaviours is challenging. A numerical simulation to account for this 
complex fluid behaviour by using a discrete description of the individual settling 
particles, including the hydrodynamic interactions between close neighbours, not to 
mention the addition of enzyme reaction kinetics, would be computationally expensive to 
perform. Although the simple mathematical model presented here does not account for 
all of the complex fluid and particle interactions observed in the falling particle biosensor, 
it matches well with experimental results for a range of silica types and distributions, 
providing a first understanding of the driving forces behind product formation in this 
system. This can be used to inform sensor design with silica-based reagents. 
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3.3.4 Implications for POCT design using falling particles 
First, it should be noted that the predictions of product formation presented above are 
under the assumption that S0 < Km. In contrast, when the local concentration of substrate 
is greater than Km, the enzyme will act at a constant rate independent of substrate 
concentration. Thus, to determine the concentration of substrate in a sample using rate of 
product formation by the immobilised enzyme, the substrate must be the limiting factor 
and less than Km.  
Given the system is expected to be largely kinetically controlled, any changes in the 
activity and/or amount of the enzyme present (i.e. Vmax_SA and/or total SA) are expected 
to affect the rate of product formation during one inversion and thus affect the rate signal 
development over time. In conjunction with the calibration curve in Figure 2.4B for 
known concentrations/amounts of product (H2O2) in the fluorescence scanner, the 
predictions of product formation can be used to estimate the corresponding fluorescent 
signal produced over the total assay time. Figure 3.36 shows the theoretical fluorescent 
signal produced by R52-mCh-mSOX-R5-6H on silica extract after 7 min in the presence 
of varying sarcosine concentration and demonstrates the effect of a ± 10 % change in 
Vmax_SA on the substrate to signal ratio. A change in total enzymatic activity, Vmax_SA (as 
determined by both specific activity, Vmax, and enzyme loading, ESC, see Eq. (3.4)), is 
predicted to change the total signal proportionally (See Eq. (3.3)). Figure 3.36 shows that 
for a measured fluorescence intensity, true analyte concentration in the sample would be 
overestimated with an increase in Vmax_SA and underestimated with a decrease in Vmax_SA 
(e.g. 30 a.u. is the predicted signal output for 4.88 µM sarcosine with 0.3 U/mg activity, 
however, this signal would be produced by 4.44 µM sarcosine with 0.33 U/mg activity). 
Such a system could be challenging to use for quantitative detection, as any change in 
activity would affect the correlation of fluorescent signal with substrate concentration. 
Nonetheless, this challenge is likely surmountable as enzyme-based biosensors have been 
successfully developed where the enzyme is under kinetic control by regulating the 
parameters affecting total enzyme activity in the system and/or including an internal 
reference. While sensor consistency will need to be established under large-scale 
production conditions, low batch-to-batch variability with respect to immobilisation 
levels and enzyme activity was observed over the course of this research. In addition, the 
stability of the dry reagent over time is promising for sensor shelf-life.  
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Figure 3.36 Theoretical fluorescent signal produced by R52-mCh-mSOX-R5-6H on silica extract 
after 7 min (where ESC = 573 mg protein / m2 silica surface area and Vmax = 0.3 U/mg and the 
device is inverted every 60 s).  
Due to the consequent reduction in the effects of sample pH, temperature, presence of 
inhibitors and variation in enzyme activity on biosensor response, operation under 
diffusional limitations can be an advantage, and thus an intentional design choice for a 
biosensor [227]. In some instances, membranes with lower permeability for the substrate 
have been used to achieve a diffusion limited system [227]; for enzymes with a low Km, 
this has the advantage of increasing the dynamic concentration range [154]. However, 
diffusion limited systems can have their own challenges when it comes to reproducibility. 
For instance, in thick-film electrochemical biosensors with glucose oxidase, the thickness 
of the enzyme layer needs to be highly controlled [259], possibly beyond the limits of 
some commonly used deposition technologies [260]. Moreover, under diffusion 
conditions the rate of signal development will be reduced as mass transport limitations 
reduce the apparent catalytic activity of the enzyme [258]. In contrast, under a kinetically 
controlled system, the particle-bound enzyme is operating at its maximum rate, which 
potentially allows for a sensitive POCT system despite an enzyme with low activity (such 
as mSOx).   
If, as the results suggest for the parameters explored here, the system is completely 
kinetically controlled for all particle sizes, then it may be that a benefit of the falling 
particle biosensor approach is that it enables greater dispersion of the particles. This 
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dispersion results in more enzyme with access to the bulk solution as compared to a settled 
bed, which likely avoids local substrate depletion. It ultimately leads to higher signals, as 
observed experimentally with an increase in number of inversions over a defined time 
period (Figure 3.35).  
With respect to the selection of silica distribution for use in the falling particle sensor, 
although the smaller particles have more surface area per unit mass and thus more 
enzymatic activity, the behaviour observed for a distribution of nanoparticles suggests 
particles in this size range may face a limitation in their ability to sample all of the fluid. 
Nanoparticles also face the challenge of aggregation which would reduce access to the 
enzymes on their surface. In addition, very small particles are almost neutrally buoyant 
in the viscosity relevant to clinical sample types and thus, would not settle out in a 
reasonable amount of time (< 10 min) for a POCT. This would lead to light scattering 
challenges for fluorescent or colorimetric detection methods and have poor utility for 
purification by sedimentation. On the other hand, large particles (e.g. 200-500 µm) have 
significantly reduced enzyme loading per unit volume and have settling rates that would 
require constant flipping of the device to achieve the benefits of dispersion.  
While particle size is important, enzyme surface coverage also has a significant effect.  
This is clear when considering the performance of silica extracted from sand compared 
to the commercially available silica gels. Despite its significant fraction of larger 
particles, silica extracted from sand outperformed all the commercially available silica 
distributions for the same mass of silica. (Although the signal from 6-35 µm silica gel 60 
was higher, it was measured at 40 min of flipping while the signal for the same mass of 
extracted silica was measured at 7 min). Given the prediction that the system is primarily 
reaction rate limited, this superior performance is likely related to its higher loading 
capacity than commercially available silica gel (ESC, Table 3.1). In light of this, the 
selection of support material for the enzyme must balance both the enzyme loading 
capacity and particle size distribution. 
 Summary 
This chapter explored a novel design for a biosensor using silica-immobilised enzymes 
as the mobile phase. While immobilisation can add stability and simplify processing 
steps, immobilised enzymes experience different mass transport limitations to soluble 
enzymes, which can limit their apparent activity. A variety of strategies have been 
Biosensor design utilizing particle-bound enzymes 
138   
explored in the past to successfully utilize immobilised enzymes by optimising the 
transport phenomena of substrates and products, including extensive exploration of 
packed bed approach to biosensors [206,208–216], but there are no examples of gravity-
driven dispersion of immobilised enzymes incorporated into a format potentially 
amenable to a POCT.  
In order to optimise the design of a falling particle biosensor, it was necessary to 
understand the forces controlling the rates of product formation, and thereby signal 
development, by the particle-bound enzymes in this system. To explore this, it was first 
necessary to examine the settling behaviour of the particles to determine the relative fluid 
movement experienced by enzyme on the surface. The particles were observed to fall 
initially in plumes followed by dispersed smaller particles. These patterns could be 
harnessed in a design that allowed for a longer suspension time of the particles with the 
sample while keeping device dimensions small and amenable to POCT through multiple 
inversions. Use of a chamber design with a narrow waist created reproducible inversion 
patterns irrespective of inversion technique not seen in the other designs. This 
reproducible settling is critical to ensure a reproducible process for the enzymatic reaction 
and hence, the narrow waisted device lends itself to a biosensor platform. 
The comparison of kinetic and mass transport rates suggests that the rate of product 
formation by the falling particles is significantly under kinetic control for the conditions 
studied here. Although the relative velocity component of the Da is not fully 
representative of the settling patterns observed in the falling particle device, for a range 
of silica size distributions, the predicted product formation matched well with 
experimental results. This suggests that the Da described here and the corresponding rates 
predicted for product formation could be used alongside experimental results to help 
select appropriate silica size and enzyme loading for a targeted substrate consumption 
rate in falling particle devices for other enzyme assays. While the analysis presented is 
limited to certain situations, it can be extended to support other geometries, enzyme 
kinetics and reactor configurations. 
Given the predicted dependence on enzyme activity for the silica-immobilised R52-mCh-
mSOx-R5-6H explored here, immobilisation at saturating levels of protein can likely be 
justified from a process approach, as this would result in the same coverage per mass of 
silica from crude lysate even with some deviation in expression level. In resource 
constrained settings, it is not likely to be easy to precisely assess total protein produced 
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in each E. coli culture, but consistently adding the same mass of silica to crude lysate 
could be achievable. With this approach, it will also be important to have consistency of 
particle size distribution given the correlation between surface area and total enzyme 
loading. With respect to the selection of particle size, it is clear that this must be balanced 
with enzyme loading to achieve desired reaction rates.  
Working towards a proof-of-concept of a POCT with the falling particle device, silica 
extracted from sand was selected for further investigation, given its high enzyme loading 
supported the fastest rate of signal development for the same mass of silica compared to 
all the commercially available silica distributions tested here. In combination with its 
settling ability for purification purposes earlier in the production process, likely promoted 
by the presence of the larger particles, and its potential to be produced on site from local 
materials, silica extracted from sand could support the local production of a POCT.  
As aforementioned, the falling particle biosensor is just one several formats for POCT 
utilizing particle-bound enzymes, each with their advantages and disadvantages. The 
performance of the falling particle design will be compared in Chapter 4 against two other 
formats commonly employed with bio-functionalised particles – (1) simple suspension in 
a microcentrifuge tube and (2) a packed bed in a microfluidic channel. The narrow 
waisted chamber design will be used for this comparison in light of its repeatability of 
inversion patterns and proven ability support the detection of low concentrations of the 
target substrate, sarcosine. However, future work could progress towards a system that 
achieves greater particle dispersion, provided additional modelling and simulation 
confirm that this is an advantage of the falling particle approach.  
Finally, for the falling particle system to have clinical utility as a biosensor, it must be 
able to detect the target substrate within the relevant range for the clinical condition. 
Figure 3.32 shows the detection of a low concentration of sarcosine within the relevant 
range for prostate cancer diagnosis (< 10 µM) within a rapid time frame (< 10 min) using 
silica extracted from sand functionalised with R52-mCh-mSOx-R5-6H in the narrow 
waisted chamber. These initial results are promising but the performance of the sensor 
across the range of relevant concentrations will be explored in Chapter 4. 
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Chapter 3 explored a novel design for a biosensor with silica-immobilised enzymes where 
gravitational force is used to drive their movement through the sample. This chapter will 
evaluate the performance of this design with respect to (A) other assay formats using 
particle-bound enzymes and (B) its potential to support quantitative or semi-quantitative 
detection.  
Preliminary demonstrations of particle-based biosensors, focusing on the development of 
the biological or chemical reagents, often use simple suspension in common laboratory 
consumables, such as well plates and microcentrifuge tubes (as was reported for the initial 
investigations of the silica-R5-mCh-Enz in Chapter 2). As discussed in Chapter 3, there 
are alternative assay formats intended for POCTs that utilize particle-bound enzymes, 
including packed beds in microfluidic channels and magnetic particles manipulated by 
external magnetic fields. Of those formats utilizing particle-bound enzymes, the packed 
particle bed is the most commonly reported format. It is also potentially amenable to use 
with the R5-mCh-Enz functionalised silica particles, whereas the magnetic particle 
approach requires additional fabrication steps (e.g. creating silica particles with magnetic 
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cores [261]). These additional complex steps would likely be inappropriate for an 
approach focussed on enabling locally produced materials. Thus, the packed particle bed 
was selected for comparison with the falling particle design (Figure 4.1). Simple 
suspension in a microcentrifuge tube was also included in the comparison as a baseline.  
 
Figure 4.1 Three assay formats used with R52-mCh-mSOx-R5-6H on silica particles. The red arrow 
highlights the flow path through the packed bed device. 
Regardless of its performance against other assay formats, in order for the falling particle 
system to have clinical utility as a biosensor, it must support detection of the target analyte 
within the range relevant to the target disease. The preference for a quantitative result 
over a semi-quantitative or qualitative result depends on the impact this information 
would have on the clinical treatment approach. For example, a qualitative lateral flow 
assay for malaria that shows a positive result will likely prompt treatment with 
artemisinin-based combination therapy regardless of parasite levels [262]. In contrast, 
quantitative measurements of glucose are important for diabetic patients, as glucose levels 
on either side of the acceptable range require distinct interventions. In the case of 
sarcosine, several studies have found elevated levels in prostate cancer patients compared 
with healthy patients [158,183,263], but the utility of sarcosine as a biomarker of prostate 
cancer is still debated [264]. Thus, it is currently unclear how sarcosine levels would be 
correlated with treatment pathways. One study showed sarcosine levels were significantly 
different in low grade versus high grade cancers [265], which could suggest that 
quantitative results could be important for selecting which patients receive non-
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aggressive therapies. Alternatively, if a threshold can be defined beyond which the 
likelihood of cancer is high, then a semi-quantitative test could be sufficient as a screening 
tool to prompt more invasive but confirmatory biopsy. Semi-quantitative tests have been 
proven as powerful tools to support differential diagnosis at the point-of-care (e.g. 
[266,267]). 
The initial results with the falling particle sensor in Chapter 3 that demonstrate detection 
of micromolar levels of sarcosine within a rapid time frame (< 10 min) are promising for 
a POCT. Nonetheless, greater understanding of its performance across the range of 
relevant concentrations will be necessary to determine its potential towards quantitative 
or semi-quantitative testing. As the fluorimetric detection scheme requires the coupled 




Material sources are described in Chapters 2 and 3 with the addition of the following: 
polydimethylsiloxane (PDMS, Sylgard® 184, Dowcorning, USA), transparent tape 
(OfficeDepot, UK). 
4.2.2 Construction and characterisation of the packed bed in a channel 
The channel system was constructed from two pieces of PMMA with machined inlets and 
outlets for fluid entry/exit and a channel of 15 × 2 × 0.3 mm3 engraved in the bottom half, 
as previously developed by Gooding and Hall [268] and pictured in Figure 4.1. Four 
corner bolts were used for mating the top plate with the bottom via mechanical pressure 
and an O-ring around the channel formed the watertight seal.  
The bed of bio-functionalised silica particles was created through serial drop casting of a 
silica slurry in the channel. The same technique was used to create packed beds in PDMS 
channels for micro-computed tomography imaging (micro-CT, Zeiss Versa 510). (The 
PMMA channel system was replaced by comparable packed beds in PDMS channels to 
reduce thickness of the material external to the area of interest (i.e. the packed bed).) The 
PDMS channel, with a cross-section of 1 × 0.1 mm2, was fabricated as described in the 
author’s parallel publication with collaborators [206]. In brief, PDMS and its curing agent 
were mixed together in a 10:1 ratio and cured on an in-house fabricated negative 
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aluminium mould for two hours at 80 °C to create the channel structures. The negative 
mould was designed using 3D modelling software (SolidWorks 2015, Dassault Systems, 
USA) and manufactured by computer numerical control milling (Department of Chemical 
Engineering and Biotechnology, University of Cambridge). Prior to curing, the PDMS 
was degassed under vacuum for 20 min to release any bubbles resulting from mixing and 
conform the mixture to the surface of the mould. Post-curing, the PDMS channel system 
was cut out from the aluminium mould, washed once with ethanol and gas dried with 
nitrogen. Transparent tape was used to seal the PDMS channel system once the silica was 
deposited in the channel. 
In the micro-CT, images were taken 360⁰ about the z-axis (Figure 4.2) using settings of 
80 kV and 7 W with a pixel size of 2.251 µm, and the resulting tiff stack was rendered in 
VGstudio (Volume Graphics). A region of interest was defined within the packed bed and 
greyscale thresholding used to differentiate the void volume from the particles. 
 
Figure 4.2 Set-up for micro-CT imaging showing (A) schematic of axes orientation relative to 
channel and (B) PDMS channels filled with silica variants. 
4.2.3 Performance evaluation of a range of assay formats 
Two assay formats were compared against the custom narrow waisted falling particle 
chamber presented in Chapter 3 for their rate of conversion of substrate to product: (A) 
simple suspension in a microcentrifuge tube and (B) a packed bed in a microfluidic 
channel (Figure 4.1). The falling particle devices were constructed as described in 
Chapter 3 and the packed bed as described above in Section 4.2.2.  
Fusion protein R52-mCh-mSOx-R5-6H and its corresponding substrate sarcosine were 
used to compare assay formats. Conversion of sarcosine was detected using the 
AmplexTM UltraRed (AR) assay with soluble WT HRP as previously described in Chapter 
2 and 3 with the following changes. The amount of silica was increased from 0.875 mg 
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to 2.5 mg per assay to enhance detection within short timescales. Final concentration of 
AR was 25 µM and of sarcosine was 5 µM in all cases. 
Residence times of substrate with enzyme were kept equivalent across formats by 
correlating flow rates through the packed bed system such that 200 µL would pass 
through the bed in the same time that the falling particle and tube assays of the same 
volume were allowed to react (Table 4.1). The falling particle chamber was flipped every 
60 s throughout the residence time. These flow rates and corresponding residence times 
were selected based on flow rates observed for capillary flow systems during work by the 
author with collaborators [206], as equipment free operation (e.g. no syringe pumps) is 
desirable in low resources settings [18]. However, for the purposes of this comparison, a 
syringe pump was used to provide consistent flow rates (KDS Model 100, kdScientific), 
with the tip of the syringe inserted into the entry port of the PMMA channel device.  
Table 4.1 Residence times and corresponding flow rates used in device format comparison assays 




4.2.4 Falling particle assays for sarcosine and hydrogen peroxide 
Falling particle assays were performed in narrow waisted chambers as described in 
Chapter 3, with some modifications for each assay depending on the target substrate: 
 For the detection of sarcosine, R52-mCh-mSOx-R5-6H immobilised on silica 
extracted from SC sand (0.875 mg silica, ~90 µg protein per 1 mg silica) was 
mixed with AR (4.17 µM), HRP (0.016 mg/mL) and sarcosine (0 µM (blank), 2, 
4, 6, 8 µM)) and loaded into the device. 
 For the detection of H2O2, HRP-mCh-R5-6H immobilised on silica extracted from 
SC sand (0.5 mg silica, ~20 µg protein per 1 mg silica) was mixed with AR 
(10.8 µM) and H2O2 (0 µM (blank), 21, 42, 84, 126 µM)) and loaded into the 
device.  
 For the detection of sarcosine combining both fusion constructs, R52-mCh-mSOx-
R5-6H immobilised on silica extracted from SC sand (1 mg silica, ~90 µg protein 
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per 1 mg silica) was mixed with AR (10.8 µM), HRP-mCh-R5-6H immobilised 
on silica extracted from SC sand (1 mg silica, ~20 µg protein per 1 mg silica) and 
sarcosine (0 µM (blank) to 100 µM)) and loaded into the device.  
All of the above were performed using the narrow waisted design with a total volume of 
200 µL and all concentrations reported are final concentrations in the assay. As in Chapter 
3, the devices were imaged using the fluorescence flatbed scanner and images were 
analysed for grey scale intensity of the red channel in the chamber area using ImageJ 
software. Fluorescent signal was determined by measuring the average intensity in the 
device or by integrating a plot of red channel intensity at right angle from the base along 
the central line of the chamber. 
For the endpoint assay, the reagent concentrations were as described in Chapter 2 for the 
endpoint assay in well plates. A mini-chamber was designed to accommodate the reduced 
volume (50 µL) of this assay (Figure 4.10). Given the height of this design is ~50 % of 
the narrow waisted device, flipping was done every 30 s instead of 60 s using an analogue 
servo motor (Seeed Studio) and a microcontroller board (Arduino Uno Rev3). 
 Results and Discussion 
4.3.1 Comparison of assay formats using particle-bound enzymes  
As aforementioned, particle-bound enzymes can be utilized in a variety of formats for 
POCT, each with their advantages and disadvantages. The custom falling particle device 
presented in Chapter 3 was compared against two other formats commonly employed 
with particle-bound enzymes: (A) simple suspension in a microcentrifuge tube and (B) a 
packed bed in a microfluidic channel (Figure 4.1). The degree of interaction of the 
immobilised bio-recognition element (R52-mCh-mSOx-R5-6H) with analyte in fluid 
(sarcosine) in each format was measured by the rate of conversion of substrate to product 
using fluorescence. 
In contrast to most packed bed approaches in the literature that required additional 
structures to maintain particle position [207,212,213], the packed bed explored here was 
created through serial drop casting of a silica slurry. This simple manufacturing technique 
was demonstrated by the author and collaborators for an immunoassay in a packed silica 
bed and no sign of particle washout was observed after flow [206]. Figure 4.3 and Figure 
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4.4 show micro-CT images of packed beds in microchannels with the commercial silica 
gel <63 µm and the silica extracted from SC sand, respectively.  
Despite the variation in particle size distributions between the two silica variants and the 
observable increase in irregularity of packing in the case of the silica extract, analysis of 
the micro-CT scans using greyscale thresholding to differentiate between particle and 
void volume returned a void volume of ~25 % for both (indicating a packing fraction of 
~75 %). For a packed bed of homogenous spheres in hexagonal close packed 
arrangement, 26 % is the lowest expected fraction of void space. The silica variants 
explored here are neither homogenous nor spherical, so their low void volume is likely a 
result of the smaller particles within the distribution filling the gaps between the largest 
particles. Although a uniformly sized catalyst is known to reduce the chance and severity 
of non-ideal behavior in packed bed reactors [136], the silica extract was selected to form 
the packed bed used in the comparison test to maintain consistency of silica type, and 
corresponding enzyme loading, across the formats.  
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Figure 4.3 Compiled 3D renderings of micro-CT images for PDMS channels filled with commercial 
silica gel 60 <63 µm, showing (A) overall channel structure and (B) region of interest used for void 
volume analysis. 
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Figure 4.4 Compiled 3D renderings of micro-CT images for PDMS channels filled with silica 
extracted from SC sand, showing (A) overall channel structure and (B) region of interest used for 
void volume analysis. 
Figure 4.5 shows the signal produced by each assay format for two residence times/flow 
rates. For all assay formats, increasing residence time of the substrate with the 
immobilised enzyme (longer reaction time or slower flow rate), increased fluorescence 
signal. This is expected considering no product inhibition is anticipated and the amount 
of enzyme added was calculated not to achieve total consumption over even the longest 
residence time of 14 minutes (endpoint assay showed total consumption only at 40 min 
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with 1.5 times the silica weight used here, see Figure 2.30). In addition, at all flow 
rates/residence times studied, the fluorescence signal from the falling particle device was 
greater than the two other formats explored here. An analysis of the expected kinetics by 
particle-bound enzymes in the packed bed and in simple suspension can help explain the 
relative performance of the formats.  
 
Figure 4.5 Fluorescence signal (ex. 530 nm/ em. 580 nm) in the presence of 5 µM sarcosine for three 
assay formats (microcentrifuge tube, narrow waisted channel and packed bed) at residence 
times/flow rates of (grey) 3.5 min / 3.6 mL/hr and (orange) 14 min / 0.9 mL/hr.  
A microfluidic channel filled with particles is essentially a small scale version of an 
industrial packed bed reactor (PBR). Product formation by the immobilised enzyme in a 








where square brackets denote concentration of substrate (S) and product (P), hA is the 
void volume of the packed bed and Q is the volumetric flow rate applied to the bed. 
Derived by integrating classic Michaelis-Menten kinetics (Eq. (3.1)) along the length of 
a packed bed, this relationship accounts for the change in substrate concentration for each 
volume element along the length; however, this equation neglects the effects of mass 
transport to and from the surface (assumes [S]surface = [S]bulk). In some cases when this 
equation is used to model dependence of conversion rate on initial substrate 
concentration, it can result in apparent enzyme parameters being dependent on length of 
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enzyme reactor and/or flow rate [270–273]. As discussed in Chapter 3, the rate of mass 
transport is related to the flow rate in the system. The Reynolds number for a packed bed 
(Repb) can give an indication of the flow regime and is typically expressed as: 
 𝑹𝒆𝒑𝒃 =
𝝆𝒇 ∗ 𝒖𝒔 ∗  𝒅
𝜼𝒇 (𝟏 − 𝜽𝒗)
 (4.2) 
where ρf is the density of the fluid, ηf is the dynamic viscosity of the fluid, us is the 
superficial velocity of the packed bed, θv is the void fraction of the bed and d is the 
spherical equivalent diameter of the particle (typically mean diameter of the distribution). 
The superficial velocity, us, is the volumetric flowrate, Q, divided by the cross-sectional 
area of the packed bed channel. As the flow in packed beds is complex, the limits of Repb 
for laminar and turbulent regimes are not as well defined as those of the Reynold’s 
number for pipe flow, but it is generally accepted to be laminar flow when Repb < 10. 
Calculating Repb for the flow rates used here with the mean diameter and void volume 
observed for the extracted silica returns Repb < 10 in all cases, indicating that the packed 
bed is operating under laminar flow. Although it is often suggested in reactor design to 
operate packed beds under turbulent flow to reduce mass transport limitations [227], the 
flow rates used for this comparison were selected specifically to mimic those of capillary-
driven flow as non-equipment operation is preferable for resource-limited settings [18]. 
While it is important to consider the effects of mass transport in a biosensor design using 
a particle bed [269], there may be conditions where the effects are negligible (such as 
high flow rates leading to efficient mass transfer or low rates of conversion to product 
due to low enzyme activity or low enzyme loading). Under conditions where the effects 
of mass transport are negligible, the concentration of product formed is expected to be 
dependent on residence time with enzyme and hence inversely dependent on flow rate 
[227,269]. This dependence was observed for the packed bed format explored here 
(Figure 4.6) and suggests it is under kinetic control. This is unsurprising given the low 
enzyme activity of the silica-R52-mCh-mSOx-R5-6H after drying (Chapter 2).  
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Figure 4.6 Fluorescent signal of outflow against residence time for the packed bed format. The 
results from Figure 4.5 have been combined with an additional residence time of 7 min 
corresponding to a flow rate of 1.8 mL/hr. 
Given both the falling particle and packed bed formats are expected to be kinetically 
controlled, the reduced signal observed for the packed bed could be the result of reduced 
accessible surface area (and thus, enzyme) in this format compared with the surface area 
exposed during the dispersion observed in the falling particle device. More than point 
contact of the particles against one another in the packed bed due to the non-spherical 
nature of the silica could reduce the accessible surface area. While some evidence of this 
is observed in the micro-CT images of the packed bed in Figure 4.4, the packing observed 
does not suggest sufficient surface contact to explain the ~70 % reduction in signal 
observed (Figure 4.5).  
The reduction in signal may also be the result of the formation of channels preferential 
for fluid flow, or channelling, resulting in some of the substrate passing through the 
channel more rapidly while other areas are stagnant or experience a negligible flow rate. 
Channelling is known to occur in PBRs and results in deviations from ideal behaviour 
[227]. For example, Luckarift et al. observed that in a small-scale PBR filled with 
butylrlcholinesterase entrapped in silica nanospheres (formed through co-precipitation 
with the R5-tag), the conversion rate decreased with time but could be regenerated. The 
authors did not observe this effect when the same encapsulated enzymes were employed 
in a fluidized bed format, and proposed that this type of behavior was the result of the 
formation of channels in the packed silica that lowered the overall retention time [136]. 
Channels form not only due to an excessive pressure drop or uneven application of the 
substrate stream, but also due to irregular packing. The latter is likely in the system 
explored here given the heterogeneity of the extracted silica. This suggests that 
improvements to avoid the formation of channels could improve the performance packed 
bed format. Although tightly controlled particle distributions may reduce the risk of 
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channeling, this would add cost and complexity to the production of the silica particles. 
A change in the method to construct the packed bed could also provide a more uniformly 
packed bed, however, the incorporation of particles into packed beds on microchips 
remains a challenge as the classical methods of column preparation in chromatography 
function poorly at the microscale [274].  
In the case of simple suspension of the particles in a microcentrifuge tube, good dispersion 
of the particles was observed when the sample was initially mixed with the particles. After 
1 min, 76.3 ± 0.4 % particle mass had settled, and the remaining settled over the next few 
minutes of the assay. Once the particles have settled, they can be expected to consume at 
a similar rate to the settled bed in the falling particle design. For silica extract, the 
stationary settled bed of particles consumes substrate at a lower rate compared to the 
dispersed falling particles, as shown experimentally in Figure 3.35. Hence, a larger 
contribution to the overall signal is expected from the initial period where the particles 
are dispersed and settling as compared to the contribution from the remainder of the assay 
where the particles have settled and likely begin experiencing local substrate depletion. 
If, on the other hand, substrate consumption occurred at a constant rate in this system, the 
signal would increase linearly with time; thus, a ratio of 25 % would be expected when 
comparing the signal produced in 3.5 min to that produced in 14 min. In the case of the 
tube assay, the signal at 3.5 min is ~37 % of the signal at 14 min, which supports the 
greater contribution of the initial dispersion to the overall signal. The increase in signal 
from dispersed particles likely also explains the reduced signal of the simple suspension 
in a tube relative to the falling particle design, as the latter achieves greater dispersion of 
the particles over the same period of time through repeated flips of the device.  
The superior performance of the falling particle format with respect to signal generation 
as compared with the other two assay formats is encouraging. Nonetheless, its batch 
format may not be suitable for all enzyme assays, such as those processes involving 
product inhibition. In these cases, packed beds are the preferred design, all other factors 
being equal [227]. Packed beds can also avoid potential enzyme inactivation due to shear 
and abrasion during particle collisions [86]. However, packed beds also face the 
challenges of clogging resulting in stopped flow, especially with heterogeneous catalyst 
particles like the silica extracted from sand. In contrast, batch formats, like the falling 
particle design, have the benefit of simplicity of process development and use, which 
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could be advantageous for a diagnostic platform, especially one intended for production 
and use in resource-limited settings. 
For the falling particle system to have clinical utility as a biosensor, it must support 
detection of the target substrate within the relevant range for the clinical condition. Given 
these comparative tests were performed with sarcosine concentration (5 µM) within the 
clinically relevant range for prostate cancer [157,158] and sufficient fluorescent signal 
was generated for detection within 5 min, this suggests that falling particle format has the 
potential to enable a POCT biosensor for sarcosine detection. 
4.3.2 Towards a POCT for sarcosine using the falling particle design 
Although the detection of sarcosine by fluorescence requires the cascade from SOx to 
HRP, the performance of the fusion proteins in the falling particle format was initially 
tested separately for peroxide and sarcosine measurement, using HRP-mCh-R5-(6H)-
silica or silica-R52-mCh-mSOx-R5-6H, respectively (Figure 4.7 and Figure 4.8).  
 
Figure 4.7 Immobilised HRP-mCh-R5-(6H) on silica extracted from sand used in the narrow 
waisted device for H2O2 detection. (A) Images taken following two device inversions with 60 s 
settling and 5 min stationary signal development. (B) The change in fluorescence over the 
stationary 5 min, where fluorescence is the AUC of a central line plotted perpendicular to the base.  
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Figure 4.8 Immobilised R52-mCh-mSOx-R5-6H on silica extracted from sand used in the narrow 
waisted device for sarcosine detection. (A) Images taken following two device inversions with 60 s 
settling and 5 min stationary signal development. (B) The change in fluorescence over the 
stationary 5 min, where fluorescence is the AUC of a central line plotted perpendicular to the base, 
and (C) average red channel intensity of the upper and lower chamber of the device at 7 min 
plotted against sarcosine concentration. 
Figure 4.7A and Figure 4.8A show visually that the fluorescence increases in the device 
with concentration of substrate. The fluorescence intensity was measured and the 
intensity plotted on a trajectory perpendicular to the base through the central line of the 
chamber. The change in area under the curve (AUC) over 5 min shows a linear 
relationship (R2 > 0.98, see Table 4.2) with concentration for both hydrogen peroxide and 
sarcosine (Figure 4.7B and Figure 4.8B, following two inversions). The different 
concentration ranges measured for these two silica-bound enzymes within the same time 
period reflect their different activities (Chapter 2). 
The plots in Figure 4.7B and Figure 4.8B use the rate of fluorescence signal development 
from the stationary settled bed after two inversions of the device to determine substrate 
concentration. As discussed in Chapter 3, flipping the system every 60 s until the signal 
time point increased the overall rate of signal development in the device (Figure 3.35), 
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and thus could increase the sensitivity of the assay. Figure 4.9 shows the results for the 
silica-R52-mCh-mSOx-R5-6H using this approach, both visually and with average 
intensity results at 7 min. (The performance of the HRP-mCh-R5-6H-silica was not 
investigated with this protocol given the signal increase observed with the change in 
protocol (~2-fold) was unlikely to overcome the inherently poor activity of the enzyme 
to reach the desired range of substrate detection. This will be discussed further with 
respect to the assay combining both constructs below). Good linearity of average 
fluorescence intensity with sarcosine concentration (R2 > 0.98) is observed with the multi-
inversion approach along with a lower limit of detection (LOD) as compared to using the 
two inversion technique (Figure 4.9B versus Figure 4.8C, respectively). Comparing the 
average signal in the top and bottom compartments following the multi-inversion protocol 
shows consistent distribution of the signal throughout the device; no significant difference 
is observed in the slopes of the linear regression for the top and bottom chambers 
(confidence interval (CI) = 95 %, see Table 4.2). In contrast, the upper chamber under the 
stationary protocol shows reduced intensity (Figure 4.8), as would be expected with 
conversion of substrate largely by the settled bed. Nonetheless, the dissimilarity in slope 
is not significantly different (CI = 95 %) between the two chambers.  
Table 4.2 Linear regression results, where slope and intercept are reported with 95 % confidence 
intervals. Protocol A and B refer to 7 inversions or 2 inversions with 5 min stationary, respectively. 
LOD is calculated based on slope and standard deviation of the blank, as described in Eq. (2.5). 
Figure Enzyme Protocol Chamber Slope Intercept R2 LOD (µM) 
Figure 4.7B HRP B -  7.3 ± 1.8 111 ± 128 0.981 11.3 
Figure 4.8B mSOx B - 59.4 ± 14.8 24.4 ± 72.8 0.981 3.9 
Figure 4.8C mSOx B Upper 8.8 ± 2.3 1.38 ± 11.0 0.985 3.9 
Figure 4.8C mSOx B Lower 13.0 ± 2.8 2.7 ± 13.8 0.986 4.5 
Figure 4.9B mSOx A Upper 8.2 ± 0.6 -1.0 ± 3.7 0.996 2.7 
Figure 4.9B mSOx A Lower 9.1 ± 1.6 0.7 ± 10.0 0.983 2.4 
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Figure 4.9 Immobilised R52-mCh-mSOx-R5-6H on silica extracted from sand used in the narrow 
waisted device for sarcosine detection. (A) Images taken 7 min after sample addition, following 
device inversions every 60 s. (B) Average red channel intensity of the upper and lower chamber of 
the device at 7 min plotted against sarcosine concentration. (C) Theoretical fluorescence intensity 
plotted with experimental results (average of top and bottom chamber).  
The experimental results with the multi-inversion protocol can be compared against 
theoretical signals predicted using the model for product formation presented in Chapter 3 
(Figure 4.9C). Predicted concentrations of product formed have been converted into 
fluorescence signal using the calibration curve for fluorescence in the presence of a 
known concentration of H2O2 (Figure 3.6B). While the experimental results are higher 
than predictions made with the Vmax_SA value used in Chapter 3, this difference could be 
explained by a difference in enzyme activity; only a 35 % increase in Vmax_SA is required 
to observe a good fit of the model with experimental results.  
The detection range (2.5 to 10 µM) for this assay format corresponds to the range required 
to detect elevated sarcosine levels in the urine of prostate cancer patients (> 5 µM 
[157,158,181]). However, the change in fluorescence intensity per micromolar unit of 
sarcosine concentration (as determined by the slope of the linear regression, Table 4.2) is 
of the same magnitude as the standard deviation in intensity measurements for discrete 
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concentrations. This suggests that this assay may be suitable for semi-quantitative 
detection (high/low level of sarcosine) rather than quantitative measurement. Semi-
quantitative tests can be powerful tools as POCTs, but in the event that quantitative results 
are required, controlling total enzyme activity in the system will be particularly important, 
given the likelihood of kinetic control for this system (as discussed in Section 3.3.3). 
In light of the dependence of enzyme activity, it may be desirable to design an endpoint 
assay where the signal is correlated with total substrate in the sample rather than reaction 
rate. Thus, provided the detection time point is set based on the lowest activity of the 
expected range for the enzyme and the signal is stable once developed, an endpoint assay 
would be largely insensitive to small changes in activity. Following a similar protocol 
explored in Chapter 2 with the bio-functionalised particles in a well plate, an endpoint 
assay could be developed by designing a falling particle chamber with a smaller volume; 
Figure 4.10 shows a 50 µL waisted chamber imaged at 60 min with clear visual distinction 
between 0, 2 and 10 µM sarcosine as a preliminary example of this approach. The smaller 
volume also potentially lends itself to assays on clinical sample types where volume is 
limited and collection is onerous, such as blood. However, achieving an endpoint assay 
within a reasonable time frame for a POCT requires adding more reagents, which 
increases the final cost of the test. This would need to be balanced against the cost of 
achieving consistent activity between batches and throughout storage in order to select an 
approach for a falling particle POCT using silica-R52-mCh-mSOx-R5-6H. 
 
Figure 4.10 Endpoint assay showing (A) visual detection of fluorescence in 50 µL mini-chamber at 
60 min and (B) dimensions of the design. 
The performance of the separately immobilised fusion constructs suggests that achieving 
sensitive detection with the multi-enzyme cascade combining separately immobilised 
HRP-mCh-R5-(6H)-silica and silica-R52-mCh-mSOx-R5-6H may be challenging. 
Nonetheless, Figure 4.11 shows an initial proof of concept for multi-enzyme cascades in 
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the falling particle device. The lowest concentration detectable with this 2-enzyme system 
was 100 µM sarcosine, so an increase in sensitivity would be necessary to make this 
system applicable to clinically relevant range of sarcosine in urine for prostate cancer 
detection (< 10 µM) [157,275].  
 
Figure 4.11 Detection of sarcosine via AR fluorescence in the (A) narrow waist design using multi-
enzyme cascades combining separately immobilised HRP-mCh-R5-(6H)-silica and silica-R52-mCh-
mSOx-R5-6H, with (B) corresponding change in AUC for red channel intensity plotted on a 
trajectory perpendicular to the base through the central line of the chamber. 
In the design of multi-enzyme cascades for the detection of a target species, the total 
activity of the downstream enzyme in the system (e.g. HRP) should exceed that of the 
substrate specific enzyme (e.g. mSOx) such that the rate of reaction is dependent on the 
species of interest. Generally, the efficiency increases as the ratio of activity of second 
enzyme compared to the first enzyme increases [276]. However, in this instance, kcat, or 
turnover rate, for immobilised HRP-mCh-R5-6H is only ~ 6 % of immobilised R52-mCh-
mSOx-R5-6H (based on specific activity after drying, Chapter 2). This suggests the low 
activity of the HRP-mCh-R5-6H is limiting the sensitivity of the assay and makes 
optimisation of this assay challenging. A range of strategies could be explored to 
overcome this limitation, as outlined in Figure 4.12 and discussed below.  
An increase in the overall substrate conversion rate in the system could be achieved by 
increasing the concentration of HRP. With the particle-bound enzymes, increasing the 
concentration of HRP in the assay would involve increasing the mass of silica added 
and/or increasing the enzyme surface coverage (ESC) of the silica (Figure 4.12A and B). 
Using the experimentally determined values of kcat and ESC for silica functionalised with 
HRP-mCh-R5-6H, it is possible to estimate the mass of silica needed such that the overall 
turnover rate would be in excess relative to the rate of product formation by the 
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immobilised R52-mCh-mSOx-R5-6H (assuming kinetic control rather than mass 
transport). Keeping ESC consistent with experimental conditions above, > 70 mg of silica 
would be required for the relative turnover rates to be at least 1:1. In the case of HRP-
mCh-R5-6H, poor levels of expression resulted in a low concentration used during 
immobilisation, which corresponded to a ESC below the capacity of the extracted silica 
(ESC = 128 mg protein / m2 silica surface area). However, even with an increase in ESC 
to the loading observed for R52-mCh-mSOx-R5-6H on the extracted silica (ESC = 
573 mg protein / m2 silica surface area), a 1:1 ratio of turnover rates would still require 
> 15 mg of silica. This would take up ~10 times more volume in the system (~4 % total 
volume) and would likely cause a significant change in the behaviour of the falling 
particle system that would require further investigation.  
However, this preliminary demonstration of the 2-enzyme combination on silica in the 
falling particle sensor has the R5-mCh-Enzs immobilised separately. Alternatively, the 
enzymes could also either be co-immobilised on the silica or introduced as part of a larger 
fusion enzyme (Figure 4.12C and D). Both strategies have been shown to improve 
activity. For the fusion route, it has been previously shown for a multi-enzyme 
bioluminescence resonance energy transfer pairing [277] that this route is only 
advantageous if a 1:1 ratio is needed. In addition, the large size of such a fusion protein 
would likely be a disadvantage for expression in E. coli as large proteins require more 
metabolic energy during overproduction [142]. They also tend to drive the formation 
inclusion bodies [123], which adds time and complexity to purification and 
immobilisation.  
Dual catalysts (where enzymes are immobilised on the same particle) are generally 
superior to mixed catalysts (separate particles) when it comes to reaction efficiency [276] 
and co-assembly of the paired enzymes in close proximity has generally shown several-
fold signal enhancement relative to the soluble system [278,279]. However, both 
theoretical and experimental work show the benefit of proximity only when there is 
generation of a favourable microenvironment with respect to concentration of the 
intermediate (e.g. bi-enzyme aggregates perform no better than soluble enzymes [278]). 
Thus, the facilitated transport of the intermediary product from one enzyme to another 
owing to proximity is a temporary effect that is only relevant until the concentration of 
the intermediate substrate becomes significant (i.e. during the lag period of a two-step 
reaction). A decreased lag phase is observed in the case of co-immobilised enzymes 
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because local concentration of the intermediate within the domain of the particle is higher 
than in the bulk; thus, the second enzyme sees a more favourable concentration of the 
rate-limiting intermediate substrate. In contrast, enzymes on separate particles operate in 
a larger effective volume than the co-immobilised system, so the build-up of intermediate 
concentration takes longer time, and therefore the lag phase is longer. However, given 
kinetic control is predicted for the R5-mCh-Enz fusion proteins on silica extract (Chapter 
3) and this multi-enzyme system involves a small-molecular intermediate (peroxide) with 
a high diffusion coefficient, the lack of proximity due to separate immobilisation is 
unlikely to be the rate limiting step. Instead, the final activity of the cascade is dependent 
on the slower enzyme, HRP-mCh-R5-6H. Thus, significant improvements in the activity 
(i.e. turnover rate per reaction site) of the fusion proteins with HRP would be required to 
achieve a 2-enzyme system using silica-immobilised R5-mCh-Enz in the future. 
Further improvements in the activity of the immobilised HRP could come with further 
modifications to the genetic sequence and/or improvements in the expression. There are 
over 40 isoenzymes of HRP and they vary in their activity (Figure 4.12E). For example, 
HRP isoenzyme C1a (as used here) demonstrated a higher activity with the colorimetric 
substrate 3,3’5,5’-tetramethylbenzidine (TMB) than isoenzyme A but lower activity with 
another substrate, ABTS [195]. Thus, the choice of the HRP isoenzyme for a diagnostic 
should be based on the colorimetric substrate to achieve optimal assay sensitivity. With 
respect to expression, recombinant HRP expressed in E. coli has been previously reported 
with activity similar to the isoenzyme isolated from the plant [160]. However, the 
challenges in recombinant expression of HRP (as mentioned in Chapter 2) that result in 
low yields and time-consuming, reagent-heavy re-activation steps may ultimately limit 
the applicability of the immobilisation approach using recombinant expression with an 
affinity tag for this protein.  
Alternative approaches for immobilisation of plant-extracted WT HRP exist if an entirely 
particle based sensor is desirable, e.g. glutaraldehyde crosslinking (as shown in a parallel 
publication by the author with collaborators [181]). Although a loss of activity compared 
to the soluble form was observed for WT HRP following glutaraldehyde crosslinking 
(consistent with other reports of reduced activity following glutaraldehyde crosslinking 
[280]), the immobilised HRP retained sufficient activity to avoid limiting the assay 
pathway with SOx. However, this alternative immobilisation method is outside the scope 
of a local production approach that uses molecular biology to produce the biological 
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components and achieve reagent-free immobilisation. To eliminate the need for HRP 
altogether, an electrochemical approach which detects the peroxide product produced by 
SOx, akin to the detection approach in the ubiquitous glucose meter, could be explored 
in place of the fluorimetric approach taken here.  Figure 4.12 provides a summary of the 
strategies discussed above for overcoming the low activity of the HRP fusions with R5-
mCh that could be explored in future work. 
 
Figure 4.12 Potential strategies for overcoming the limitation of HRP’s low activity within a local 
production approach. One approach is to increase the concentration of HRP in the assay by (A) 
increasing the enzyme surface coverage (ESC) of the silica and/or (B) by increasing the mass of 
silica added. Another approach is to decrease the distance that the co-product has to travel between 
HRP and mSOx by (C) co-immobilisation of separate fusion proteins or (D) design and expression 
of a larger fusion protein containing both enzymes. Alternative strategies include (E) change of 
isoenzyme or (F) eliminating the need for HRP altogether with an electrochemical approach. (For 
simplicity the mCh and R5 subunits have been left out of this diagram.) 
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 Summary 
This chapter explored a range of simple, low-cost designs for a biosensor using the silica-
immobilised R5-mCh-Enzymes developed in Chapter 2. The falling particle format 
explored in depth in Chapter 3 was compared against more classical formats of simple 
suspension in a microcentrifuge tube and a packed particle bed. The falling particle device 
outperformed both formats under the conditions studied, likely by achieving good 
dispersion and thus more enzyme with access to substrate in this kinetically controlled 
system. However, as discussed in Chapter 3, further simulation of the reaction kinetics in 
particle clouds and in the settled bed are required in the future to be able to optimise the 
design of the falling particle system.  
Proof of concept was shown for the detection of H2O2 with HRP-mCh-R5-(6H)-silica and 
for sarcosine with silica-R52-mCh-mSOx-R5-6H across a range of concentrations. The 
latter showcased an acceptable range of detection for elevated sarcosine levels in the urine 
of prostate cancer patients (> 5 µM [157,275]) when used with WT HRP. If a fully 
quantitative result is desired, some improvements in the signal-noise ratio would be 
required. Nonetheless, the system has potential as a semi-quantitative POCT that could 
help triage patients by quickly indicating when additional, more invasive tests should be 
performed.  
In addition, further improvements in the activity of R5-mCh-Enz fusion proteins with 
HRP would be needed for a silica-based reagent system that is capable of the sensitivity 
required for prostate cancer detection. Alternatively, an electrochemical approach could 
be explored in the future that would eliminate the need for HRP altogether. This approach 
will be discussed in the next chapter alongside other improvements which would be 
necessary to move towards a POCT for sarcosine. Other applications for the falling 
particle biosensor format and, more generally, for a local production approach through 
recombinant expression with affinity tags for low-cost materials will also be discussed. 
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5 CONCLUDING REMARKS 
 Summary of findings 
With access to diagnostics unaffordable in vulnerable LMICs, there is a need to consider 
a different approach that doesn’t presume the use of expensive off-the-shelf reagents. The 
overall goal of the research was to explore whether recombinant protein technology in 
combination with a low-cost support matrix could provide a basis for an inexpensive, 
simple, and robust production process for the bio-sensing element of a diagnostic. Given 
its wide-availability and biocompatibility, silica was selected as the low-cost solid support 
for this work. 
The fluorescent protein mCh and the enzymes SOx and HRP were employed as first 
models of biological reagents. Downstream processing of these reagents was reduced by 
employing the affinity binding sequence for silica, R5, in fusion with the central assay 
reagent protein targeting the analyte. The R5 peptide was shown to have affinity for silica 
comparable to the His-tag affinity for Ni-NTA resin classically used in protein 
purification (KD ≈ 1 × 10
-6 M). Simultaneous isolation and immobilisation onto silica 
carrier particles was achieved directly from lysate without the use of chemical coupling 
reagents, with 95 % of the immobilisation occurring in less than 5 minutes. In addition, 
it was shown that by incorporation of a coloured protein in the fusion construct design 
the protein production and immobilisation could be followed visually without major 
infrastructure resources.  
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Functionality was largely retained in the fusion proteins, before and after immobilisation. 
The fluorescence emission spectra and lifetime values of the mCh subunits were 
comparable to expected values for this fluorescent protein, indicating correct folding of 
the protein. Both HRP constructs were observed to have similar specific activities after 
refolding in the presence of heme; however, both the soluble and immobilised versions 
only showed minimal activity when compared to the commercially available WT HRP. 
This was shown later to be a limitation towards their use in a platform with the fusion 
SOx for the detection of sarcosine, as HRP should have activity in excess of its oxidase 
partner in the coupled enzyme assay.  
For R52-mCh-mSOx-R5-6H, specific activity for both soluble form and immobilised was 
observed to be of a similar order of magnitude as WT SOx. In addition, a comparable 
limit of detection was achieved with immobilised fusion protein as with the soluble form. 
Although the drying process should be improved in the future to prevent loss of activity, 
the dry reagent retained what activity remained for over two months at room temperature, 
an advantage compared to the soluble reagents. Taken together with the reduced 
downstream processing achieved by a one-step purification and immobilisation approach, 
this supports the use of directly immobilised reagents in the development of POCTs. 
Sand was investigated as a natural source for silica using a simple extraction process of 
alkali treatment and subsequent acidification. While not all sands produced sufficient 
yields of silica, yields of 11.5 ± 1.4 % and 4.7 ± 0.9 % weight were obtained for beach 
sands from South Carolina (SC) and Ghana (GH), respectively. These sands showed 
higher Si counts in XRF analysis, which suggests that only sands with high silica content 
may be suitable as source materials for the production of the low-cost purification matrix.  
FTIR spectra of the dried precipitates from this extraction process showed characteristic 
spectra for Si-O-Si and Si-OH groups, confirming the presence of silica. Comparative 
TGA with commercially produced silica suggested other inorganic components may be 
present in the extracted silica and XRF analysis highlighted in which elements differences 
exist. Nevertheless, all extracted silica supported purification and immobilisation of the 
fusion proteins, which indicates that these trace elements have limited effect on the 
binding interaction between the affinity peptide and the silica particles.  
Immobilisation was demonstrated to be largely on the surface of the particles for both 
extracted silica and for silica gel with pore size of 60 Å in spite of an observed difference 
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porosity determined by N2 adsorption/desorption studies (non-porous / macroporous and 
mesoporous behaviour, respectively). Increasing the average pore size of commercial 
silica gel from 60 Å to 150 Å increased the immobilisation efficiency for an equivalent 
size class of particles, which is in line with the expected size of the fusion proteins. 
Despite an increased immobilisation efficiency, less activity was observed for the 150 Å 
pore silica gel. This suggests that the enzymes immobilised in the pore are not as 
accessible for the reaction with the analyte, and hence, primarily surface immobilisation 
is desirable. Compared to commercially available silica distributions, silica extracted 
from sand was shown to have higher enzyme loading capacity per mass of silica. 
Therefore, silica extract not only supports R5 mediated binding, but is preferred over 
commercial silica gels when high surface loading is desired.   
Silica particles not only make the process of separation and purification simple, but they 
also function as a versatile protein-silica preparation for many classical assay formats, 
like microfluidics, as well as more innovative designs, like the novel falling particle 
biosensor presented here. The sedimentation pattern of the particles in a falling particle 
approach was studied using PIV, which showed that a chamber shape with a narrow waist 
gave the best control of particle trajectory, creating reproducible settling position 
irrespective of inversion technique. Comparative analysis of expected kinetic and mass 
transport rates suggested that the rate of product formation by the falling particles was 
considerably under kinetic control for the fusion proteins. The product formation 
predicted by modelling for the immobilised R5-mCh-Enzymes matched well with 
experimental trends for a range of silica size distributions, supporting the conclusion that 
enzyme kinetics are dominating the rate of product formation in this system. 
Under such reaction conditions, the increased enzyme loading capacity per mass of silica 
for the extracted silica corresponded to the fastest rate of signal development in the falling 
particle device. In combination with its settling ability for purification purposes earlier in 
the production process, and its potential to be produced on site from local materials, silica 
extracted from sand could support the in-country production of a POCT.  
The performance of the falling particle design was compared against two other formats 
commonly employed with bio-functionalised particles: (A) simple suspension in a 
microcentrifuge tube and (B) a packed bed in a microfluidic channel. The falling particle 
device outperformed both formats under the conditions studied (~ 150 % and ~ 325 % 
signal increase, respectively), likely by achieving good dispersion and thus, more 
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accessible enzyme in this kinetically controlled system. Proof-of-concept was shown for 
the detection of H2O2 with HRP-mCh-R5-(6H)-silica and for sarcosine with silica-R52-
mCh-mSOx-R5-6H across a range of concentrations in the falling particle device. The 
latter showcased acceptable detection in the clinically useful range in urine for prostate 
cancer [157,275]. However, further improvements in the activity of R5-mCh-Enz fusion 
proteins with HRP would be necessary for a silica-based reagent system that is capable 
of the sensitivity required for prostate cancer detection. 
Nevertheless, this research has demonstrated a proof-of-concept for a “gene to 
diagnostic” pathway, highlighting the use of silica as a protein carrier and presenting a 
novel biosensor format for utilizing particle-bound enzymes. It is the hope that this 
research provides a first step towards reducing the hurdles to local production of 
biosensors in LMICs.  
 Suggested future work 
In light of the findings from this research, a few key areas were identified in which further 
work would be required to progress towards a locally-produced POCT – (1) stability of 
the reagent, including greater retention of activity during the drying process, (2) further 
development of assay formats with silica-immobilised reagents to optimise signal output, 
and (3) development of a handheld imaging system for interpretation of the fluorescence 
results. This section will describe some promising avenues for the next stages of research 
into these areas.  
5.2.1 Stability of the reagent 
This work explored the use of immobilised reagents stored in a dry form. Once dried, 
silica-immobilised R52-mCh-mSOx-R5-6H was shown to largely retain its activity when 
stored at room temperature for over two months. This stability without refrigeration 
would be an advantage for the use of these reagents in remote areas as refrigeration is 
often lacking [26] and the expense of cold-chain distribution can account for large portion 
of the cost [40]. However, there was a significant loss of activity during drying, which 
indicates the need for further improvements in this step of the process.  
Lyophilisation, or freeze-drying, is one of the oldest methods for post-treatment of an 
immobilised enzyme aimed at improving their storage stability [281]. This process 
involves quickly freezing the product and placing it under extremely low pressure to 
Chapter 5: Concluding Remarks 
   169 
induce sublimation of water content from the material. However, the cost of the 
specialised equipment to perform lyophilisation can be substantial, and may be 
prohibitive towards a local production process.  
Enzyme stability during dehydration can also be improved by the addition of sugars 
[203,282]. Sugars are common additives during the lyophilisation process [281] but they 
can also protect enzymes even when dried under ambient or even higher temperatures 
(e.g. 37 ⁰C [283]). They are hypothesized to protect proteins by (i) preventing molecular 
mobility (vitrification hypothesis) and/or (ii) preventing changes in protein structure by 
replacing hydrogen bonds between the protein and water (water replacement hypothesis). 
Ideal sugars are thought to be relatively small with a relatively high glass transition 
temperature [282], e.g. trehalose [283] and sucrose. Interestingly, sarcosine was shown 
to increase the thermal stability of enzymes co-precipitated with the R5 peptide [136], 
however, this strategy would clearly not be suitable for a SOx-based biosensor. Future 
work should look to compare the stabilising capacity of different sugars during drying of 
silica-immobilised R5-mCh-Enz proteins, varying the protein-sugar ratio and the drying 
regime to find the optimum conditions. 
5.2.2 Optimisation of assay formats with functionalised particles  
Although the falling particle design explored in this work enabled signal production at a 
faster rate than either the packed bed or simple suspension approach, the design parameter 
space for this approach has yet to be fully explored. Design changes could include varying 
the particle volume fraction as well as optimisation of the aspect ratio, including not only 
height and width of the chamber but also depth (transitioning from a largely 2D design to 
3D space). On the condition that further modelling and simulation confirms that particle 
dispersion is the advantage of the falling particle approach, designs should be considered 
that increase the time particles spend in suspension. Figure 5.1 provides a diagram of 
some of the design options discussed below.  
Adding mechanical mixing or flow-driven dispersion (akin to stirred tank and fluidised 
bed reactors in classical reactor design [227,284–286]) would add cost and complexity, 
making such approaches impractical for the design of a disposable device. Instead, as 
mentioned in Chapter 3, magnetisation could be considered to induce particle movement 
via an external component (Figure 5.1A). This could be accomplished either by inclusion 
of additional magnetic particles in the system or by incorporating the magnetic 
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component into the bio-functionalised particles (e.g. silica shell particles with magnetic 
cores [261] for use with the R5 peptide or a change of peptide sequence to one with 
affinity for bare magnetic nanoparticles [287–290]). If incorporated as part of the affinity 
matrix for the biological reagent, the magnetic nature could be also utilized in 
purification. However, the addition of magnetic particles would add cost and complexity 
to the production process. 
Alternatively, a system of neutrally buoyant particles could be considered where 
dispersion would be maintained without requiring intervention beyond the initial shaking 
to distribute the particles throughout the fluid (Figure 5.1B). This could be achieved by 
increasing fluid density to match that of silica or more likely (because the fluid is 
determined by the nature of the sample), decreasing particle density by changing material. 
For instance, the polystyrene or polyethylene microspheres typically used in PIV analysis 
of flows (with densities near to 1 g/cm3) could be coated with a silica shell before 
functionalisation with R5-mCh-Enz. Although neutrally buoyant particles would be 
advantageous for dispersion, they would have limited utility during the earlier purification 
stage. Moreover, the additional synthesis steps required for coupling R5-tagged proteins 
with such particles would again add cost and complexity to the production process.  
Without transitioning from silica particles, chamber shapes can be considered that 
contribute to increased dispersion time. For instance, a helical channel creates an 
extended settling length without drastically increasing the overall length of the device 
(Figure 5.1C); however, this geometry is known to lead to the size segregation of particles 
through the simultaneous application of gravitational and centripetal forces on the 
particles [291]. In addition, the particles in a helical design would require a steep helix 
angle to avoid collecting the smallest particles on the inclined surface. Alternatively, a 
rotating drum or torus could be used to provide continuous movement of the particles 
relative to the fluid, achieving dispersion over time rather than space (Figure 5.1D). The 
rotational speed could be tuned to ensure the particles become suspended without being 
stuck to the outer wall by the centrifugal force. Similar to the optimisation of rotational 
speed for a drum or torus, the time between inversions of the falling particle device could 
be adjusted to achieve maximum dispersion and, correspondingly, signal output (Figure 
5.1E). Decreasing the time between inversions should increase overall time of dispersion 
and preliminary results have shown an increase in signal. Nevertheless, this requires 
further experimentation to tune the timing of inversions with relation to particle size.  
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Figure 5.1 Potential approaches to achieving dispersion of particle-bound enzymes. (A) Particle 
movement driven by an external magnet, showing options of magnetic-core silica-shell particles for 
use with the R5 peptide or bare magnetic particles for use with a magnetic binding protein (MBP) 
incorporated with a fluorescent protein and the functional enzyme. (B) A suspension of neutrally 
buoyant particles in a chamber device. (C) A helix design for increased duration of particle 
sedimentation. (D) Rotating drum or torus. (E) Optimising the time between inversions of the 
falling particle chamber. 
With a falling particle approach, the dispersion of the particles is also dependent on the 
size distribution of the particles. A narrower size distribution would achieve a more 
uniform settling time (excluding any initial particle plumes), which would reduce the time 
spent by particles in the inefficient settled bed at the base of the device. Despite its broad 
size distribution, the performance of the silica extracted from sand with respect to enzyme 
loading capacity and ultimately signal development was clearly superior to the 
commercial silica gel. Nonetheless, size selection could be used to further optimise its 
behaviour in the falling particle device. Particles should be small to maximise the 
enzymatic activity per unit mass and to achieve long settling times without lengthy reactor 
chambers, but not so small that the sediment laden portion of the fluid becomes a pseudo-
immiscible fluid with the rest of the sample (as in the case of the silica nanoparticles). 
However, the time and cost of achieving a narrower distribution from the locally produced 
silica will need to be balanced against the benefit in assay performance.  
Although the falling particle approach was the clear frontrunner in the comparison 
conducted in this thesis, there are applications for which the packed particle bed is better 
suited (e.g. in the presence of product inhibition or in assay protocols with multiple wash 
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steps). The packed bed format would also likely be improved by narrowing the size 
distribution of the particles, as this is known to reduce the risk of channelling behaviour 
[136]. Upgrading from simple drop-casting to more advanced particle loading techniques, 
such as flowing the particle slurry into a channel fitted with a filter plug, could also be 
used to improve the structure of the packed bed and thus, improve signal development 
with this format. 
Regardless of assay format, the final design will ultimately need to take manufacturability 
into consideration so that the device can be efficiently produced at the scale and price 
required to meet the demands of a healthcare system. 
5.2.3 Development of handheld imaging  
Signal processing of the biological reaction to the target analyte is a key element in any 
biosensor and an additional functionality required for the falling particle system to move 
towards POCT applications. While the custom-built fluorescence scanner used in this 
work provided spatial information about signal development patterns, supporting analysis 
of reaction kinetics, ultimately, a smaller, handheld instrument would be desirable for a 
POCT.  
Mobile phones are an attractive platform for signal analysis given the high mobile phone 
penetration (including an increasing adoption of smartphones) and rapidly growing 
telecommunications infrastructure in emerging markets [42,249,292,293]. Multiple 
reports have testified that mobile phones hold the power to not only transform diagnostic 
technologies for low resource settings but to more broadly strengthen healthcare systems, 
with mHealth platforms covering range of applications in clinical medicine [294–296]. 
Smartphones, in particular, contain all the necessary components for a portable diagnostic 
reader (e.g. screen for display and control, image collection (camera), data processing and 
data communication). It should be noted that the audio jack in mobile phones can also be 
harnessed for both bi-directional signal (data transfer) and power, supporting external 
peripherals such as LEDs, photodiodes and other sensors [297–299]. With regards to 
image capture, phone cameras typically contain CMOS (complementary metal-oxide 
semiconductor) sensors, capable of taking high-quality images/videos [300]. The 
circuitry behind each pixel of the CMOS sensor converts photon counts to Red (R), Green 
(G), and Blue (B) channel values, which can then be described in a variety of colour 
spaces for analysis [249,301]. Thus, it is advantageous to select an appropriate indicator 
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dye based on spectral properties that align well with the RGB sensitivities of common 
cell phone camera sensors [302,303].  
Smartphones can be harnessed to not only perform automatic interpretation of the results, 
but also to support the administration of POCTs through in context assistance to users 
[293], to integrate with medical record systems that are currently in use in developing 
countries and to enable data collection for public health monitoring. They have been used 
for the analysis of commercially available rapid diagnostic tests (lateral flow assays, 
e.g.[293,304]), as well as custom built microfluidic chips (e.g. [298,302]) and paper-
based analytical devices (e.g.[31,305] ) .  
While they are a potentially powerful platform, camera phones typically have integrated 
colour balancing functions optimised for photography in ambient light. These make the 
collected images more pleasing to the eye, but skew measurements and make 
standardisation challenging [301,302]. Several groups have addressed the variability of 
ambient lighting conditions and other challenges associated with using smartphone 
cameras for detection (e.g. user positioning, shadows, focal distance [305]) with phone 
holders and adapters. These are often 3D-printed forms and typically include additional 
components to aid in image capture such as lenses, plastic colour bandpass filters, LEDs, 
and/or batteries (e.g. [304,306,307]). Although these solutions are successful in 
alleviating ambient light challenges, this approach requires additional, often phone-
specific components, which would face some of the same challenges as dedicated readers 
(e.g. maintenance/repair). Other have addressed this challenge through calibration with 
reference images (test assays/colour cards) [308,309], but again this requires additional 
components unless these reference points can be built in to the test. An attractive 
alternative is to get behind the image processing algorithms and extract the raw sensory 
data from the scanner, an approach advocated for by several publications [303,306,310]. 
However, this approach may be challenging with fully integrated smartphone cameras 
without support from the manufacturer of the sensor and/or smartphone. Ultimately, 
surmounting these technical hurdles towards the use of smartphone for POCT analysis 
will need to be balanced against the cost of developing specialised handheld reader 
alternatives. 
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 Outlook and opportunities 
The research presented in this thesis provides an initial validation of a production process, 
including the downstream integration into an assay format that could enable in-country 
manufacture of affordable POCTs by combining molecular biology and a low-cost 
support material for simultaneous purification and immobilisation. This section will 
discuss a potential application for the silica-based reagents developed in this work as well 
as future opportunities for the expansion of this approach with other materials and other 
IVD assays. As mentioned in Chapter 2, the coupled enzyme system (SOx and HRP) 
explored here as a first model has potential application in prostate cancer diagnosis 
(Section 5.3.1). While this work focused on silica, other materials with known affinity 
tags could be investigated in the future for their potential as a low-cost support material 
(Section 5.3.1). Finally, the local production approach could be also be applied to other 
IVD assays (Section 5.3.3).  
5.3.1 Towards a diagnostic for prostate cancer 
Prostate cancer is one of the leading causes of cancer death among men globally [12,13]. 
Although elevated levels of prostate specific antigen (PSA) are now widely used in 
connection with prostate cancer screening, PSA was originally intended only as a marker 
of disease progression in already diagnosed patients. Its wider use and resulting ambiguity 
in the result (including false-positives and overdiagnosis of clinically insignificant 
cancers [311]) is now driving the search for better biomarkers and subsequently IVDs 
[312,313]. Molecular biomarkers (metabolite, gene and protein based) are being 
identified that collectively may lead to better diagnostics and treatment management 
[314], one of which is sarcosine [183].    
Significantly elevated levels of sarcosine in urine of prostate cancer patients have been 
recorded in some studies [183,263]. While the possible role of sarcosine as a biomarker 
for prostate cancer is still debated [158], some of the discrepancy in reports may be due 
to the variation in assay methods, as discussed with respect to the original conflicting 
studies that both measured sarcosine levels using mass spectrometry (MS) techniques 
[170,183,198,315]. One of the challenges in detecting sarcosine via MS is differentiating 
it from its isomer, alanine, which is present in urine at 1000 fold higher levels [170]. 
Several methods have been developed to separate the two isomers that may make MS 
approaches still viable [316,317], however, the MS technique requires considerable skill 
and specialized equipment not amenable to POCTs, especially in LMICs. 
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Currently available laboratory test kits for sarcosine primarily use an oxidase-linked 
chromogenic assay (akin to the system presented in this thesis) [265]. Unlike MS 
techniques, enzymatic assays show excellent selectivity for sarcosine. Nevertheless, 
although these kits are suitable for use in plasma and serum, interference in measurements 
made in urine is typically reported, producing erroneous results. It is well known that 
some substances in urine such as glucose, ascorbic acid, bilirubin, as well as uric acid 
often affect enzymatic methods that utilize peroxidase [152]. 
Some attention has been given to overcoming this interference, with strategies including 
the use of nanoparticles with pseudo-peroxidase activity instead of HRP [157,318] and 
the detection the other co-product (formaldehyde) via a pH change associated with its 
conversion to formic acid [153]. However, these methods required significant laboratory 
processing steps that would make the design of a near patient diagnostic with these 
approaches complex and thus, the interference of the measurement of sarcosine in urine 
remains a challenge for a POCT.  
Alternatively, a simple system using silica-based reagents has shown potential to 
overcome the interference in urine in work performed with collaborators at the University 
of Valencia [181].  This study used the silica-immobilised enzyme construct R52-mCh-
SOx-R5-6H in conjunction with WT HRP immobilised via glutaraldehyde crosslinking 
and AR dye encapsulated using a sol-gel technique as a layer on the surface of silica 
particles. In contrast to the commercial kit using soluble reagents, the silica-based 
reagents were shown to be less affected by the interferents in human urine and provided 
greater sensitivity in the concentration range relevant to prostate cancer detection (0-
10 µM) [157,158]. In a preliminary study, the system was able to differentiate between 
urine from healthy and from prostate cancer patients. While this approach was successful 
in overcoming interference in urine, to move away from classical cross-linking methods 
(i.e. glutaraldehyde) and towards the local production approach presented in this thesis, 
significant improvements in the activity of R5-mCh-Enz constructs with HRP would be 
required (as discussed in Chapters 3 and 4). In addition, it would be necessary show that 
they also are not affected by urine interferents. Alternatively, it could be advantageous to 
move from a chromogenic agent to an electrochemical approach that doesn’t rely on HRP 
(as discussed briefly in Chapter 2).  
Electrochemical biosensors are one of the most common biosensor techniques, including 
the very successful glucose biosensor (~ 50 % of the biosensor market [319]). Typically, 
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the redox enzyme is immobilised on the surface of the working electrode and the product 
monitored amperometrically. With an electrochemical approach, it is generally 
advantageous to have peptide affinity tags that bind directly to inorganic surfaces to 
minimize the distance between the active site of the enzyme and the electrode surface 
[56]. To enable binding with the R5 peptide fusions presented in this thesis, the electrode 
surface could be modified with silicalite [320], a microporous material which has silanol 
groups [321] that could interact with positive residues of the affinity tag. Alternatively, 
the presence of the R5 peptide could be used to drive silica sol gel encapsulation on the 
electrode surface, as previously shown for the fusion construct mSOx-R5-6H [159].  
While these strategies enable immobilisation of the R5-tagged fusions on the electrode 
surface, the addition of the silica layer would likely impede diffusion of the mediator and 
could have a deleterious effect on sensitivity by increasing background noise. Thus, it 
may be beneficial to switch the R5-tag for another polypeptide tag with affinity for 
common electrode materials. Polypeptide sequences exist for a variety of common 
electrode materials (Ag, Au, Pt, etc.) [56]; however, this switch of affinity peptide would 
require corresponding changes in the purification matrix which may be unfavourable for 
a local production approach. Alternatively, silica particles pre-immobilised with enzyme 
could be deposited around the working electrode. While this could reduce the speed of 
the response by increasing the distance the mediator has to travel, it could be more 
amenable to direct integration with the one-step purification and immobilisation process 
presented in this thesis.  
In summary, new detection strategies are required that can accurately detect the presence 
of sarcosine among the interferents in urine in order to, in the first instance, establish if 
sarcosine is a valid marker for prostate cancer, and second, if this is the case, to provide 
a POCT for its measurement. An electrochemical approach with R52-mCh-mSOx-R5-6H 
could be one potential option for this POCT. 
5.3.2 Alternate low-cost, local materials as the support matrix 
Since the R5-tag promotes affinity for negatively charged surfaces, it can likely be used 
with other materials having anionic surfaces. For example, R5-tagged proteins have 
previously shown affinity for microbubbles synthesised with natural polymer surface 
coatings (alginate and lignosulfonate) [141]. Another SBP, Car9, was originally identified 
for its affinity for carbonaceous substrates [71,127]. Given the interaction is thought to 
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be mediated by similar electrostatic forces to those involved in R5 affinity for silica, R5 
may also have affinity for this class of materials.  
As mentioned above, other affinity peptides have also been identified for a wide range of 
substrates [56] including materials like cellulose and lignin, indicating that this approach 
has broad applicability to abundant, naturally occurring materials. Cellulose-binding 
modules (CBMs) are particularly attractive given the wealth of research developing 
advanced paper-based diagnostic tests for resource-limited settings. Paper is proposed to 
be a good fit with A.S.S.U.R.E.D. principles for the development of POCTs, with cited 
advantages including passive transport of fluids through wicking behaviour, compatibility 
with biological samples, disposal by incineration, and scalable for manufacture (as 
described in recent reviews [31,322–324]).  
CBM-tagged proteins can be easily integrated into microfluidic paper-based analytical 
devices (e.g. [325]). In addition, a number of publications have demonstrated affinity 
purification with CBMs for a variety of expression hosts using both microcrystalline and 
amorphous cellulose and filter paper [58,326–330]. Pardee et al. have  estimated using 
regenerated amorphous cellulose could result in a cost reduction of five orders of 
magnitude compared to Ni-NTA resin [40]. CBMs typically contain 
aromatic/hydrophobic and polar amino acids and their binding to cellulose can be 
attributed, at least in part, to their hydrophobic surface [329]. It should be noted that 
addition of these hydrophobic regions can decrease fusion protein solubility and in some 
cases, lead to formation of inclusion bodies. Interestingly, Nahalka and Nidetzky 
proposed an approach for biocatalyst formation that capitalised on the inter-molecular 
aggregation of CBMs due to their hydrophobic nature. Insoluble enzyme aggregates were 
produced without prior isolation of the protein and retained 40 % activity of the highly 
purified form [331]. Despite their tendency towards insolubility, CBMs still offer a 
promising alternative option to SBPs for affinity driven immobilisation on low-cost and 
locally available materials.  
5.3.3 Application of the local production approach to other diagnostic 
targets 
Depending on the choice of functional enzyme, the silica-R5-protein constructs can be 
adapted for other types of IVD assays (e.g. small molecule, nucleic acid, immunoassay), 
all of which have utility at different points in the patient care pathway. For example, 
immunoassays and nucleic acids are particularly relevant to the detection of infectious 
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diseases which are leading causes of mortality and morbidity in LMICs [8,332]. Most 
rapid diagnostic tests typically used in resource-limited settings are based on lateral flow 
immunoassay technology [293,333,334]. Immunoassays employ antibodies and/or 
antigens as the biological reagents, but the recombinant production of antibodies is made 
challenging by their large size, structural complexity, disulphide bonds, and post-
translational modification requirements [40]. Nevertheless, directed evolution and other 
engineering techniques have created designer binding proteins, which maintain the high 
affinity and specificity of the antibody-antigen interaction but are smaller in size and have 
been successfully produced in E. coli hosts [40,335]. These antibody mimetics or single 
chain antibodies could be designed for the analyte of choice and fused with silica-R5-
protein constructs for detection. Irrespective of antibody mimetic selected, the sequential 
wash steps required by immunoassay protocols would likely make the packed bed assay 
format preferable to the batch-reactor approach of the falling particle design.  
Nucleic acid amplification (NAA) is an alternate diagnostic method to immunoassay 
which detects the molecular signature of the pathogen, i.e. DNA/RNA. This approach 
potentially offers greater sensitivity, especially in the early stages of a disease when the 
body’s immune system is just beginning to respond to the presence of the pathogen 
antibody concentrations are low [336]. The laboratory standard for NAA is polymerase 
chain reaction (PCR), which requires thermocycling patterns for denaturation of the 
double-stranded target, annealing of the primers to the target sequence and extension by 
the polymerase (95 °C, 50 °C, 72 °C, respectively). R5 fusion proteins have been 
developed with a variant of the Taq polymerase (Klentaq [337], in collaboration with 
Dr. David Bailey), but, due to PCRs high temperature step, these constructs required a 
change in the fluorescent protein to a thermostable variant (thermal green protein [338]). 
Nonetheless, initial tests have shown both good immobilisation from lysate and 
successful amplification of template sequences with silica-immobilised fusion 
polymerase (Appendix E). However, these fusion constructs require further optimisation 
as they lost all their activity upon drying.  
Recently, isothermal NAA techniques (e.g. loop isothermal amplification, LAMP 
[339,340]) have risen in popularity, especially for use in resource-limited settings, as they 
eliminate the need for complex thermocyclers. A R5-mCh-Enz fusion containing the 
polymerase for the LAMP approach (Bst) has also been developed (by Dushanth 
Seevratnam) and preliminary tests have shown amplification by the silica-based reagent 
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in the falling particle device (done in collaboration, see Appendix E). The 50 µL chamber 
design was used for this proof-of-concept but further work will be required to move 
towards a design that could support the small-scale reaction volumes typically used for 
LAMP (12.5 - 25 µL). In the optimisation of this design, it will be necessary to consider 
the reaction kinetics of this assay and what mass transport limitations exist, if any. The 
diffusivity of DNA will be dependent on its size [341], but it is generally expected to be 
slower than the small molecules discussed in this work (sarcosine and peroxide). This 
could mean the system is more likely to be under diffusion control, however, this will 
depend on the kinetic activity of the fusion Bst (measured by rate of nucleotide 
incorporation [342]). It will also be necessary to consider the potential electrostatic 
repulsion effects, given the negative charge at the silica surface [103] and the negative 
charge of DNA, and the influence this would have on diffusion to the particle surface. 
The modelling approach presented in Chapter 3 could be adapted to incorporate these 
parameters and determine the rate limiting step for the LAMP assay with the fusion 
construct on silica particles.  
While still in the initial stages of development and optimisation, these fusions 
demonstrate the potential of the local production approach for a range of biological 
reagents which would be applicable to the development of a diverse set of diagnostic 
tools. It is the hope that this approach can not only increase access to quality diagnostics 
in LMICs but also provide a more self-sustaining healthcare system and support the 
development of the local economy.   
 
 
Biosensor design utilizing particle-bound enzymes 




   181 
 
APPENDICES 
A. Experimental details regarding recombinant protein design 
B. Details of video submissions  
C. MATLAB code for particle settling analysis 
D. Technical specifications for the FFEI fluorescence flatbed scanner  
E. Experimental details and preliminary results for nucleic acid amplification assays with 
silica-based reagents 
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APPENDIX A: EXPERIMENTAL DETAILS REGARDING 
RECOMBINANT PROTEIN DESIGN 
A.1 mCh-6H, R5-mCh-6H, R53-mCh-6H, R52-mCh-mSOx-R5-
6H 
E. coli glycerol stock with mCh-6H, R5-mCh-6H, R53-mCh-6H constructs in pET24a 
expression vector were prepared previously in-house as described in [141]. The pET24a 
vector encoding mSOx-R5-6H (prepared as described in [159]) was used as a template 
for R52-mCherry-mSOx-R5-6H fusion protein construction by Elizabeth Pumford. The 
vector was subjected to site directed mutagenesis aimed to add two restriction sites of 
NdeI and BamHI for insertion of the mSOx-R5 gene, while the stop codon was placed at 
the end of the sequence. Chemically competent NovaBlue Singles E. coli cells (endA1 
hsdR17 (rK12– mK12+) supE44 thi-1 recA1 gyrA96 relA1 lacF’[proA+B+lacI
qZΔ 
M15::Tn10] (TetR)) were used for transformation and plasmid propagation and were 
cultured in LB medium supplemented with 5 μg/ml kanamycin at 37 °C.  
PCR was performed using Q5 Hot Start High-Fidelity Polymerase following the 
manufacturer’s instructions (New England Biolabs, UK) using a thermocycler 
(Mastercycler, Eppendorf). PCR product was purified by using QIAquick DNA 
purification kit and stored at -20 °C. Primers were designed by using ApE plasmid editor 
and purchased from the Sigma Aldrich Custom DNA Oligo Service. The primers were 
re-suspended in water (100 μM stock solution) and stored at -20 °C. Transformed E. coli 
colonies were screened by colony PCR using Q5 Hot Start High-Fidelity Polymerase. 
Transformation was completed using a standard heat shock method. Plasmid DNA was 
purified from transformant E. coli using the QIAprep Spin miniprep kit and stored at -
20 °C for further use. Validation of plasmid DNA was confirmed by DNA sequencing 
services (Department of Biochemistry, University of Cambridge). DNA size was checked 
by agarose gel electrophoresis, 1 % (w/v). 
A.2 HRP-mCh-R5-6H and 6H-R5-mCh-HRP 
The HRP sequences (isoenzyme C1a, RCSB Protein Data Bank 1ATJ) were ordered from 
GeneArtTM Gene Synthesis. The genes were cloned into pAK plasmid. The constructs 
were assembled in NEB Turbo cells using the Klenow Assembly Method. PCR, 
transformation and DNA sequencing were completed as aforementioned. 
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APPENDIX B: DETAILS OF VIDEO SUBMISSIONS  
Sample videos have been provided on a USB drive to provide additional context for the 
results and discussion in Chapter 3. Table B.1 provides a list of the videos along with 
experimental details.  
Table B.1 Experimental details for videos of particle sedimentation patterns. 
File name Silica Shape Rotation 
SCextract_narrow_flip SC extract narrow waist flip 
SCextract_narrow_flip_long SC extract narrow waist flip 
SCextract_narrow_tilt SC extract narrow waist tilt 
SCextract_parallel_flip SC extract parallel sided flip 
SCextract_parallel_tilt SC extract parallel sided tilt 
SCextract_standard_flip SC extract standard waist flip 
SCextract_standard_tilt SC extract standard waist tilt 
Si60_6-35_narrow_flip Si60 6-35 µm narrow waist flip 
Si60_40-63_narrow_flip Si60 40-63 µm narrow waist flip 
Si60_63-210_narrow_flip Si60 63-210 µm narrow waist flip 
Si60_200-500_narrow_flip Si60 200-500 µm narrow waist flip 
Si60_less63_narrow_flip Si60 <63 µm narrow waist flip 
SiNPs_narrow_flip_1 Nanoparticles narrow waist flip 
SiNPs_narrow_flip_2 Nanoparticles narrow waist flip 
SiNPs+LGparticles_narrow_flip Nanoparticles with 200-500 µm narrow waist flip 
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APPENDIX C: MATLAB CODE FOR PARTICLE SETTLING 
ANALYSIS  
The supplementary code used in addition to PIVlab [242] for analysis of particle settling 
behaviour using MATLAB is provided below.  
C.1 Function for image conversion to inverse grayscale  
Description of key functions: 
 rgb2gray converts RGB values to grayscale values (I) by forming a weighted sum 
of the R, G, and B components using Eq. (C.1). 
 𝑰 =  𝟎. 𝟐𝟗𝟖𝟗 × 𝐑 +  𝟎. 𝟓𝟖𝟕𝟎 × 𝐆 +  𝟎. 𝟏𝟏𝟒𝟎 × 𝐁 (C.1) 
 Imcomplement computes the complement of the image, where each pixel value is 
subtracted from the maximum pixel value supported by the class (e.g. 255). The 
difference is used as the pixel value in the output image. In the output image, dark 
areas become lighter and light areas become darker.  
 
The following script was used with the imageBatchProcessor application in MATLAB. 
function results = myimfcn(im) 
% IM      - Input image. 
% RESULTS - A scalar structure with the processing 
results. 
if(size(im,3)==3) 
    % Convert RGB to grayscale 
    imgray = rgb2gray(im); 
else 
    imgray = im; 
end 
reverseIM=imcomplement(imgray); 
results.reverse = reverseIM; 
C.2 Function for extraction of maximum velocity from PIV 
analysis frames 
The following script was used to extract maximum velocity values and position on the x-
axis from .csv output files for each frame (image pair) from PIV analysis.  
%% Max velocity over all frames in PIV 
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sz=1234 %number of last files to extract from 
 
%% Loop containing import and output for each frame 
for i=3:sz 
    
pathf=strcat(allfiles(i).folder,"\",allfiles(i).name); 
%recombine filename and path 
    [maxvel(i), maxposn(i)] = 
importoutputmaxvelposn(pathf, 2, 2000); %call function 
to return maximum velocity and position along the line 
at which that occurs 
    clear pathf 
    splitname=strsplit(allfiles(i).name,["_",".txt"]) 
%split up the filename to find the number of the frame 
    frame(i)=str2num(cell2mat(splitname(4))) %convert 
the frame number from text to a number  
end 
  
scatter(frame,maxvel)%plot frame vs maxvel to check 
splitname=strsplit(allfiles(5).folder,["\"])%split 







where importoutputmaxvelposn is described by: 
 
function [maxvel, maxposn] = 
importoutputmaxvelposn(filename, startRow, endRow) 
 
%% Initialize variables. 
delimiter = ','; 
if nargin<=2 
    startRow = 2; 
    endRow = inf; 
end 
  
%% Format for each line of text: 
%   column1: double (%f) 
%   column2: double (%f) 
% For more information, see the TEXTSCAN 
documentation. 
formatSpec = '%f%f%[^\n\r]'; 
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%% Open the text file. 
fileID = fopen(filename,'r'); 
  
%% Read columns of data according to the format. 
dataArray = textscan(fileID, formatSpec, endRow(1)-
startRow(1)+1, 'Delimiter', delimiter, 'TextType', 
'string', 'EmptyValue', NaN, 'HeaderLines', 
startRow(1)-1, 'ReturnOnError', false, 'EndOfLine', 
'\r\n'); 
for block=2:length(startRow) 
    frewind(fileID); 
    dataArrayBlock = textscan(fileID, formatSpec, 
endRow(block)-startRow(block)+1, 'Delimiter', 
delimiter, 'TextType', 'string', 'EmptyValue', NaN, 
'HeaderLines', startRow(block)-1, 'ReturnOnError', 
false, 'EndOfLine', '\r\n'); 
    for col=1:length(dataArray) 
        dataArray{col} = 
[dataArray{col};dataArrayBlock{col}]; 
    end 
end 
  
%% Close the text file. 
fclose(fileID); 
  
%% Allocate imported array to column variable names 
Distanceonlinem = dataArray{:, 1}; 
Velocitymagnitudems = dataArray{:, 2}; 
  
%% Find maximum velocity and output with position 
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APPENDIX D: TECHNICAL SPECIFICATIONS FOR THE FFEI 
FLUORESCENCE FLATBED SCANNER 
The custom fluorescence scanner was developed by FFEI as part of EU funded 
BiognostiX project. Figure D.1 shows the LED emission spectra and CCD spectral 
response from the user manual provided by FFEI. Illumination by LEDs was double-sided 
47.5 degrees from the horizontal plane with a shortpass filter (cut-off 505 nm). The CCD 
detector is positioned parallel to the horizontal sample tray (See Figure 3.5) with a 
longpass filter (cut-off of 580 nm).  
 
Figure D.1 Technical specifications for the custom scanner as specified in the user manual provided 
by FFEI, showing (A) LED emission spectra (Cyan) and (B) CCD spectral response. 
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APPENDIX E: EXPERIMENTAL DETAILS AND PRELIMINARY 
RESULTS FOR NUCLEIC ACID AMPLIFICATION ASSAYS WITH 
SILICA-BASED REAGENTS 
This section contains the experimental methods and preliminary results for nucleic acid 
amplification (NAA) assays using silica-based reagents, as mentioned in Chapter 5. Two 
approaches are under development: loop-isothermal amplification (LAMP) and more 
traditional polymerase chain reaction (PCR). Fusion proteins were designed, transformed 
and expressed by Dushanth Seevaratnam (R5-mCh-Bst-6H) and Dr. David Bailey (R55-
TGP-10H-Klentaq) with the appropriate polymerase for LAMP and PCR, respectively. 
In the case of the Klentaq variant, mCh is replaced by thermal green protein (TGP) [338] 
as mCh was observed to denature under the high temperature step of PCR. Sequences for 
these proteins are provided in Section E.3 and Section E.4. Immobilisation onto silica was 
completed following the protocol outlined in Chapter 2, with Ni-purified protein and 
silica gel 60 <63 µm for R5-mCh-Bst-6H and direct from lysate with silica extracted from 
sand for R55-TGP-10H-Klentaq. Experimental details for amplification assays and results 
are described below.  
E.1 Loop-mediated isothermal amplification (LAMP) 
The LAMP tests were performed in PCR tubes using 25 µL reaction volume or in mini-
chambers using 50 µL reaction volumes in collaboration with Dushanth Seevaratnam. 
The primers were designed by Dr. Hui Yee Chee (Universiti Putra Malaysia) against the 
secY gene of Leptospira interrogans (bacterial pathogen causing leptospirosis [343]) . 
Each reaction mixture contained 40 pmol of FIP and BIP, 20 pmol of LF and LB, 5 pmol 
of F3 and B3 primers (sequences in Table E.1), 1.4 mM deoxyribonucleotide triphosphate 
(dNTP), 100 mmol MgSO4, 0.2X Isothermal Amplification Buffer II (New England 
Biolabs), 1 mM MnCl2, 0.964 ng/µL of template DNA, and 0.4 µg/µL silica-R5-mCh-
Bst-6H DNA Polymerase (~ 0.1 mg R5-mCh-Bst-6H per 1 mg silica).  
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Table E.1 Primer sequences for LAMP assay 








Falling particle chambers were laser cut from PMMA using the 50 µL mini-chamber 
design described in Chapter 4 for an endpoint assay (Figure 4.10) and sealed with thin-
film plastic coated with a pressure sensitive adhesive (AR90349, Adhesive Research 
Inc.). Control studies where strips of plastic were added to PCR tube reactions showed 
AR90349 resulted in minimal inhibition, unlike the PCR plate seal used in the rest of this 
thesis. The solution was incubated in the chambers on Peltier (19.6 W, Farnell) at a 
constant 65 °C for 90 min. The Peltier temperature was controlled by a proportional-
integral-derivative function on a microprocessor (Arduino) with temperature input from 
a thermistor (10 kΩ, B57551G1 Series, EPCOS) and voltage output by DC voltage 
generator (thandar, 30 V – 2 A) (See Figure E.1 for experimental set-up). Function 
constants were Kp = 5, Ki = 0.2, and Kd = 1 when temperature input was within +/- 2 °C 
from set-point; otherwise, Kp = 50, Ki=1, and Kd = 2. The Peltier control circuit was built 
in collaboration with Andrew Stretton and Sebastian Cosnefroy. The amplification 
products were stained and analysed with a 1 % w/v agarose gel containing ethidium 
bromide; Figure E.1B shows successful amplification in the presence of the template 
(positive) and no amplification without the template (negative). In LAMP, amplification 
produces a heterogeneous distribution of polymers which are not distinguished as a single 
individual band for a positive signal [340]. 
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Figure E.1 (A) Experimental set-up for providing heat to LAMP reaction in the mini-chamber. (B) 
agarose gel image showing DNA amplification by soluble R5-mCh-Bst-6H (1 - positive, 
2 - negative), on silica (3 - positive, 4 - positive without MnCl2, 5 - negative) and on silica in the 
mini-chamber (6 - positive, 7 - negative), in the presence of the template (positive) and without the 
template (negative). 
E.2 Polymerase chain reaction (PCR) 
The PCR tests were performed in PCR tubes with 25 µL reaction volume using the fusion 
protein R55-10H-TGP-Klentaq. A 2X master mix was prepared with 50 µL ThermoPol 
buffer, 10 µL dNTPs (200 µM final concentration), 1 µL of each primer stock and 2 µL 
of 135 bp target to a total volume of 250 µL with H2O. For each reaction, 12.5 µL of 2X 
master mix was added to 12.5 µL H2O and 0.5-1.0 µL of lysate or protein immobilised 
on silica extract. Immobilised proteins were re-suspended in 150 µL of H2O per 5 mg of 
silica in order to compare activity with crude lysate (as 150 µL of lysate was added to 
5 mg of silica extract). PCR was performed using 2 min at 94 °C at the start, then 25 
cycles of 5 s at 94 °C, 5 s at 55 °C, 60 s at 74 °C, and finally 2 min at 74 °C as final 
extension. Amplification was assessed by gel electrophoresis in 1 % w/v agarose gel run 
for 20 min at 90 V.  
Figure E.2 shows the retention of both fluorescent and polymerase functionality by the 
fusion protein R55-TGP-10H-Klentaq. The fluorescence spectra of the construct showed 
no observable difference between the soluble and immobilised protein (Figure E.2C); 
both match well with literature reported peaks for green fluorescent proteins (ex. 480 nm 
/ em. 510 nm). Good immobilisation of the fusion protein was observed on silica extracted 
from SC sand (Figure E.2B). Based on a reported value of 8000 U/mg for commercial 
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Taq, R55-TGP-10H-Klentaq was estimated to be 120 times less active per mg protein than 
commercial (when used from crude lysate). Nonetheless, similar levels of amplification 
were observed for soluble and immobilised protein (Figure E.2D).  
 
Figure E.2 Characterisation of the R55-TGP-10H-Klentaq fusion protein. (A) Fluorescence 
microscopy of immobilised protein on silica extract (from lysate) and (C) emission (solid) and 
excitation (dots) spectra of the soluble (black) and immobilised (red) protein, showing no 
observable difference. (B) Efficiency of immobilisation as assessed by fluorescence intensity for 
target protein (navy) and Bradford assay for total protein (green). (D) Gel electrophoresis result of 
PCR products produced by the fusion polymerase, showing similar levels of amplification with the 
silica-bound protein as the soluble form. In both cases, lane 1 is a 2log ladder and lane 2 is the 
amplification product. 
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